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New methodology involving Pd-mediated catalysis that proposes PdII/IV 
mechanisms has exploded over the past decade. Despite the implication of PdIV 
intermediates prior to bond-forming C–X reductive elimination in these catalytic 
reactions, the reported organometallic PdIV complexes in the literature primarily 
underwent C–C bond-forming reductive elimination. The goal of this dissertation 
was to design systems to study C–X reductive elimination from observable PdIV 
complexes. In addition to reductive elimination reactions from PdIV, we sought to 
explore other organometallic reactions at PdIV centers such as C–H activation. 
This thesis presents the design and synthesis of novel PdIV complexes 
that undergo clean sp2- and sp3-carbon-heteroatom coupling as well as C–H 
activation at a discrete PdIV center. Furthermore, mechanistic aspects of these 
reactions are discussed in detail. 
Chapter 2 presents a detailed mechanistic study of C–O and C–C bond-
formation from isolable PdIV complexes. A variety of complexes were synthesized 
to explore how electronic factors, activation parameters, solvent effects and 
additive effects are involved in/influence C–O reductive elimination from a PdIV 
center. Additionally, we identified a system that yielded competing C–O and C–C 
reductive elimination from PdIV. Therefore, we conducted mechanistic studies to 
probe C–C bond formation from PdIV; we were able to propose a mechanism for 
this transformation as well.  
Chapter 3 investigates sp2 versus sp3-C–X bond formation from PdIV 
complexes. Interestingly, in all of the systems that were studied, sp3-C–X bond 
formation out competes sp2 reductive elimination. This chapter presents novel 
examples of sp3-C–F, C–N and C–O reductive elimination from PdIV in addition to 
 xxi 
sp3-C–Cl bond-formation. These reactions represent the first examples of high 
yielding sp3-C–X reductive elimination from PdIV. Furthermore, the mechanisms 
of these transformations were explored. Lastly, the mechanistic insights gained 
from these studies lead us to examine systems for sp3-C–X bond-formation that 
do not use the oxidant to deliver the desired functionality.  
Next, Chapter 4 of this thesis describes the development a ligand system 
to explore C–H activation directly at a PdIV center. We designed a complex where 
reductive elimination is slow and C–H activation is observed. This enabled us to 
compare the selectively of C–H activation at a PdIV center versus a PdII center.  
 Finally, the thesis concludes with a discussion of the future for the 






Chapter 1: Introduction 
1.1 Introduction 
Palladium represents an essential tool for organic synthesis due to its 
wide spread use in catalysis for the construction of challenging types of C−C and 
C−heteroatom bonds.1 As a result, palladium-catalyzed reactions have found 
vast applications in the area of pharmaceutical, natural product, and commodity 
chemical synthesis. The development of novel methodologies, the invention of 
new catalysts, and the investigation of mechanism for insight into how these 
reactions proceed account for the continued advancement in the arena of Pd 
catalysis. Over the past 70 years, the vast majority of reported, well-developed 
catalytic reactions have involved Pd0/II catalysis. For instance, in 2010 the Nobel 
Prize was awarded to Heck, Negishi and Suzuki for the development of cross-
coupling reactions, which utilize two different pre-functionalized starting materials 
to afford new C−C bonds through a Pd0/II catalytic cycle (Scheme 1.1). Only since 
2004 has PdIV routinely emerged as a proposed intermediate in Pd-catalyzed 
reactions. 2 
 








PdII/IV catalysis has the potential to afford highly complementary and 
unique reactivity compared to Pd0/II catalysis. One key feature of organometallic 
PdIV intermediates is that they are generally moisture-stable due to the highly 
 2 
polarized nature of the PdIV–C bond (Scheme 1.2). Additionally, PdIV complexes 
are typically octahedral and diamagnetic with a low spin t2g6 configuration, thus 
forming fully saturated complexes that are not prone to β-hydride elimination 
reactions (a common source of unwanted side products in Pd0/II catalytic 
reactions) (Scheme 1.3).3 PdIV also has a unique advantage over PdII or PtIV 
because of its decreased stability, which contributes to the enhanced propensity 
of PdIV species towards reductive elimination to form challenging types of 
C−heteroatom bonds (Scheme 1.4). 4 





















Coordinatively saturated  
 











As early as 1971, C–O bond-forming reductive elimination from a 
PdIV(Ph)(OAc) species was implicated in the Pd(OAc)2-catalyzed oxidation of 
benzene with K2Cr2O7 by Henry (Scheme 1.5).5 In 1974 Eberson proposed a 
similar mechanism for the acetoxylation of benzene with K2S2O8 and Pd(OAc)2.6 
Although these reactions were quite interesting because they directly converted 
 3 
inert C−H bonds of benzene to C−O bonds, the reactions were not selective and 
resulted in mixtures of mono and diacetoxylated products. While PdIV complexes 
were alluded to as possible intermediates in these catalytic reactions, no 
examples of PdIV complexes containing a carbon ligand had been reported in the 
literature up to this point.  
Scheme 1.5 Acetoxylation of Benzene with Proposed PdIV Intermediate  













The first organometallic PdIV complex was synthesized in 1975 by Uson 
via the oxidation of PdII(C6F5)2(tmeda) with Cl2 to afford PdIV(Cl)2(C6F5)2(tmeda).7 
In 1986, another seminal milestone for PdIV came in the realm of stoichiometric 
chemistry, when Canty reported the first example of a crystallographically 
characterized organometallic PdIV complex, fac-[(bpy)PdIV(CH3)3(I)] (bpy = 2,2’-
bipyridine) (1). In addition, his group demonstrated that this species undergoes 
facile C–C bond-forming reductive elimination to release ethane (Scheme 1.6).8 
This report supported the hypothesis that an organometallic PdIV complex could 
undergo clean reductive elimination to generate organic products. 
Scheme 1.6 C–C Bond-Forming Reductive Eliminaton from the First 

















However, even though PdIV intermediates have been implicated since the 
1970’s it was not until mid-2000 that the field of PdII/IV catalysis exploded. Over 
the past decade, carbon-heteroatom bond-forming reductive elimination from 
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transient PdIV intermediates has been proposed as the product-release step of a 
variety of important Pd-catalyzed transformations, including arene and alkane C–
H bond functionalization9,10,11 allylic acetoxylation,12 alkene borylation13, and 
olefin difunctionalization.14 Examples of C–C bond forming reactions from 
proposed PdIV intermediates have also emerged;15 however, this thesis will focus 
predominantly on carbon-heteroatom bond forming reactions from PdIV. 
The rapid expansion in the area of PdII/IV catalysis was initially due to the 
merger of ligand directed C−H activation and functionalization. One of the pivotal 
reports emerged from our group in 2004.16 In this communication, we 
demonstrated the conversion of C−H bonds to C−OAc bonds using Pd(OAc)2 and 
PhI(OAc)2 affording products selectively and in high yields (Scheme 1.6).  
 









This methodology was in contrast to the reactions developed by Henry, Eberson 
and later by Crabtree.17 The incorporation of a ligand for directed C−H activation 
was a key development for limiting the formation of over functionalized side 
products. The following mechanism was proposed for this transformation: (1) rate 
limiting ligand directed C−H activation to afford a palladacycle, (2) oxidation with 
PhI(OAc)2 to yield a PdIV intermediate, and (3) product forming reductive 





























Since then, ligand-directed oxygenation of sp2 and sp3 C–H bonds with 
PhI(OAc)218,19, Oxone20,21, K2S2O820, IOAc21, CH3CO2OtBu22, lauroyl peroxide23, 
and O224 have all been suggested to proceed via PdII/IV pathways in which C–O 
bond-forming reductive elimination serves as the product-forming step of the 
catalytic cycle. 
 Numerous Pd-catalyzed olefin difunctionalization reactions are also 
hypothesized to involve C–O bond-forming reductive elimination from PdIV as a 
key step. For example, diverse α-olefins have been shown to undergo Pd-
catalyzed dioxygenation with oxidants including PhI(OAc)224,25, O226,27, and 
peracetic acid28 via a putative PdII/IV pathway (Scheme 1.8). In addition, the Pd-
catalyzed aminooxygenation of olefins with PhI(OAc)2 is thought to involve C–
OAc bond formation at PdIV as the product release step (Scheme 1.9)29,30 ,31. 
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Scheme 1.8 Olefin Difunctionalization Reactions 
Ph Ph Ph Ph
OAc
OAc(72%)
2 mol % [Pd(dppp)(H2O)2]2(OTf)2
PhI(OAc)2
3 equiv H2O/AcOH, 50 °C, 2 h
[dppp = diphenylphosphinopropane]  
 






2 mol % PdCl2(CH3CN)2
PhI(OAc)2







A wide variety of Pd-catalyzed ligand-directed C–H halogenation reactions 
have also been reported. For example C–H iodination with N-iodosuccinimide 
(NIS)32, IOAc/Bu4NI33, and I2/PhI(OAc)234, C–H bromination with N-
bromosuccinimide (NBS)35, Cu(OAc)2/CuBr236, BrOAc/Bu4NBr37, and 
CuBr2/LiBr38,39, C–H chlorination with Cl240, N-chlorosuccinimide (NCS)32, 
PhICl232, and Cu(OAc)2/CuCl236,39, and C–H fluorination with N-fluoropyridinium 
reagents41,42 have all been applied to both arene and alkane substrates (Scheme 
1.10-1.12). The structures of reactive Pd intermediates in these transformations 
have not been definitively elucidated. However, PdII/IV mechanisms that involve 
carbon-halogen bond formation from transient PdIV intermediates have been 
proposed in many of these systems. 
 






tBu10 mol % Pd(OAc)2
1 equiv PhI(OAc)2







Scheme 1.11 C–H Bromination with NBS 
 
5 mol % Pd(OAc)2
1.5 equiv NBS
















Several Pd-catalyzed olefin difunctionalization reactions have also been 
terminated by oxidative carbon–halogen bond formation. For example, both intra- 
and intermolecular aminohalogenations with NCS43, NIS44, CuCl245,46, CuBr2/O247, 
and AgF/PhI(O2CtBu)2 48 have been achieved (Scheme 1.13). Henry has reported 
a related synthesis of halohydrins via oxypalladation/C–X coupling (Scheme 
1.14) 48. In addition, the arylhalogenation of diverse α-olefins with PhICl2, CuCl2, 
and CuBr2 was recently disclosed (Scheme 1.15)49,50. While the reactive 
intermediates in these transformations have not been characterized, C–halogen 
bond-formation from PdIV intermediates has been suggested in many cases. 













Scheme 1.14 Oxypalladation/C–X coupling 
 







Scheme 1.15 Arylhalogenation of α-Olefins 
+
10 mol % PdCl2(PhCN)2
CuBr2







Although examples of C–S bond formation from proposed PdIV 
intermediates are rare, a recent report by Dong and coworkers demonstrated the 
Pd-catalyzed ligand-directed sulfonylation of arylpyridine, arylpyrazole, and 
aryloxime ether derivatives with ArSO2Cl (Scheme 1.16)51a. The authors 
speculated that a PdII/IV mechanism (involving oxidative addition into the S–Cl 
bond and subsequent C–S bond-forming reductive elimination from PdIV) was 
potentially operative.  Recently, the authors have isolated PdIV sulfinate 
complexes and studied C–S bond formation directly from the metal center. 51b 





10 mol % PdCl2(CH3CN)2
2 equiv K2CO3
4Å MS, 1,4-dioxane







Since the rate determining step of the above mentioned catalytic reactions 
usually precedes the product determining reductive elimination step from the 
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proposed PdIV intermediate, it is challenging to identify how these 
transformations occur by directly studying the catalytic reactions. Therefore, a 
variety of PdIV model complexes have been synthesized to study reductive 
elimination reactions at PdIV centers. Since the report of the first characterized 
organometallic PdIV complex by Canty8, numerous examples of C–C bond-
forming reductive elimination from PdIV complexes have been 
demonstrated51,52,53,54,55,56. In contrast, C–heteroatom bond-forming reactions 
from PdIV species remain much rarer. This thesis presents the design and 
synthesis of novel PdIV complexes that undergo clean sp2- and sp3-carbon-
heteroatom coupling as well as C–H activation at a discrete PdIV center. 
Furthermore, mechanistic aspects of these reactions are discussed in detail. 
Chapter 2 presents a detailed mechanistic study of C–O and C–C bond-
formation from isolable PdIV complexes. A variety of complexes were synthesized 
to explore how electronic factors, activation parameters, solvent effects and 
additive effects are involved in/influence C–O reductive elimination from a PdIV 
center. Additionally, we identified a system that yielded competing C–O and C–C 
reductive elimination from PdIV. Therefore, we conducted mechanistic studies to 
probe C–C bond formation from PdIV; we were able to propose a mechanism for 
this transformation as well. The work in this Chapter on C–O reductive 
elimination from PdIV lends support for the proposed mechanism for the Pd-
catalyzed acetoxylation reaction represented in Scheme 1.7. 
Chapter 3 investigates sp2 versus sp3-C–X bond formation from PdIV 
complexes. Interestingly, in all of the systems that were studied, sp3-C–X bond 
formation out competes sp2 reductive elimination. This chapter presents novel 
examples of sp3-C–F, C–N and C–O reductive elimination from PdIV in addition to 
sp3-C–Cl bond-formation. These reactions represent the first examples of high 
yielding sp3-C–X reductive elimination from PdIV. Furthermore, the mechanisms 
of these transformations were explored. Lastly, the mechanistic insights gained 
from these studies lead us to examine systems for sp3-C–X bond-formation that 
do not use the oxidant to deliver the desired functionality.  
 10 
As mentioned above, most of the catalytic reactions that propose PdII/IV 
mechanisms suggest C–H activation at a PdII center, followed by oxidation, then 
reductive elimination. The next goal of my thesis was to explore organometallic 
transformations other than reductive elimination at a PdIV complex. Until very 
recently, no organometallic transformation (either catalytically or 
stoichiometrically) besides reductive elimination had been proposed at PdIV. 
Since there is a large driving force for PdIV to undergo reductive elimination, it 
was typically assumed that this reaction would always out compete any other 
type of organometallic transformation at PdIV. Then in 2006 our group disclosed a 
mechanism for the oxidative dimerization of 2-arylpyridine derivatives, in which a 
second C–H activation event takes place at a PdIV center.57 Following this initial 
publication, there emerged four other reports in the literature of catalytic 
reactions that are believed to involve C–H activation at PdIV.58 Chapter 4 of this 
thesis describes the development a ligand system to explore C–H activation 
directly at a PdIV center. We designed a complex where reductive elimination is 
slow and C–H activation is observed. This enabled us to compare the selectively 
of C–H activation at a PdIV center versus a PdII center.  
 Finally, Chapter 5 concludes this thesis and also presents an outlook for 
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Chapter 2: Detailed Study of C−O and C−C Bond-
Forming Reductive Elimination from Stable 
C2N2O2−Ligated Palladium(IV) Complexes 
 
2.1 Introduction 
Our group has recently reported a Pd-catalyzed reaction for the ligand-
directed acetoxylation of carbon-hydrogen bonds using PhI(OAc)2 as the terminal 
oxidant (Scheme 2.1.1).1,2,3 The key carbon-oxygen coupling step of this 
transformation was proposed to involve C–O bond-forming reductive elimination 
from a rare, high oxidation state PdIV species of general structure A.1,4 While 
analogous C–O bond-forming reductive elimination reactions from NiIII,5 PdII,6  
and PtIV 7 centers have been studied extensively, detailed investigation of such 
reactions at PdIV complexes has thus far remained elusive.8,9 
 
















Studies of C–O bond formation at PdIV have proven challenging for two 
major reasons. First, there are relatively few examples of isolable PdIV complexes 
containing oxygen donor ligands.8,9 Second, the available complexes are 
typically stabilized by the presence of multiple σ-alkyl and/or aryl ligands. As a 
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result, investigations of C–O bond-forming reductive elimination have been 
hampered by competing C–C coupling processes.8,9 Hence, we sought to design 
a new model system that would allow for systematic mechanistic investigations of 
C–O bond-forming reductive elimination from PdIV centers.  
We reasoned that PdIV complexes of general structure (N~C)2PdIV(O2CR)2 
(B) (N~C = a rigid cyclometalated ligand) might serve as attractive models for A 
on the basis of several key design features (Scheme 2.1.2). First, the N~C 
ligands were selected to stabilize the desired PdIV species, due to their rigid, 
bidentate structures8-10 and the fact that they contribute two electron-donating σ-
aryl ligands to the high oxidation state Pd complex.8-11 Additionally, we 
hypothesized that the rigid and chelating nature of the two N~C ligands would 
limit competing C–C bond-forming processes relative to the desired C–O 
coupling. Finally, we reasoned that the two carboxylates could be incorporated 
by oxidation of (N~C)2PdII with PhI(O2CR)2, which is the same terminal oxidant 
used for the catalytic reactions in Scheme 2.1.1. 
 
Scheme 2.1.2. Design of Complex B for Study of C–O Bond-Forming 




• stabilize PdIV (rigid and electron donating)
• minimize C–C coupling
• allow study of C–O coupling








Herein, we report detailed studies on the synthesis and reactivity of PdIV 
complexes of general structure B. These complexes are readily prepared by the 
oxidation of (N~C)2PdII with PhI(O2CR)2 and are remarkably stable at room 
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temperature.12,13 However, at elevated temperatures, most undergo clean C–O 
bond-forming reductive elimination to afford ester products. This chapter 
describes full mechanistic investigations of this C–O bond-forming process and 
also provides mechanistic insights into competing C–C coupling reactions. 
 
 
2.2 Results and Discussion for C–O Bond-Formation from Pd(IV) 
The following work was done in collaboration with Dr. Allison Dick and 
Professor Melanie Sanford. Where Dr. Allison Dick carried out the experiments I 
have denoted them specifically in this chapter.  
 
Initial Investigations. 2-Phenylpyridine (Phpy) was selected as the N~C 
chelating ligand due to its high reactivity in Pd-catalyzed C–H 
activation/acetoxylation reactions1 and the availability of the starting material 
(Phpy)2PdII (1).14 Gratifyingly, treatment of 1 with PhI(OAc)2 in CH2Cl2 at 25 ºC for 
30 min produced a single inorganic product (2) (Scheme 2.2.1). Complex 2 was 
isolated in 93% yield as a pale yellow solid by precipitation with diethyl ether. 
This species was remarkably stable in the solid state and could be stored for 12 
months at –35 ºC without significant decomposition. 
 
 















The 1H NMR spectrum of 2 in acetone-d6 shows 16 distinct aromatic 
signals between 6.29 and 9.46 ppm and two different acetate resonances at 1.63 
and 1.74 ppm. These spectroscopic data are indicative of an unsymmetrical 
octahedral PdIV species with two different Phpy and acetate ligand environments. 
Further characterization of 2 by X-ray crystallography confirmed that this complex 
has an octahedral geometry with cis-phenylpyridine and acetate ligands (Figure 
2.2.1). Importantly, this is a highly unusual example of a room temperature stable 
PdIV complex containing a C2N2O2 coordination environment. 
 
 











Next, we examined the reactivity of PdIV complex 2 towards thermally-
induced reductive elimination. Two possible reductive elimination reactions are 
possible from 2 – carbon–oxygen bond-forming reductive elimination to generate 
2-(2-acetoxyphenyl)pyridine (3) and/or C–C bond-forming reductive elimination to 
afford 2,2’-di(pyridin-2-yl)biphenyl (4) (Scheme 2.2.2). Literature reports have 
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shown that related PdIV species [for example, (bipy)PdIV(Me)3(O2CPh) (bipy = 
2,2’-bipyridine)] undergo C–C bond formation at comparable or faster rates than 
the desired C–O coupling reaction.8,9  
 
 

















We were pleased to find that heating a solution of 2 in CH3CN for 30 min 
at 80 ºC resulted in the formation of 3 as the sole organic product in nearly 
quantitative yield (95%) as determined by 1H NMR spectroscopy. The inorganic 
product of this reaction was the cyclometalated PdII dimer 5, which was obtained 
in 98% yield (Scheme 2.2.3). This is the first direct observation of sp2 C–O bond-
forming reductive elimination from an isolated PdIV center. As a result, this system 
presented a unique opportunity for mechanistic studies relevant to the proposed 
product-forming step in Pd-catalyzed C–H bond acetoxylation reactions.1-3  
 
 
























Mechanistic Considerations. We considered three mechanisms for C–O 
bond-forming reductive elimination from complexes of general structure I (Scheme 
2.2.4). The first possibility was an ionic mechanism (A), which would proceed via 
carboxylate dissociation from I to form five-coordinate intermediate II, followed by 
reductive elimination from this cationic species. Mechanism B, concerted bond 
formation, would involve direct C–O reductive elimination from the coordinatively 
saturated octahedral PdIV complex I. Finally, Mechanism C, chelate dissociation, 
would involve dissociation of an N-donor ligand to generate the neutral 5-
coordinate species III, followed by reductive elimination. Notably, within all three 
mechanisms, there are two distinct carboxylates that could participate in C–O 
bond-forming reductive elimination. In mechanism A, C–O coupling from 
intermediate II could occur via nucleophilic attack by the dissociated carboxylate 
or by direct reaction of the coordinated carboxylate. In mechanisms B and C, 
reductive elimination could involve C–O coupling with the carboxylate trans to the 
pyridine nitrogen or with the carboxylate trans to the σ-Ar ligand. 
 






































There is literature precedent for each of these mechanisms in reductive 
elimination reactions at group 10 metal centers. For example, mechanism A has 
been implicated for sp3 C–O,7 sp3 C–halogen,15 sp3 C–N,16 and sp2 C–halogen17 
bond-forming reductive elimination from PtIV. A concerted mechanism has been 
proposed for sp2 C–O,5 sp2 C–N,18 and sp2 C–S19 bond-forming reductive 
elimination from PdII centers. Finally, mechanism C has been reported for some 
C–C bond-forming reactions from PtIV.20 
We aimed to distinguish among these mechanistic possibilities by 
systematically studying C–O bond-forming reductive elimination from 
(Arpy)2PdIV(O2CR)2 (Arpy = substituted arylpyridine, O2CR = substituted 
carboxylate). These complexes were synthesized by the reaction of 1 with 
PhI(O2CR)2 (Scheme 2.2.5).21  
 



























































Initial investigations in this area provided preliminary evidence in support 
of mechanism C.12 More recently, a computational study by Liu and coworkers 
has suggested that mechanism B is operating in these systems.22 To gain further 
insights into this transformation, I carried out numerous additional experiments to 
probe both C–O and related C–C bond-forming reductive elimination processes 
from (Arpy)2PdIV(O2CR)2. As detailed below, these new investigations, as well as 
reevaluation/reinterpretation of the previous data, lead me to conclude that 
mechanism A is, in fact, most likely operating in this system. 
Mechanism of C–O Bond-Forming Reductive Elimination: 
Carboxylate Exchange. Initial mechanistic studies probed the viability of 
mechanism A by investigating whether complex 2 undergoes exchange between 
free and bound carboxylates at temperatures below those required for reductive 
elimination (Scheme 2.2.6). Because 2 is coordinatively saturated, carboxylate 
exchange would require dissociation of an acetate ligand via a process 
analogous to the first step of mechanism A. Notably, Goldberg and coworkers 
have shown that such exchange reactions occur rapidly at the PtIV complex fac-
(dppbz)PtMe3(OAr) (dppbz = bis(diphenylphosphino)benzene), which undergoes 
C–O bond-forming reductive elimination via mechanism A.7b  
 




























Carboxylate exchange was first studied by treating complex 2 with 1 equiv 
of NBu4(O2CC9H19) at 25 ºC in acetone-d6. Importantly, these conditions are far 
milder than those required to induce C–O bond-forming reductive elimination 
from 2. Analysis of the reaction by 1H NMR spectroscopy after 5 min showed 
formation of one major new PdIV species with characteristic upfield and downfield 
1H NMR resonances at 6.31 and 9.49 ppm. These are slightly shifted relative to 
the starting material, which has signals at 6.29 and 9.44 ppm. We hypothesized 
that this new complex was the mono-acetate adduct 19 where the acetate ligand 
trans to C was replaced with O2CC9H19. The selective replacement of this OAc 
can be rationalized on the basis of the larger trans influence of the σ-aryl ligand 
versus the pyridine nitrogen.23  
The isolation of 19 from the reaction mixture was challenging because this 
species was not readily separable from tetrabutylammonium-containing by-
products. Thus, an authentic sample of 19 was synthesized independently by 
reaction of (Phpy)2PdIV(Cl)(OAc)24 (21) with 1 equiv of AgO2CC9H19 (Scheme 9). 
This product showed identical 1H NMR resonances to those observed in the 
exchange reaction. In addition, its structure was unambiguously established by 


























While 1H NMR spectroscopic analysis was consistent with 19 as the major 
product of the exchange process, we were unable to definitively establish 
whether small quantities of 20 and 7 were also formed, since these have closely 
overlapping 1H NMR resonances. As such, electrospray mass spectrometry was 
used to analyze the products of a closely related reaction – the thermoneutral 
exchange between (Phpy)2PdIV(OAc)2 and NBu4(OAc-d3) (Scheme 2.2.8). 
Electrospray MS of all of the possible products (which were each synthesized 
independently)25 showed major peaks consistent with loss of the acetate ligand 
trans to the σ-aryl group. For example, the peak for (Phpy)2PdIV(OAc-d3)(OAc) 
(2a-d3) was [(Phpy)2PdIV(OAc)]+ (MW = 473.0) while that for 
(Phpy)2PdIV(OAc)(OAc-d3) (2b-d3) was [(Phpy)2PdIV(O2CCD3)]+ (MW = 476.0). 
Furthermore, co-injection of a 1 : 1 mixture of 2 : 2-d6 showed peaks of equal 
intensity, demonstrating that peak intensities can be used to determine the 
relative concentrations of these species.  
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(2) (2a-d3) (2b-d3) (2-d6)





When a 1 : 1 mixture of (Phpy)2PdIV(OAc)2 and NBu4(OAc-d3) was 
combined in CH2Cl2, stirred for 20 min, and then analyzed by electrospray MS, a 
single peak for [(Phpy)2PdIV(OAc)]+ (MW = 473.0) was observed (Scheme 2.2.8). 
This result indicates that neither 2b-d3 nor 2-d6 is formed, thereby providing 
further evidence that carboxylate exchange occurs solely at the site trans to the 
σ-aryl ligand.  
As discussed above, carboxylate exchange cannot occur by an 
associative mechanism, since the starting complex is coordinatively saturated. 
Thus, the observation of rapid exchange suggests strongly that carboxylate 
dissociation (the first step of mechanism A) can occur at temperatures below 
those required for reductive elimination. However, more experiments were 
required to determine whether this exchange was mechanistically relevant to C–
O bond-forming reductive elimination.  
Mechanism of C–O Bond-Forming Reductive Elimination: Cross-Over 
Studies.  Next, Dr. Allison Dick investigated whether cross-over between free 
and bound carboxylate occurred during the course of the reductive elimination 
reaction. A first cross-over study involved thermolysis of the bis-benzoate 
complex 8 in the presence of 5 equiv of NBu4OAc in either CDCl3 or DMSO.12 
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Analysis of the reaction mixture by GC and GCMS showed that the predominant 
organic product was 22, and that <5% of the cross-over product 3 was formed.  
 



















We reasoned that the absence of cross-over might be due to an electronic 
bias for reductive elimination of the benzoate in preference to the acetate ligand. 
As such, we designed a system to eliminate this electronic bias and differentiate 
the bound and free carboxylates solely based on isotopic labeling. However, 
thermolysis of (Phpy)2PdIV(OAc-d3)2 (2-d6) in the presence of 5 equiv of 
NBu4OAc under otherwise identical conditions to Scheme 2.2.9 still afforded <6% 
of cross-over product 3 (Scheme 2.2.10).  
 
 

















These results indicate that the non-exchangeable carboxylate ligand 
participates selectively in the C–O bond-forming reaction. This was confirmed by 
subjecting complex 2b-d3,25 which contains two different carboxylate ligands, to 
the standard reductive elimination conditions. The major product (>95% yield) 
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was 3-d3 and <5% of 3 was observed as determined by 1H and 2H NMR 
spectroscopy (Scheme 2.2.11).  
 

















Mechanism of C–O Bond-Forming Reductive Elimination: Solvent 
Effects. Polar solvents often accelerate reductive elimination and ligand 
exchange reactions that proceed via ionic mechanisms.7,26,27 Thus, we next 
investigated the effect of solvent on the rates of both C–O bond-forming 
reductive elimination and carboxylate exchange in a series of solvents with 
diverse polarities. The bis-decanoate complex (Phpy)2PdIV(O2CC9H19)2  (7) was 
used for these studies due to its high solubility in many different solvents.  
The rate of C–O bond-forming reductive elimination from 7 was examined 
as a function of solvent under standard conditions (55 ºC, 15.2 mM in solvent 
with 5% v/v pyridine) by Dr. Allison Dick.28 The disappearance of starting material 
7 and concomitant formation of 23 and 24 were monitored by 1H NMR 
spectroscopy. Interestingly, changing the solvent had very little influence on the 
reaction rate, and kobs varied by only ~3-fold over a wide array of solvents (Table 
2.2.1). In addition, there was no clear correlation between kobs and the solvent 
polarity. For example, nearly identical rates were observed in benzene and 
acetone (krel = 1), despite a large difference in dielectric constant (e = 2 and 21, 
respectively). Furthermore, comparable and relatively fast rates were observed in 
















(with 5% v/v C5D5N)
(7)




Entry Solvent ε  krel 
1 acetone-d6 21 1.0 ± 0.1 
2 C6D6 2.3 1.0 ± 0.1 
3 chlorobenzene-
d5 
5.6 1.0 ± 0.1 
4 DMSO-d6 47 2.0 ± 0.3 
5 CDCl3 4.8 2.3 ± 0.2 
6 CD3CN 38 2.4 ± 0.1 
7 nitrobenzene-d5 36 3.1 ± 0.3 
 
 
We investigated the rate of carboxylate exchange as a function of solvent. 
In these experiments, 1 equiv of 7 and 1 equiv of Bu4N(OAc) were dissolved in 
the appropriate solvent in an NMR tube at –38 ºC, and the rate of formation of an 
equilibrium mixture of 7 and 20 was monitored by 1H NMR spectroscopy. 
Intriguingly, kobs for carboxylate exchange did not show a clear correlation with 
the polarity of the reaction medium (Table 2.2.2). For example, the fastest rate 
(kkel = 19) was observed in CDCl3 (e = 4.7), while the slowest (krel = ~0.1)29 was 





















(7) (20)  
 
 
Entry Solvent ε  krel 
1 toluene-d8 2.4 <0.1 
2 acetone-d6 21 1.0 ± 0.1 
3 CD3CN 38 2.0 ± 0.2 
4 CDCl3 4.8 19.0 ± 0.1 
 
 
The solvent data for C–O bond-forming reductive elimination (particularly 
the low correlation between e and kobs) was initially interpreted as a strong piece 
of evidence against mechanism A.7,9 However, the results from the 
corresponding solvent study for carboxylate exchange indicate that this 
interpretation should be reconsidered. 
 
Mechanism of C–O Bond-Forming Reductive Elimination: Entropy of 
Activation. Previous work has shown that reductive elimination reactions 
proceeding via mechanism A are often characterized by large negative values of 
ΔS‡. For example, Canty has reported that C–Se bond-forming reductive 
elimination from PdIV has ΔS‡ ranging from –40 to –49 eu, depending on the 
 30 
reaction solvent.9b This has been rationalized on the basis of significant 
orientation of solvent molecules around the charged transition state.  
The rate of C–O bond-forming reductive elimination from 7 was examined 
over a range of temperatures from 30 to 70 ºC in both CDCl3 and DMSO-d6 by 
Dr. Allison Dick. Eyring plots showed that ΔS‡ is close to zero in both solvents 
(ΔS‡ = –1.4 ± 1.9 eu in CDCl3 and +4.2 ± 1.4 eu in DMSO-d6). While values of 
ΔS‡ between 10 and –10 eu are considered difficult to interpret, these values are 
substantially less negative than those reported by Canty.27 As such, we initially 
viewed this data as inconsistent with mechanism A.12 
We conducted similar studies to obtain an Eyring plot for carboxylate 
exchange. In these experiments, the reaction of 7 with 1.0 equiv of Bu4N(OAc) in 
CDCl3 was monitored by 1H NMR spectroscopy over temperatures ranging from 
–58 to –38 ºC, and an Eyring plot provided ΔS‡ = –7.2 ± 3 eu. Again, this value is 
considerably less negative than those reported by Canty,9b but is quite similar to 
that obtained for C–O bond-forming reductive elimination from 7.30  The ΔS‡ 
obtained for both the reductive elimination and the carboxylate exchange are 
consistent with mechanism A if a tight ion is formed between the dissociated 
carboxylate and ther positive Pd center. 
 
Mechanism of C–O Bond-Forming Reductive Elimination: Acidic 
Additives. Goldberg has shown that both Brønsted and Lewis acids accelerate 
C–O and C–C bond-forming reductive elimination from (dppe)PtIV(OAc)(Me)3 
(dppe = diphenylphosphinoethane), which both proceed via mechanism A.7b For 
example, the addition of 0.1 equiv of AcOH increased the rate of C–O coupling 
by a factor of 2, while the use of 0.1 equiv of AgOTf lowered the temperature 
required for C–C bond-forming reductive elimination from 99 ºC to 25 ºC. Both 
additives were proposed to act by promoting OAc– dissociation. On the basis of 
this report, I reasoned that if mechanism A were operative in our system, both C–
O bond-forming reductive elimination and carboxylate exchange at complex 7 
should be accelerated to similar extents by these additives. 
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We first studied the rate of C–O bond-forming reductive elimination from 
(Phpy)2PdIV(O2CC9H19)2 (7) in the presence of AcOH or AgOTf. The addition of 
AcOH (2.0 equiv) resulted in a 3.6-fold acceleration of C–O bond-forming 
reductive elimination (Table 2.2.3, entries 1 and 2), while AgOTf (0.3 equiv) led to 
a 16-fold increase in kobs for this reaction (Table 2.2.4, entries 1 and 2).  
The effect of HOAc and AgOTf on the rate of carboxylate exchange was 
next determined, and, remarkably, a very similar effect was observed. For 
example, the addition of AcOH (2.0 equiv) resulted in a 4.5-fold increase in the 
rate (Table 2.2.3, entry 2), while AgOTf (0.3 equiv) afforded an 8.7-fold increase 
in kobs for exchange (Table 2.2.4, entry 2). These results are consistent with the 
hypothesis that carboxylate exchange and C–O bond-forming reductive 














Table 2.2.3 Effect of AcOH on C–O Bond-Forming Reductive Elimination 



































1 none 1.0 ± 
0.0a 
1.0 ± 0.0 
2 HOAc 3.6 ± 
0.2a 
4.5 ± 0.5b 










Table 2.2.4 Effect of AgOTf on C–O Bond-Forming Reductive Elimination 



































1 none 1.0 ± 
0.2a 
1.0 ± 0.1b 
2 AgOTf 16 ± 0.8a 8.7 ± 0.0b 
a 23 ºC in CDCl3; b –53 ºC in CDCl3 
 
Mechanism of C–O Bond-Forming Reductive Elimination: 
Carboxylate Electronic Effects. A series of PdIV complexes (8-18) were 
designed to place both σ- and π-electron donating and electron withdrawing 
substituents on the benzoate ligand. The kinetics of C–O bond-forming reductive 
elimination from PdIV complexes 8-18 was then studied at 60 ºC in a solution of 
5% v/v C5D5N in CDCl3 (Scheme 2.2.12) by Dr. Allison Dick.28 A Hammett plot of 
this data showed very good correlation with σpara (R2 = 0.95) and yielded a ρ 
value of −1.36 ± 0.04 (Figure 2.2.2). 
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Ar =  C6H4p-X  
 
 
































A previous report showed that r = +1.44 for C–O bond-forming reductive 
elimination from (dppbz)PtMe3(OAr), which proceeds by mechanism A.7b As 
such, we initially reasoned that the observed r value of –1.36 provided evidence 
against an ionic mechanism.12 However, the overall value of ρ (ρobs) for a 
reaction proceeding by mechanism A is the sum of ρeq and ρ2 (Figure 2.2.3).31 
 35 
The ρobs of +1.44 in the Pt system was rationalized based on the assumption that 
|ρeq| > |ρ2|;7b however, since the overall ρ value (ρobs) is a composite, a positive ρ 
value is not an inherent feature of such mechanisms.32 Thus, since all of the 
possible mechanisms (A, B, and C) involve the carboxylate acting as a 
nucleophillic partner in a rate-determining C–O bond-forming step (Scheme 
2.2.4), the observed negative ρ value is potentially consistent with any of these 
pathways. 
 
























Mechanism of C–O Bond-Forming Reductive Elimination: 
Arylpyridine Electronic Effects. A series of complexes containing electronically 
varied arylpyridine ligands (15, and 46-50) were designed to place various 
electron withdrawing and electron donating substituents trans to the Pd-bound 
carbon atom. The kinetics of C–O bond-forming reductive elimination from 15 
and 46-50 were studied at 60 ºC in a solution of 5% v/v C5D5N in CDCl3 by Dr. 
Allison Dick. Reductive elimination generally proceeded fastest with electron-
withdrawing substituents (Table 2.2.5), although Hammett plots showed only 
modest correlation with σpara (R2 = 0.79), s+ (R2 = 0.47), and s– (R2 = 0.36). This 































Compound  kobs (s-1 x 105) 
*OMe (46) ~3a 
Me (47) 4.81  
H (15) 20.0  
F (48) 3.64  
Cl (49) 36.9  
*CF3 (50) ~320a 
 
aThese values of kobs are approximate, as samples of 46 and 50 were contaminated  
with ~10% of inseparable impurities.  
 
 
Mechanism of C–O Bond-Forming Reductive Elimination: Ligand 
Rigidity.  Originally, it was hypothesized that a decrease in reaction rate with 
increasing N~C ligand rigidity would provide support for mechanism C.12 
Complexes 62-64 were designed to systematically vary the flexibility of the tether 
between the two pyridine rings (Figure 2.2.4). The kinetics of C–O bond-forming 
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reductive elimination from 62-64 was studied by 1H NMR spectroscopy at 50 ºC 
in a solution of 5% v/v C5D5N in CDCl3 by both Dr. Allison Dick and myself. As 
summarized in Table 2.2.6, the rates of reductive elimination did show a 
correlation with the rigidity of the N~C ligand. For example, complex 62 reacted 
twice as fast as 63 and more than 10 times faster than the most rigid 64. 
 
 



































Table 2.2.6 kobs Rate of C–O Bond-Forming Reductive Elimination as a 
















Entry Complex krel 
1 62 1.9 
2 63 1.0  
3 64 ~0.1a 
 
aThe slow reaction rate along with competing C–C bond-formation 
prevented quantitative rate measurement in this system. 
 
As discussed above, it was originally interpreted that these results were 
most consistent with the chelate dissociation mechanism (C).12,20 However, a 
number of literature reports have shown that rigid ancillary ligands stabilize PdIV 
complexes towards reductive elimination, even when the ligand plays no direct 
role in the bond-forming process.10 Therefore, these results do not definitively 
establish or rule out any of the three mechanistic manifolds.  
 
Summary of Mechanistic Data for C–O Bond-Forming Reductive 
Elimination. Mechanisms A, B, or C for C–O bond-forming reductive elimination 
from (N~C)2PdIV(O2CR)2 are kinetically indistinguishable; therefore, we have 
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conducted a series of alternative mechanistic experiments to interrogate this 
transformation. The original publication on this work suggested that mechanism 
C, chelate dissociation, was most consistent with initial studies of this process.12 
This conclusion was based on 5 key pieces of data: (i) the absence of a clear 
correlation between kobs and solvent polarity, (ii) the lack of cross-over between 
free and bound carboxylate, (iii) the small entropy of activation, (iv) the negative 
ρ value obtained upon substitution of the carboxylate ligand, and (v) the 
decreased reaction rate with more rigid N~C ligands.33  
However, we have conducted a variety of new experiments, and these, 
along with a re-evaluation of the previous data, have led us to conclude that 
mechanism A is, in fact, most likely operating in this system. These new 
experiments were particularly focused on the exchange of free and bound 
carboxylate at (Phpy)2PdIV(O2CR)2, which is expected to proceed by an identical 
mechanism to the first step of mechanism A. This exchange occurs at 
temperatures far below reductive elimination, and shows similar solvent effects 
and activation parameters to C–O bond-formation.34 In addition, the rates of 
carboxylate exchange and of C–O coupling are increased to very similar extents 
upon addition of AcOH and AgOTf, additives that have both been reported to 
promote carboxylate dissociation. The C–C bond-forming reactions discussed 
below offer further evidence in support of mechanism A. In addition, they provide 
a more complete picture of the reactivity of these PdIV complexes. 
 
2.3 Results and Discussion for C–C Bond-Formation from Pd(IV) 
 
 C–C Bond-Forming Reductive Elimination from (Bzq)2PdIV(O2CR)2. In 
the context of the ligand rigidity studies, we noted that benzo[h]quinoline complex 
64 reacted to form significant quantities of C–C bond-forming reductive 
elimination product 66 along with the expected C–O coupled product 65 (Scheme 
2.3.1). This result was intriguing, since analogous C–C coupling was not 
observed in any of the phenylpyridine systems. As such, a series of experiments 
were designed to further interrogate the mechanism of this process. 
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Scheme 2.3.1 Competing C–O and C–C Bond-Forming Reductive 













(65, 24%) (66, 76%)
(64)  
 
   
  Mechanism of C–C Bond-Forming Reductive Elimination: Solvent 
Effects. A first study probed the effect of solvent on the relative rates (krel) of C–
C and C–O bond-forming reductive elimination from (Bzq)2PdIV(O2CC9H19)2 (64). 
The values of krel were determined under a standard set of conditions (80 ºC, 4 h, 
15.2 mM) on the basis of the ratio of C–C coupled product 66 to C–O coupled 
product 65 in the crude reaction mixtures. As summarized in Table 2.3.1, solvent 
had a significant influence on the product distribution, with the ratio of 68 to 66 
ranging from >20 : 1 to 0.25 : 1. While there was no clear relationship between 
the dielectric constant of the solvent and the product ratio, the largest amounts of 
66 were observed in solvents where C–O coupling from the analogous 2-
phenylpyridine complex (Phpy)2PdIV(O2CC9H19)2 (7) was relatively slow. For 
example, in benzene and acetone (with krel = 1 for C–O bond-forming reductive 
elimination from 7, Table 2.2.1), >10 : 1 selectivity was observed for 66 (Table 
2.3.1, entries 5 and 6). Conversely, in CH3CN and CHCl3, (solvents where C–O 
bond-forming reductive elimination from 7 was relatively fast), 65 was the major 































(with 5% v/v C5D5N)
(7)









66 : 68 
krel for C–O  
coupling from 
7 
1 CH3CN 0.25 : 1 2.4 
2 CHCl3 0.77 : 1 2.3 
3 nitrobenzene 2.2 : 1 3.1 
4 DMSO 3.3 : 1 2.0 
5 acetone 13 : 1 1.0 




Mechanism of C–C Bond-Forming Reductive Elimination: Acidic 
Additives. Complex 67 was subjected to standard reductive elimination 
conditions (80 ºC, 3 h, 15.2 mM in acetone) in the presence of 5.0 equiv of AcOH 
or 0.10 equiv AgOTf (additives that both accelerate C–O bond-forming reductive 
elimination from (Phpy)2PdIV(O2CC9H19)2 (7)), and the ratio of organic products 
was determined using 1H NMR spectroscopy. As summarized in Table 2.3.2, 
both additives led to a large increase in the relative amount of the oxygenated 
product 68. For example, with AcOH, the ratio of 68 to 66 changed from 13 : 1 to 
3.6 : 1. The effect was even more dramatic with AgOTf, where the major organic 
product was 66 (ratio of 68 : 66 = 0.10 : 1).  
 
Table 2.3.2 Effect of Acidic Additives on the Product Ratio of Reductive 

















Entry Additive Ratio 66 : 
68 
1 none 13 : 1 
2 AcOH (5.0 
equiv) 
3.6 : 1 
3 AgOTf (0.1 
equiv) 




Mechanism of C–C Bond-Forming Reductive Elimination: Carboxylate 
Electronics. Earlier studies showed that C–O bond-forming reductive elimination 
from (Phpy)2PdIV(O2CAr)2 is slowed significantly with electron withdrawing 
benzoate ligands (c.f., Figure 2.2.2), and, as such, we first examined complexes 
of general structure (Bzq)2PdIV(O2CAr)2, where the substituents on the benzoate 
ligands were systematically varied. However, the low solubility of these 
compounds precluded quantitative mechanistic studies. Thus, subsequent efforts 
aimed to compare (Bzq)2PdIV(O2CC9H19)2 (73) to (Bzq)2PdIV(O2CC9F19)2 (75), 
which contains sterically similar but highly electron withdrawing perfluorinated 
carboxylates. In all of the solvents examined (pyridine-d5, acetone-d6, DMSO-d6, 
and CD3CN), electron deficient complex 69 was much less reactive than 67, and 
it could be recovered quantitatively from the reaction mixtures following our 
standard reductive elimination conditions (80 ºC, 3 h). Complete consumption of 
(Bzq)2PdIV(O2CC9F19)2 required heating at 80 ºC for 3-16 d depending on the 
solvent. In addition, C–C coupled 66 was the sole organic product in every 











Table 2.3.3 Solvent Effects on Product Distribution of Reductive 














(70) (66)  
 
Entry Solvent Organic Product 
1 pyridine-d5 66 
2 acetone-d6 66 
3 DMSO-d6 66 
4 CD3CN 66 
 
   
Mechanism of C–C Bond-Forming Reductive Elimination: Added 
Carboxylate. Under standard reaction conditions (80 ºC, 3 h, 15.2 mM in 
CH3CN), 68 was the major product, and the 66 : 68 ratio was 0.2 : 1 as 
determined by 1H NMR spectroscopy (Table 2.3.4). However, when 1 equiv of 
NBu4(O2CC9H19) was added, the selectivity completely reversed, and 66 
predominated (66 : 68 ratio = 2 : 1). To confirm that this effect was not just due to 
the increased ionic strength of the solution, a control experiment was conducted 
using 1 equiv of NBu4PF6. This experiment provided an identical product ratio to 
the initial reaction (66 : 68 = 0.2 : 1). Therefore, the reversal in product selectivity 
is clearly specific to the carboxylate ion. 
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Table 2.3.4 Effect of NBu4(O2CC9H19) on the Product Distribution of 




















Entry Additive Ratio 66 : 
68 
1 none 0.2 : 1 
2 NBu4(O2CC9H19) 2 : 1 
3 NBu4PF6 0.2 : 1 
 
 
2.4 Mechanistic Discussion and Unifying Experiments for C–O and C–C 
Bond-Forming Reductive Elimination from PdIV 
 
Proposed Mechanism for C–C and C–O Bond-Forming Reductive 
Elimination from (N~C)2PdIV(O2CR)2. The solvent, additive, and ligand effect 
studies, as well as the influence of added carboxylate, all suggest that reductive 
elimination processes from 67 occur via the pathway outlined in Scheme 2.4.1. 
This proposal is consistent with all of the mechanistic data and also provides a 
unifying mechanism for C–O and C–C bond-forming reductive elimination for 
complexes of general structure (N~C)2PdIV(O2CR)2. In this scenario, C–O bond-
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forming reductive elimination from 67 proceeds by an analogous mechanism to 
that proposed for (Phpy)2PdIV(O2CR)2 (via pre-equilibrium carboxylate 
dissociation followed by C–O coupling, mechanism A). In contrast, C–C bond-
forming reductive elimination takes place by direct reductive elimination from the 
6-coordinate starting material 67.  
 
Scheme 2.4.1 Proposed Mechanisms for C–C and C–O Bond-Forming 

























The data presented in this chapter are all consistent with Scheme 2.4.1 In 
the presence of added carboxylate, the equilibrium for carboxylate dissociation 
(step i of mechanism A) should be shifted to the left, thereby leading to increased 
formation of the C–C coupled product by direct reductive elimination from I. 
Under conditions that accelerate C–O bond-forming reductive elimination by 
mechanism A (i.e., solvents like CH3CN or CHCl3, additives like HOAc or AgOTf, 
electron donating carboxylate ligands), the C–O coupled product predominates. 
In contrast, under conditions shown to slow C–O coupling (e.g., solvents like 
acetone or benzene, electron withdrawing carboxylate ligands), the C–C coupled 
product is formed in high yield.  
To provide final evidence in support of this mechanistic manifold, we 
generated [(Bzq)2PdIV(O2R)]+ in situ and examined the distribution of organic 
products from this species. As shown in Scheme 2.4.2, treatment of 
(Bzq)2PdIV(OAc)(Cl) (71) with AgBF4 at 80 ºC [conditions that are expected to 
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afford [(Bzq)2PdIV(OAc)]BF4 (72)] resulted in rapid C–O bond-forming reductive 
elimination to afford 73, with none of the C–C coupled product 66 observed by 1H 
NMR spectroscopy.35 This result is in striking contrast to the reaction of 71 in the 
absence of AgBF4, which yielded a 1 : 0.21 ratio of 73 to 74, as well as to the 
reaction of (Bzq)2PdIV(OAc)2 (74) (which gave a 0.5 : 1 ratio of 73 to 66). 
Therefore, it provides a final piece of compelling evidence in support of the 
proposed mechanism.  
 
Scheme 2.4.2 Effect of AgBF4 on the Product Distribution of Reductive 


























with AgBF4 : >95% <5% (not observed)
w/o AgBF4:  ratio = 1            :                0.21  
 
Unified Mechanism: C–C Coupling from Phenylpyridine Complexes. 
If Scheme 2.4.2 does, in fact, represent a unified mechanism for reductive 
elimination from (N~C)2PdIV(O2CR)2, we reasoned that it should be possible to 
rationally design conditions to achieve C–C coupling from complexes where  
N~C = 2-phenylpyridine. Guided by the studies above, we examined conditions 
under which krel for C–O bond-forming reductive elimination is predicted to be 
slow – with a highly electron withdrawing carboxylate ligand and in the presence 
of an excess of added carboxylate. We was delighted to find that the reaction of 
(Phpy)2PdIV(O2CAr)2 [Ar = p-CF3C6H4] in the presence of 5 equiv of Bu4N(O2CAr) 
at 80 ºC in DMSO for 5 h resulted in a 1.6 : 1 mixture of oxygenated product 32 
to biaryl product 4 (Scheme 2.4.3). This result demonstrates that perturbations of 
the ancillary ligand set and additives have similar effects in the 2-phenylpyridine 
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and benzoquinoline systems, providing support for similar mechanisms in both 
systems. 
 
Scheme 2.4.3 Effect of AgBF4 on the Product Distribution of Reductive 















– [PdII] (32) (4)
Ratio:         1.6       :        1  
2.5 Conclusions 
This chapter described the synthesis of a series of unusually stable PdIV 
complexes of general structure (N~C)2PdIV(O2CR)2. These complexes have 
allowed us to conduct the first detailed mechanistic studies of C–O bond-forming 
reductive elimination from PdIV centers. In addition, we have studied competing 
C–C coupling processes. Based on these investigations, we propose that C–O 
bond-forming reductive elimination proceeds via an ionic mechanism involving 
initial carboxylate dissociation, followed by C–O coupling from a 5-coordinate 
cationic intermediate. In contrast, the C–C bond-forming reaction is believed to 
involve direct reductive elimination from the octahedral PdIV starting material. The 
mechanistic understanding of these processes has facilitated the rational tuning 
of ancillary ligands and reaction conditions in order to control the ratio of organic 
products. Current efforts are focused on applying the mechanistic insights 
obtained from these studies towards the design and optimization of new PdII/IV-






2.6.1 Synthesis of PdII Complexes S1-S4536 
General Procedure. A solution of the aryl bromide (2-3 equiv relative to Pd) in 
THF or diethyl ether was cooled to –78 oC in a dry ice/acetone bath. n-BuLi (1 
equiv relative to ligand) or t- BuLi (2 equiv relative to ligand) was added 
dropwise. After stirring at –78 oC for 5-10 min, a solution of (Et2S)2PdCl2 in 
diethyl ether was added. The resulting mixture was stirred at –78 °C for 30-120 
min, then the reaction was quenched with water. The reaction mixture was 
diluted with water, and the palladium(II) product was extracted into CH2Cl2 or 
toluene. The organic extracts were filtered through a plug of aluminum oxide 
(certified, anhydrous, Fisher A591), the solvent volume was reduced to ~5 mL, 
and hexanes was added to precipitate the product. The resulting yellow solid was 







PdII(Cl-Arpy)2, S1: This complex was synthesized according to the general 
procedure above. The aryl bromide was dissolved in diethyl ether, n-BuLi was 
used as the lithiating reagent, and the extraction was carried out with CH2Cl2. 
Complex S1 was obtained in 41% yield as a yellow solid. 1H NMR (CDCl3): δ 
8.63 (d, J = 5.5 Hz, 1H), 7.91 (d, J = 8.0 Hz, 1H), 7.88 (td, J = 8.5, 2.5 Hz, 1H), 
7.85 (d, J = 7.0 Hz, 1H), 7.61 (d, J = 2.5 Hz, 1H), 7.32 (ddd, J = 7.0, 5.5, 1.5 Hz, 
1H), 7.26 (dd, J = 8.0, 2.5 Hz, 1H). 13C{1H} NMR (CDCl3): δ 164.28, 159.23, 







PdII(F-Arpy)2, S2: This complex was synthesized according to the general 
procedure above. The aryl bromide was dissolved in diethyl ether, n-BuLi was 
used as the lithiating reagent, and the extraction was carried out with CH2Cl2. 
Complex S2 was obtained in 43% yield as a yellow solid. 1H NMR (CDCl3): δ 
8.64 (d, J = 5.5 Hz, 1H), 7.94 (dd, J = 8.5, 6.5 Hz, 1H), 7.89 (td, J = 7.5, 1.5 Hz, 
1H), 7.83 (d, J = 8.0 Hz, 1H), 7.36 (dd, J = 11.0, 2.0 Hz, 1H), 7.32 (ddd, J = 7.5, 
5.0, 1.5 Hz, 1H), 7.05 (td, J = 9.0, 2.5 Hz, 1H). 13C{1H} NMR (DMSO-d6): δ 
162.81 (d, J = 4 Hz), 160.40 (d, J = 238 Hz), 156.12 (d, J = 3 Hz), 149.04, 147.77 
(d, J = 6 Hz), 139.28, 138.76 (d, J = 6 Hz), 123.52, 119.85, 115.77 (d, J = 19 Hz), 





PdII(Me-Arpy)2, S3: This complex was synthesized according to the general 
procedure above. The aryl bromide was dissolved in diethyl ether, n-BuLi was 
used as the lithiating reagent, and the extraction was carried out with CH2Cl2. 
Complex S3 was obtained in 55% yield as a yellow solid. Characterization data 







PdII(BzqH2)2, S4: This complex was synthesized according to the general 
procedure above. The aryl bromide was dissolved in THF, n-BuLi was used as 
the lithiating reagent, and the extraction was carried out with CH2Cl2. Complex 
S4 was obtained in 71% yield as a yellow solid. 1H NMR (CDCl3): δ 8.47 (d, J = 
4.5 Hz, 1H), 7.92 (d, J = 8.0 Hz, 1H), 7.57 (d, J = 7.5 Hz, 1H), 7.21 (t, J = 7.5 Hz, 
1H), 7.15 (dd, J = 7.5, 5.5 Hz, 1H), 6.91 (d, J = 7.0 Hz, 1H), 3.00 (dd, J = 11.5, 
4.0 Hz, 2H), 2.96 (dd, J = 11.5, 4.0 Hz, 2H). 13C{1H} NMR (CDCl3): δ 162.35, 
159.76, 145.97, 144.14, 136.90, 136.64, 136.47, 132.52, 129.89, 123.29, 121.68, 
28.09, 28.00. 
 
2.6.2 Synthesis of PdIV Complexes 2, 2-d6, 47-49,62-64, 69 
General Procedure. The appropriate bis-cyclometalated PdII starting material 
(0.24 mmol, 1 equiv) and oxidant (1.0-1.1 equiv) were combined in a 50 mL 
round bottomed flask equipped with a stir bar. CH2Cl2 (30 mL) was added, and 
the mixture was stirred at 25 ºC for between 10 min and 1 h. The solvent was 
evaporated to a volume of ~5 mL and hexanes (2-5 mL) was added to precipitate 
the product. The precipitate was collected and then suspended in Et2O (5-10 mL) 
and sonicated, leaving a finely suspended powder. This material was collected at 
the top of a pipette-sized column of Celite and washed with Et2O (5 mL). The 
product was then eluted with CH2Cl2, and the solvent was removed under 
vacuum. The PdIV products were isolated as off-white to yellow powders. If the 
resulting product was a tacky solid, the solid was washed with hexanes (2 mL) to 
the remove residual impurities.   
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Notably, all PdIV complexes were stored at –35 ºC. HRMS data are reported for 
each compound and showed loss of one carboxylate ligand (trans to the s-aryl 
group). The characterization of complexes 7-18, 64 was reported previously.12 In 
general the PdIV complexes were insufficiently soluble and/or insufficiently stable 








Complex 2: Yield: 81%. 1H NMR (acetone-d6): δ 9.45 (d, J = 5.5 Hz, 1H), 8.27 
(d, J = 8.0 Hz, 1H), 8.20 (t, 8.5, 1H), 8.09-8.06 (multiple peaks, 2H), 7.95-7.92 
(multiple peaks, 2H), 7.87 (d, J = 8.0 Hz, 1H), 7.62 (t, J = 6.0 Hz, 1H), 7.58 (d, J 
= 6.0 Hz, 1H), 7.51(t, J = 7.5 Hz, 1H), 7.46 (t, J = 7.5 Hz, 1H), 7.10-7.08 (multiple 
peaks, 2H), 6.85 (t, J = 8.5 Hz, 1H), 6.30 (d, J = 8.5 Hz, 1H), 1.75 (s, 3H), 1.62 
(s, 3H). FTIR (KBr): 1654, 1604, 1569, 1484, 1441, 1419, 1366, 1291, 1006, 759 
cm-1. HRMS-electrospray (m/z): [M – OAc]+ calcd for C24H19N2O2Pd, 473.0481; 










Complex 47: Yield: 63%. 1H NMR (CDCl3): δ 9.49 (dt, J = 5.5, 1.0 Hz, 1H), 8.07-
8.02 (multiple peaks, 5H), 7.98 (app. d, J = 8.5 Hz, 2H), 7.88 (dt, J = 8.5, 1.5 Hz, 
2H), 7.82 (app. d, J = 8.0 Hz, 2H), 7.80-7.78 (multiple peaks, 2H), 7.58 (d, J = 6.0 
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Hz, 1H), 7.54 (d, J = 2.0 Hz, 1H), 7.51 (dd, J = 9.0, 5.0 Hz, 1H), 7.49 (d, J = 2.0 
Hz, 1H), 7.31 (dd, J = 8.0, 2.0 Hz, 1H), 6.97 (td, J = 6.0, 2.5 Hz, 1H), 6.74 (dd, J 
= 8.0, 1.5 Hz, 1H), 6.39 (d, J = 8.0 Hz, 1H), 2.59 (s, 3H), 2.56 (s, 3H), 2.48 (s, 
3H), 2.29 (s, 3H). FTIR (KBr): 1683, 1652, 1603, 1558, 1483, 1426, 1260 cm-1. 
HRMS-electrospray (m/z): [M – O2C(p-AcC6H4)]+ calcd for C42H34N2O6Pd 










Complex 48: Yield: 77%. 1H NMR (CDCl3): δ 9.50 (dd, J = 5.5, 1.0 Hz, 1H), 8.15-
8.11 (multiple peaks, 2H), 8.04 (d, J = 8.0 Hz, 1H), 8.01 (d, J = 8.0 Hz, 2H), 7.98 
(d, J = 8.5 Hz, 2H), 7.89 (d, J = 8.0 Hz, 2H), 7.87 (m, 1H), 7.84 (d, J = 8.0 Hz, 
2H), 7.79 (d, J = 8.0 Hz, 1H), 7.47 (dd, J = 9.5, 3.0 Hz, 1H), 7.44 (dd, J = 9.0, 2.5 
Hz, 1H), 7.27 (td, J = 9.0, 3.0 Hz, 1H), 7.06 (td, J = 7.0, 1.5 Hz, 1H), 6.72 (td, J = 
9.0, 3.0 Hz, 1H), 6.44 (dd, J = 9.0, 5.5 Hz, 1H), 2.59 (s, 3H), 2.57 (s, 3H). 19F 
NMR (CDCl3): δ –114.72 (dt, J = 9.0, 6.0 Hz), –116.69 (dt, J = 9.0, 6.0 Hz). FTIR 
(KBr): 1683, 1652, 1604, 1564, 1484, 1464, 1426, 1261 cm-1. HRMS-
electrospray (m/z): [M – O2C(p-AcC6H4)]+ calcd for C40H28F2N2O6Pd  613.0555; 












Complex 49: Yield: 70%. 1H NMR (CDCl3): δ 9.48 (dd, J = 5.5, 1.0 Hz, 1H), 8.13 
(td, J = 7.5, 1.5 Hz, 1H), 8.10 (d, J = 8.5 Hz, 1H), 8.07 (app. d, J = 8.0 Hz, 1H), 
8.01 (d, J = 8.5 Hz, 2H), 7.98 (d, J = 8.5 Hz, 2H), 7.89 (d, J = 8.5 Hz, 2H), 7.87 
(dd, J = 8.0, 1.5 Hz, 1H), 7.84 (d, J = 8.0 Hz, 2H), 7.81 (dd, J = 8.0, 1.5 Hz, 1H), 
7.72 (d, J = 2.5 Hz, 1H), 7.70 (d, J = 2.5 Hz, 1H), 7.59 (ddd, J = 7.5, 5.5, 1.5 Hz, 
1H), 7.57 (dd, J = 6.0, 1.0 Hz, 1H), 7.49 (dd, J = 8.5, 2.5 Hz, 1H), 7.07 (ddd, J = 
7.5, 6.0, 1.5 Hz, 1H), 6.94 (dd, J = 9.0, 2.5 Hz, 1H), 6.43 (d, J = 8.5 Hz, 1H), 2.60 
(s, 3H), 2.57 (s, 3H). FTIR (KBr): 1683, 1652, 1604, 1558, 1482, 1422, 1262 cm-
1. HRMS-electrospray (m/z): [M – O2C(p-AcC6H4)]+ calcd for C40H28Cl2N2O6Pd 








Complex 64: Yield: 91%. 1H NMR (acetone-d6): δ 9.97 (dd, J = 5.0, 1.6 Hz, 1H), 
8.76 (dd, J = 8.0, 1.5 Hz, 1H), 8.54 (dd, J = 8.0, 1.5 Hz, 1H), 8.44 (d, J = 7.0 Hz, 
1H), 8.14-7.87 (multiple peaks, 12H), 7.66 (d, J = 7.6 Hz, 1H), 7.40 (dd, J = 8.0, 
6.0 Hz, 1H), 7.14 (t, J = 8.0, 1H), 6.44 (d, J = 7.6, 1H). 19F NMR: (acetone-d6): δ 
–72.46 (s, 3F), –72.52 (s, 3F). FTIR (KBr): 1718, 1658, 1620, 1568, 1490, 1455, 
1406, 1319 cm-1. HRMS-electrospray (m/z): [M – O2C[(p-C(O)CF3)C6H4] + 









Complex 63: Yield: 82%. 1H NMR (CDCl3): δ 9.33 (d, J = 4.5 Hz, 1H), 8.09-8.07 
(multiple peaks, 2H), 8.01-8.00 (ap. d, J = 9 Hz, 4H), 7.94-7.92 (multiple peaks, 
2H), 7.86 (d, J = 8.5 Hz, 1H), 7.80 (d, J = 7.0 Hz, 1H), 7.53 (d, J = 8.0 Hz, 1H), 
7.47-7.41 (multiple peaks, 2H), 7.35 (d, J = 5.5 Hz, 1H), 7.19 (d, J = 7.5 Hz, 1H), 
6.92-6.83 (multiple peaks, 3H), 6.34 (d, J = 8.0 Hz, 1H). 19F NMR: (acetone-d6): δ 
–72.35 (s, 3F), –72.42 (s, 3F). HRMS-electrospray (m/z): [M – O2C[(p-








Complex 62: Yield: 71%. 1H NMR (acetone-d6): δ 9.56 (d, J = 5.6 Hz, 1H), 8.38 
(d, J = 8.4 Hz, 1H), 8.27 (td, J = 7.2, 1.6 Hz, 1H), 8.22-8.17 (multiple peaks, 2H), 
8.11 (d, J = 6.8 Hz, 2H), 8.09-7.30 (multiple peaks, 9H), 7.70 (d, J = 5.2 Hz, 1H), 
7.70 (dd, J = 7.6, 5.6 Hz, 1H), 7.56-7.48 (multiple peaks, 2H), 7.22 (td, J = 6.0, 
1.6 Hz, 1H), 7.16 (t, J = 7.2 Hz, 1H), 6.94 (td, J = 8.6, 1.6 Hz, 1H), 6.48 (d, J = 
8.0 Hz, 1H). 19F NMR (acetone-d6): δ –72.36 (s, 3F), –72.43 (3F, s). FTIR (KBr): 
1717, 1604, 1569, 1485, 1442, 1335, 1185 cm-1. HRMS-electrospray (m/z): [M – 










Complex 2-d6:  Yield: 73%. 1H NMR (CDCl3): δ 9.36 (d, J = 4.8 Hz, 1H), 8.12 
(dd, J = 7.8, 1.0 Hz, 1H), 8.10-8.00 (multiple peaks, 2H), 7.76-7.73 (multiple 
peaks, 2H), 7.55-7.49 (multiple peaks, 3H), 7.44 (td, J = 7.5, 1.2 Hz, 1H), 7.07 
(td, J = 7.5, 1.0 Hz, 1H), 6.90 (m, 1H), 6.85 (ddd, J = 8.0, 7.0, 1.5 Hz, 1H), 6.38 
(dd, J = 8.0, 1.0 Hz, 1H). 2D NMR (CHCl3): δ 1.93 (s, 3H), 1.86 (s, 3H). FTIR 
(KBr): 1648, 1604, 1570, 1484, 1442, 1353, 1309, 1286, 1007, 760 cm-1. HRMS-









Complex 69: Under the general procedure conditions (above), a mixture of 
products was formed. Therefore, the reaction was carried out in dry acetone at 
45 °C and then worked up according to the general procedure above. Yield: 64%. 
1H NMR (acetone-d6): δ 9.73 (d, J = 5.0 Hz, 1H), 8.94 (d, J = 8.0 Hz, 1H), 8.62 (d, 
J = 8.0 Hz, 1H), 8.19-8.16 (multiple peaks, 4H), 8.12 (d, J = 9.0 Hz, 1H), 8.00-
7.94 (multiple peaks, 3H), 7.95 (d, J = 9.0 Hz, 1H), 7.86 (d, J = 6.0 Hz, 1H), 7.73 
(d, J = 8.0 Hz, 1H), 7.43 (d, J = 5.0 Hz, 1H), 7.41 (d, J = 5.0 Hz, 1H), 7.17 (t, J = 
8.0 Hz, 1H), 6.38 (d, J = 8.0 Hz, 1H). 19F NMR (acetone- d6): δ –81.79 to – 81.85 
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(multiple peaks, 6F), –116.6 to –116.80 (multiple peaks, 4F), –122.48 to –123.38 
(multiple peaks, 24F), –126.88 (br. s, 4F). FTIR (KBr): 1726, 1699, 1660, 1569, 
1456, 1408, 1364, 1322, 1210 cm-1. HRMS-electrospray (m/z): [M – O2CC9F19]+ 








Complex 71: Yield: 71%. 1H NMR (acetone-d6): δ 9.83 (d, J = 5.0 Hz, 1H), 8.77 
(d, J = 8.0 Hz, 1H), 8.42 (d, J = 8.0 Hz, 1H), 8.24 (d, J = 8.0 Hz, 1H), 8.08-7.83 
(multiple peaks, 7H), 7.69 (d, J = 6.0 Hz, 1H), 7.56 (d, J = 8.0 Hz, 1H), 7.26 
(multiplet, 1H), 7.03 (t, J = 8.0 Hz, 1H), 6.24 (d, J = 8.0 Hz, 1H), 1.73 (s, 3H), 
1.57 (s, 3H). FTIR (KBr): 1646, 1616, 1558, 1405, 1353, 1309, 1283, 914, 836, 
667 cm-1. HRMS-electrospray (m/z): [M – O2C2H3]+ calcd for C30H22N2O4Pd 
521.0481; Found, 521.0489.  
 
2.6.3 Synthesis of (Phpy)2Pd(Cl)(OAc) (21), (Phpy)2Pd(Cl)(OAc-d3) (S21-d3) 
and (Bzq)2Pd(Cl)(OAc) (73) 
General Procedure. The appropriate PdIV complex [either (Phpy)2Pd(OAc)2 or 
(Phpy)2Pd(OAc-d3)2] (0.12 mmol, 1.0 equiv) was dissolved in THF (10 mL). LiCl 
(52 mg, 1.2 mmol, 10 equiv) was added, and the reaction was stirred for 30 min. 
The precipitate from the reaction was collected on a frit, washed with THF, and 
dried under vacuum. The resulting off-white solid was dissolved in acetone (12 
mL), and HCl (1 M solution in Et2O, 100 µL, 0.10 mmol, 0.84 equiv) was added. 
The mixture was stirred for 3 h, and then the solvent was removed under vacuum 









(Phpy)2Pd(Cl)(OAc) (21). Yield: 31%. 1H NMR (DMSO-d6): δ 9.62 (d, J = 4.0 Hz, 
1H), 8.39 (d, J = 8.0 Hz, 1H), 8.31-8.27 (multiple peaks, 2H), 8.08-8.04 (multiple 
peaks, 2H), 7.97 (d, J = 6.5 Hz, 1H), 7.89 (d, J = 8.5 Hz, 1H), 7.76 (t, J = 7.0 Hz, 
1H), 7.51 (t, J = 8.0 Hz, 1H), 7.22-7.18 (multiple peaks, 2H), 7.12 (t, J = 7.0 Hz, 
1H), 6.92 (t, J = 7.0, 1H), 6.19 (d, J = 8.0 Hz, 1H), 1.72 (s, 3H). FTIR (KBr): 1758, 
1650, 1603, 1567, 1464, 1421, 1294 cm-1. HRMS-electrospray (m/z): [M – Cl]+ 








(Phpy)2Pd(Cl)(OAc-d3) (S21-d3). Yield: 43%. 1H NMR (DMSO-d6): δ 9.61 (d, J = 
4.0 Hz, 1H), 8.39 (d, J = 8.0 Hz, 1H), 8.31-8.24 (multiple peaks, 2H), 8.07-8.02 
(multiple peaks, 2H), 7.96 (d, J = 7.5 Hz, 1H), 7.88 (d, J = 8.5 Hz, 1H), 7.75 (t, J 
= 6.0 Hz, 1H), 7.57 (t, J = 8.0 Hz, 1H), 7.49 (t, J = 7.5 Hz, 1H), 7.23-7.19 
(multiple peaks, 2H), 7.11 (t, J = 7.5 Hz, 1H), 6.92 (t, J = 8.0 Hz, 1H), 6.19 (d, J = 
8.0 Hz, 1H). 2H NMR (DMSO): δ 1.99 (s, 3D). FTIR (KBr): 1640, 1602, 1579, 
1567, 1484, 1439, 1410, 1305 cm-1. HRMS-electrospray (m/z): [M – Cl]+ calcd for 









(Bzq)2Pd(Cl)(OAc) (73). Yield: 96%. 1H NMR (DMSO-d6): δ 9.91 (d, J = 5.0 Hz, 
1H), 8.92 (d, J = 8.0 Hz, 1H), 8.60 (d, J = 8 Hz, 1H), 8.21-8.15 (multiple peaks, 
4H), 8.09 (d, J = 9.0 Hz, 1H), 8.03 (t, J = 8.0 Hz, 1H), 7.98-7.95 (multiple peaks, 
2H), 7.67 (d, J = 7.5 Hz, 1H), 7.42-7.40 (multiplet, 1H), 7.35 (d, J = 6.0 Hz, 1H), 
7.14 (t, J = 8.0 Hz, 1H), 6.20 (d, J = 8.0 Hz, 1H), 1.74 (s, 3H). FTIR (KBr): cm-1. 
HRMS-electrospray (m/z): [M – Cl]+ calcd for C28H19ClN2O2Pd 521.0481; Found, 
521.0488.  
 
2.6.4 Synthesis of PdIV Complexes 2a-d3, 2b-d3 and 6 Containing Mixed 
Carboxylate Ligands 
 
General Procedure. Complex 21 or S21-d3 (0.074 mmol, 1 equiv) and AgO2CR 
(0.082 mmol, 1.1 equiv) were dissolved in a 50/50 solution of CH2Cl2/EtOAc (16 
mL). The reaction mixture was stirred for 1.5 h, and was then filtered through a 












(Phpy)2Pd(O2CC9H19)(OAc) (19).  Yield: 74%. 1H NMR (CDCl3): δ 9.39 (d, J = 5.0 
Hz, 1H), 8.08 (d, J = 8.0 Hz, 1H), 8.02-7.98 (multiple peaks, 2H), 7.70 (multiple 
peaks, J = 4.0 Hz, 2H), 7.65-7.61 (multiple peaks, 2H), 7.54 (d, J = 6.0 Hz, 1H), 
7.50-7.38 (multiple peaks, 2H), 7.40 (t, J = 7.0 Hz, 1H), 7.04 (t, J = 7.0 Hz, 1H), 
6.87-6.82 (multiple peaks, 2H), 6.35 (d, J = 8.0 Hz, 1H), 2.07 (t, J = 8.0 Hz, 2H), 
1.93 (s, 3H), 1.33-0.99 (multiple peaks, 14H), 0.85 (t, J = 7.0 Hz, 3H). HRMS-









(Phpy)2Pd(OAc-d3)(OAc) (2a-d3).  Yield: 53%. 1H NMR (acetone-d6): δ 9.44 (d, J 
= 5.0 Hz, 1H), 8.26 (d, J = 8.0 Hz, 1H), 8.19 (t, J = 8.0 Hz, 1H), 8.07-8.05 
(multiple peaks, 2H), 7.94-7.91 (multiple peaks, 2H), 7.86 (d, J = 8.0 Hz, 1H), 
7.60 (t, J = 5.5 Hz, 1H), 7.57 (d, J = 5.5 Hz, 1H), 7.50 (t, J = 7.5 Hz, 1H), 7.46-
7.43 (multiple peaks, 2H), 7.07 (multiple peaks, 2H), 6.84 (t, J = 8.5 Hz, 1H), 6.29 
(d, J = 8.5 Hz, 1H), 1.73 (s, 3H). 2H NMR (CHCl3): δ 1.86 (s, 3D). HRMS-










(Phpy)2Pd(OAc)(OAc-d3) (2b-d3).  Yield: 51%. 1H NMR (acetone-d6): δ 9.42 (d, J 
= 5.0 Hz, 1H), 8.24 (dd, J = 7.0 Hz, 1H), 8.17 (t, J = 8.0 Hz, 1H), 8.06-8.03 
(multiple peaks, 2H), 7.93-7.88 (multiple peaks, 2H), 7.85 (d, J = 8.0 Hz, 1H), 
7.60-7.54 (multiple peaks, 2H), 7.50-7.41 (multiple peaks, 2H), 7.07-7.02 
(multiple peaks, 2H), 6.82 (t, J = 7.0 Hz, 1H), 6.28 (d, J = 8.0 Hz, 1H), 1.60 (s, 
3H). 2H NMR (CHCl3): δ 1.94 (s, 3D). HRMS-electrospray (m/z): [M – OAc]+ calcd 
for C26H19D3N2O4Pd 476.0670; Found, 476.0675.  
 
2.6.5 Characterization of Organic Products of C–O Bond-Forming 
Reductive Elimination 
The organic reductive elimination products were challenging to purify from the 
crude reaction mixtures. As a result they were synthesized independently 
according to the general procedure below. In all cases, the products were 
spectroscopically identical to those observed by 1H NMR spectroscopy in the 
reductive elimination reactions.  
General Procedure. The appropriate arylpyridine substrate (1.7 mmol, 1.0 
equiv), PhI[O2C(p-AcC6H4)]2 (3.4 mmol, 2.0 equiv), and Pd(OAc)2 (0.05 mmol, 3 
mol %) were dissolved in CH3CN (18 mL) in a 20 mL vial. The vial was sealed 
with a Teflon-lined cap, and the reaction mixture was heated at 80°C for 12 h. 
The solvent was removed under vacuum, and the resulting brown residue was 
re-dissolved in CH2Cl2 (15 mL). The organic layer was extracted with saturated 
NaHCO3 (2 x 30 mL) and then dried over MgSO4. The products were purified by 










Benzo[h]quinolin-10-yl-4-(2,2,2-trifluoroacetyl)benzoate (65): Yield: 37% of 
an off-white tacky solid. Rf = 0.1 in 59% hexanes/40% ethyl acetate/1% 
triethylamine. 1H NMR (CDCl3): δ 8.54 (d, J = 4.0 Hz, 1H), 8.33 (dd, J = 4.5, 1.5 
Hz, 1H), 8.3 (d, J = 8.0 Hz, 2H), 8.14 (dd, J = 8.0, 1.5 Hz, 1H), 7.93 (d, J = 7.0 
Hz, 1H) 7.9 (d, J = 9.0 Hz, 1H), 7.76 (t, J = 8.0 Hz, 1H), 7.73 (d, J = 9.0 Hz, 1H), 
7.55 (d, J = 8.0 Hz, 1H), 7.39 (dd, J = 8.0, 4.5, 1H). 19F NMR (CDCl3): δ –71.55 
(s, 3F). FTIR (KBr): 1741, 1718, 1595, 1410, 1270, 1190, 1087, 942, 836, 716 
cm-1. When this compound was dissolved in DMSO-d6 (required for sufficient 
solubility to obtain a 13C NMR spectrum), partial hydration of the 
trifluoromethylketone was observed. The reductive elimination products from 64 










(5,6-Dihydrobenzo[h]quinolin-10-yl 4-(2,2,2-trifluoroacetyl)benzoate (S5): 
Isolated directly from reductive elimination of 63 (0.028 mmol) at 80°C in CH3CN 
(1.8 mL) and purified via column chromatography. Yield: 78% of an off-white 
tacky solid. Rf = 0.2 in 59% hexanes/40% ethyl acetate/1% triethylamine. 1H 
NMR (CDCl3): δ 8.38-8.35 (multiple peaks, 2H), 8.18 (d, J = 8.0 Hz, 2H), 7.89 
(dd, J = 5.0, 2.0 Hz, 1H), 7.44 (dd, J = 8.0, 2.0 Hz, 1H), 7.36 (t, J = 8.0 Hz, 1H), 
7.21 (dd, J = 6.5, 1.0 Hz, 1H), 7.13 (dd, J = 8.0, 1.0 Hz, 1H), 6.95 (dd, J = 5.0, 
3.0 Hz, 1H), 2.95-2.91 (multiple peaks, 4H). 19F NMR (CDCl3): δ –71.38 (s, 3F). 
FTIR (KBr): 1744, 1718, 1278, 1227, 1202, 1179, 1141, 1091, 941, 802, 720 cm-
1. When this compound was dissolved in DMSO-d6 (required for sufficient 
solubility to obtain a 13C NMR spectrum), partial hydration of the 
trifluoromethylketone was observed. The reductive elimination products were 
further characterized by treatment with a solution of NaOH in methanol to convert 
S5 to 5,6-dihydrobenzo[h]quinolin-10-ol. 1H NMR (CDCl3): δ 14.01 (s, 1H), 8.30 
(d, J = 4.5 Hz, 1H), 7.56 (d, J = 7.0 Hz, 1H), 7.20-7.16 (multiple peaks, 2H), 6.86 
(d, J = 8.0 Hz, 1H), 6.69 (d, J = 7.0 Hz, 1H), 2.89 (multiplet, 4H). 13C{1H} NMR 
(CDCl3): δ 159.47, 154.68, 144.11, 138.99, 136.34, 131.93, 131.04, 121.52, 
118.39, 116.61, 116.01, 28.19, 27.95. HRMS-electrospray (m/z): [M + H]+ calcd 









2-(pyridin-2-yl)phenyl 4-(2,2,2-trifluoroacetyl)benzoate (S6): Yield: 26% of an 
off-white tacky solid. Rf = 0.1 in 59% hexanes/40% ethyl acetate/1% 
triethylamine. 1H NMR (CDCl3): δ 8.51 (d, J = 6.0, 2.0 Hz, 1H), 8.24 (d, J = 8.0 
Hz, 2H), 8.24 (d, J = 8.0 Hz, 2H), 7.74 (dd, J = 6.0, 2.0 Hz, 1H), 7.67 (td, J = 8.0, 
2.0, 1H), 7.55-7.50 (multiple peaks, 2H), 7.44 (td, J = 8.0, 1.0 Hz, 1H), 7.33 (dd, J 
= 8.0, 1.0 Hz, 1H), 7.16 (ddd, J = 5.0, 3.0, 1.0 Hz, 1H). 19F NMR (CDCl3): δ –
71.64 (3F, s). FTIR (KBr): 1733, 1469, 1270, 1180, 1116, 1072, 1053, 1016, 923, 
859, 755, 709 cm-1. When this compound was dissolved in DMSO-d6 (required 
for sufficient solubility to obtain a 13C NMR spectrum), partial hydration of the 
trifluoromethylketone was observed. The reductive elimination products were 
further characterized by treatment with a solution of NaOH in methanol to convert 





Benzo[h]quinolin-10-yl deconate (68): Yield: 36 % of a yellow oil. Rf = 0.2 in 
79% hexanes/20% ethyl acetate/1% triethylamine. 1H NMR (acetone-d6): δ 8.99 
(dd, J = 4.0, 2.0 Hz, 1H), 8.36 (dd, J = 8.0, 2.0 Hz, 1H), 7.97-7.94 (multiple 
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peaks, 2H), 7.85 (d, J = 9.0 Hz, 1H) 7.74 (t, J = 8.0 Hz, 1H), 7.62 (dd, J = 8.0, 4.0 
Hz, 1H), 7.40 (dd, J = 8.0, 1.0 Hz, 1H), 2.89 (t, J = 7.5 Hz, 2H), 1.83 (m, 2H), 
1.54 (m, 2H), 1.42-1.29 (multiple peaks, 10H), 0.88 (t, J = 7.0 Hz, 3H). 13C{1H} 
NMR (CDCl3): δ 173.77, 149.01, 148.18, 145.89, 136.20, 135.87, 128.25, 128.22, 
127.43, 126.77, 126.51, 123.63, 122.43, 121.67, 35.06, 32.11, 29.71, 29.67, 
29.65, 29.53, 24.90, 22.89, 14.34. FTIR (KBr): 3048, 2925, 2853, 1757, 1622, 
1593, 1444, 1403, 1142, 834, 806, 746, 721 cm-1. HRMS-electrospray (m/z): [M 
+ H]+ calcd 350.2120 for C23H27NO2; Found, 350.2126. 
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2.6.5 Characterization of Inorganic Products of C–O Bond-Forming 
Reductive Elimination 
 
The inorganic reductive elimination products were challenging to purify cleanly 
from the crude reaction mixtures. As a result they were synthesized 
independently according to the following three-step sequence. In all cases, the 
products were spectroscopically identical to those observed by 1H NMR 
spectroscopy in the reductive elimination reactions. 
 



















ArCO2 212 h 12 h  
 
General Procedure. Step 1: The appropriate N~C ligand (0.56 mmol, 1.0 equiv) 
and Pd(OAc)2 (0.56 mmol, 1.0 equiv) were dissolved in MeOH (8 mL). The 
orange reaction mixture was allowed to stir for 12 h. The resulting solid 
precipitate was collected on a frit and washed with hexanes. For further 
purification, the solid was re-dissolved in CH2Cl2, precipitated with hexanes and 
dried under vacuum to afford the products as bright yellow solids. Step 2: The 
yellow solid from step 1 (0.30 mmol, 1.0 equiv) was combined with LiCl (1.45 
mmol, 4.8 equiv) in acetone (3.25 mL) and water (325 µL). The reaction mixture 
was stirred for 12 h. A precipitate was formed and collected on a frit. The product 
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washed with hexanes and dried under vacuum to afford a pale yellow solid. Step 
3: The solid from step 2 (0.25 mmol, 1.0 equiv) was combined with Ag(O2CAr) 
(0.62 mmol, 2.5 equiv) in a mixture of CH2Cl2 (12 mL) and EtOAc (8 mL). The 
reaction mixture was stirred for 12 h, then filtered through a plug of celite. The 
solvent was removed under vacuum, and the resulting residue was recrystallized 








BzqPd(C5D5N)OBzC(O)CF3 (S7): Yield: 56%. 1H NMR (CDCl3 containing 20% 
C5D5N): δ 8.71 (d, J = 4.8 Hz, 1H), 8.30 (dd, J = 8.4, 1.2 Hz, 1H), 8.26 (d, J = 8.0 
Hz, 2H), 8.07 (d, J = 8.0 Hz, 2H), 7.76 (d, J = 8.4 Hz, 1H), 7.63-7.58 (multiple 
peaks, 2H), 7.45 (dd, J = 8.0, 5.2 Hz, 1H), 7.30 (d, J = 7.2 Hz, 1H), 6.47 (d, J = 
7.6 Hz, 1H). 19F NMR (CDCl3): δ –71.44 (s, 3F). FTIR (KBr): 1599, 1555, 1485, 








BzqH2Pd(C5D5N)OBzC(O)CF3 (S8): Yield: 51%. 1H NMR (CDCl3 containing 20% 
C5D5N): δ 8.27 (d, J = 8.8 Hz, 1H), 8.07 (d, J = 8.4 Hz, 1H), 7.50 (d, J = 7.6 Hz, 
2H), 7.00 (t, J = 6.4 Hz, 2H), 6.90-6.86 (multiple peaks, 3H), 6.08 (d, J = 6.4 Hz, 
1H), 2.93 (app. s, 4H). 19F NMR (CDCl3): δ –71.57. FTIR (KBr): 1599, 1564, 









(Phpy)2Pd(C5D5N)OBzC(O)CF3 (S9): Yield: 43%. 1H NMR (CDCl3 containing 20% 
C5D5N): δ 8.51 (d, J = 4.4 Hz, 1H), 8.21 (d, J = 7.6 Hz, 2H), 8.05 (d, J = 7.6 Hz, 
2H), 7.80 (td, J = 8.0, 1.2 Hz, 1H), 7.68-7.65 (multiple peaks, 2H), 7.47 (d, J = 7.6 
Hz, 1H), 7.10-7.07 (multiple peaks, 2H), 6.94 (t, J = 7.8 Hz, 1H), 6.25 (d, J = 8.0 
Hz, 1H). 19F NMR (CDCl3): δ –71.50 (s, 3F). FTIR (KBr): 1600, 1556, 1384, 1319, 
1164, 1065, 941, 712, 532 cm-1.  
 
Attempts to isolate clean samples of the dimeric PdII species observed in the 
reductive elimination of PdIV complexes 58-60 were hindered by the hazards 
associated with working with Ag(O2C(p-C(O)AcC6H4). Although the explosive 
nature of this salt has not been reported previously, it was found that when dried 









2.6.6 General Procedure for Crossover studies 
 



































Complex 2-d6 or 2b-d3 (6.2 mg, 0.012 mmol) was dissolved in DMSO or CHCl3 
(0.8 mL) in a 4 mL vial in a N2-filled drybox. If appropriate, NBu4(OAc) (18 mg, 
0.060 mmol, 5.0 equiv) was added to this solution. The vial was sealed with a 
Teflon-lined cap, removed from the drybox, and heated at 60 °C for 5 h. The 
resulting mixture was evaporated to dryness, redissolved in CH2Cl2 (3 mL), then 
filtered through a pipette plug containing 25% poly-4-vinylpyridine and 75% silica 
gel. The plug was washed with a 9 : 1 solution of hexanes : ethyl acetate that 
contained 1% triethylamine (~20 mL total volume). The solvent was then 
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removed under vacuum, and the organic products were analyzed by 1H and 2H 
NMR spectroscopy. The ratio of 3-d3 to 3 was determined by integration of H6 of 
the pyridine (8.68 ppm) relative to the methyl group of the acetate (2.17 ppm) in 
CDCl3. Each experiment was carried out in triplicate, and the results reported in 
the manuscript represent an average of three runs.  
 
2.6.7 Source of error in Kinetics Experiments 
Error in the kinetics experiments most likely arises from a slight temperature 
instability in the NMR spectrometer. Additionally minor inconsistencies in the 
amount of pyridine added to the reaction have been shown to affect the rate of 
C–O bond formation. In the case of the carboxylate exchange reactions, the 
close proximity of the resonances associated with the starting materials and 
products leads to some error in the integration values. The error was calculated 
by taking an average of the trials. The standard deviation of the average was 
then calculated. The average was added to the standard deviation, and the 
difference and sum of these values were taken against the average to obtain the 
plus/minus values. 
2.6.8 General Procedure for Solvent Study of Kinetics of Carboxylate 
Exchange 
 

















Complex 7 (5.8 mg, 0.0076 mmol, 1.0 equiv) was dissolved in an appropriate 
deuterated solvent (0.25 mL) in a screw cap NMR tube in a N2-filled drybox. The 
NMR tube was sealed with a Teflon-lined cap fitted with a septum, and removed 
from the drybox. Bu4NOAc (2.4 mg, 0.0076 mmol, 1.0 equiv) was dissolved in the 
appropriate deuterated solvent (0.25 mL) in a 4 mL vial, and the vial was sealed 
with a Teflon-lined cap fitted with a septum and removed from the glovebox. The 
solution in the NMR tube was frozen in liquid nitrogen, and the [Bu4NOAc] 
solution was added via syringe. The NMR tube was placed in the NMR 
spectrometer where the probe had been pre-cooled to –38 ºC. The sample was 
allowed to equilibrate in the spectrometer for six minutes before acquiring 
spectra. The rate of carboxylate exchange was then studied by 1H NMR 
spectroscopy at –38 ºC by monitoring the disappearance of the most downfield 
resonance (9.51 ppm in acetone-d6, 9.33 in CD3CN, 9.27 in CDCl3, 9.82 in 
toluene-d8). The reaction was followed until it reached equilibrium and then fitted 
to a first order kinetics plot for a reversible reaction.37 Each experiment was 
carried out in duplicate, and the k values represent an average of two runs. 
Notably, when the experiment was run in toluene, no exchange was observed 
over the course of approximately 6 h at –38 ºC.  
 
2.6.9 General procedure for Eyring Plot for Carboxylate Exchange 
 

















Complex 7 (5.8 mg, 0.0076 mmol, 1.0 equiv) was dissolved in CDCl3 (0.25 mL) in 
a screw cap NMR tube in a N2-filled drybox. The NMR tube was sealed with a 
Teflon-lined cap fitted with a septum, and removed from the drybox. Bu4NOAc 
(2.4 mg, 0.0076 mmol, 1.0 equiv) was dissolved in the appropriate deuterated 
solvent (0.25 mL) in a 4 mL vial, and the vial was sealed with a Teflon-lined cap 
fitted with a septum and removed from the glovebox. The solution in the NMR 
tube was frozen in liquid nitrogen, and the [Bu4NOAc] solution was added via 
syringe. The NMR tube was placed in the NMR spectrometer where the probe 
had been pre-cooled to the appropriate temperature. The sample was allowed to 
equilibrate in the spectrometer for six minutes before acquiring spectra. The rate 
of carboxylate exchange was then studied by 1H NMR spectroscopy at –58 ºC, –
53 ºC, –50 ºC, –48 ºC and –38 ºC by monitoring the disappearance of the most 
downfield resonance (9.27 ppm in CDCl3). The reaction was followed until it 
reached equilibrium and then fitted to a first order kinetics plot for a reversible 
reaction. The rates shown in Table S2 below are an average of two trials.  
Table 2.6.9.1 Rate Data for Carboxylate Exchange at Complex 7 as a 
Function of Solvent 
 
Solvent kobs (s-1 x 104)a 
toluene-d8 <0.1 
acetone-d6 3.6 ± 0.1 
CD3CN 7.6 ± 0.1 
CDCl3 70 ± 0.1 
a Values represent an average of two kinetics runs 
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Figure 2.6.9.1 Representative Kinetics Data for Carboxylate Exchange at 7 
in CH3CN at –38 °C 
 



































Table 2.6.9.2 Rate Data for Carboxylate Exchange at Complex 7 as a 
Function of Temperature 
 
Temperature kobs (s-1 x 104)a 
–58 ºC 4.1± 0.1 
–53 ºC 5.4± 0.0 
–50 ºC 20 ± 0.4 
–48 ºC 19 ± 0.5 
–38 ºC 70 ± 0.1 
a Values represent an average of two kinetics runs 





























2.6.10 General Procedure for Kinetics with Acidic Additives 
 





















R = C9H19 R = C9H19
 
Carboxylate Exchange (HOAc). Complex 7 (5.8 mg, 0.0076 mmol, 1.0 equiv) 
was dissolved in acetone-d6 (0.25 mL) in a screw cap NMR tube in a N2-filled 
drybox. The NMR tube was sealed with a Teflon-lined cap fitted with a septum, 
and removed from the drybox. Bu4NOAc (2.4 mg, 0.0076 mmol, 1.0 equiv) and a 
stock solution of AcOH (0.25 mL of a 14 mM stock solution in acetone-d6, 0.0035 
mmol, 0.5 equiv) was dissolved in the acetone-d6 (0.25 mL) in a 4 mL vial, and 
the vial was sealed with a Teflon-lined cap fitted with a septum and removed 
from the glovebox. The solution in the NMR tube was frozen in liquid nitrogen, 
and the [Bu4NOAc]/acid solution was added via syringe. The NMR tube was 
quickly shaken and placed in the NMR spectrometer where the probe had been 
pre-cooled to –35 ºC. The sample was allowed to equilibrate in the spectrometer 
for six minutes before acquiring spectra. Carboxylate exchange was studied by 
1H NMR spectroscopy by monitoring the disappearance of the most downfield 
signal (at 9.51 ppm in acetone-d6). The reaction was followed until it reached 
equilibrium and then the data was fitted to a first order kinetics plot for a 
reversible reaction. Each experiment was carried out in duplicate, and the k 
values represent an average of two runs. 
 
 77 
Reductive Elimination (HOAc). Complex 7 (5.8 mg, 0.0076 mmol, 1.0 equiv) 
was dissolved acetone-d6 (0.5 mL) in a screw cap NMR tube in a N2-filled drybox. 
AcOH (0.5 mL of a 7 mM stock solution in acetone-d6, 0.0035 mmol, 0.5 equiv) 
was then added. The tube was sealed with a Teflon-lined cap, shaken, and 
removed from the drybox. The tube was quickly placed in the NMR spectrometer, 
and the reaction was allowed to equilibrate for six minutes in the spectrometer 
before acquisition was started. The kinetics of reductive elimination was studied 
by 1H NMR spectroscopy by monitoring the disappearance of the most downfield 
signal (at 9.51 ppm in acetone at 40 °C). The data was fit to a first order kinetics 
plot. Each experiment was carried out in duplicate, and the k values represent an 
average of two runs. 





















R = C9H19R = C9H19
 
 
Carboxylate Exchange (AgOTf). Complex 7 (5.8 mg, 0.0076 mmol, 1.0 equiv) 
was dissolved in CDCl3 (0.25 mL) in a 4 mL vial in a N2-filled drybox. AgOTf was 
added to a screw cap NMR tube as a stock solution in THF (40 µL of a 50 mM 
stock solution, 0.50 mg, 0.002 mmol, 0.3 equiv). The solvent was then removed 
from the tube under high vacuum. The NMR tube was then transferred into a N2-
filled drybox and Bu4NOAc (2.4 mg, 0.0076 mmol, 1.0 equiv) dissolved in 0.25 
mL of CDCl3 was added to the NMR tube, which was then sealed with a Teflon-
lined cap fitted with a septum, and removed from the drybox. This solution was 
frozen in liquid N2, and complex 7 (5.8 mg, 0.0076 mmol, 1.0 equiv) was 
dissolved in CDCl3 (0.25 mL) and added to the NMR tube via syringe. The NMR 
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tube was quickly shaken and placed in the NMR spectrometer where the probe 
had been pre-cooled to –53 ºC. The sample was allowed to equilibrate in the 
spectrometer for six minutes before acquiring spectra. Carboxylate exchange 
was studied by 1H NMR spectroscopy by monitoring the disappearance of the 
most downfield signal (9.42 ppm in CDCl3). The reaction was followed until it 
reached equilibrium and then the data was fitted to a first order kinetics plot for a 
reversible reaction. Each experiment was carried out in duplicate, and the k 
values represent an average of two runs. 
 
Reductive Elimination (AgOTf). AgOTf was added to a screw cap NMR tube as 
a stock solution in THF (40 µL of a 50 mM stock solution, 0.50 mg, 0.002 mmol, 
0.3 equiv). The solvent was then removed from the tube under high vacuum. The 
NMR tube was transferred into a N2-filled drybox. Complex 7 (5.8 mg, 0.0076 
mmol, 1.0 equiv) was dissolved in CDCl3 (0.5 mL) in a 4 mL vial and then 
transferred to the screw cap NMR tube that contained the AgOTf. The tube was 
sealed with a Teflon-lined cap, shaken, and removed from the drybox. The tube 
was quickly placed in the NMR spectrometer, and the reaction was allowed to 
equilibrate for six minutes in the spectrometer before acquisition was started. The 
kinetics of reductive elimination were studied by 1H NMR spectroscopy by 
monitoring the disappearance of the most downfield signal (9.42 ppm in CDCl3 at 
23 °C). The data was fit to a first order kinetics plot. Each experiment was carried 







Table 2.6.10.1 Effect of AcOH on C–O Bond-Forming Reductive Elimination 







k (s-1 x 104), -35 °C 




k (s-1 x 104), 40 °C 
AcOH 15.0 1.3 
no AcOH 3.3 0.82 
   
acceleration 4.5 ± 0.7 3.6 ± 0.4 
 











Table 2.6.10.2 Effect of AgOTf on C–O Bond-Forming Reductive Elimination 







k (s-1 x 104), -53 °C 




k (s-1 x 104), 23 °C 
AgOTf 54 4.0 
no AgOTf 6.2 0.26 
   
acceleration 8.7 ±  0.1 16 ±  0.8 











Figure 2.6.10.1 Representative Kinetics Data for Reductive Elimination of 7 
with AcOH 
 




































Figure 2.6.10.2 Representative Kinetics Data for Carboxylate Exchange at 7 
with AgOTf 











































2.6.11 General Procedure for Studies of Arylpyridine Electronics 
 
























The PdIV complex (0.0076 mmol) was dissolved in CDCl3 containing 5% by 
volume pyridine-d5 (0.5 mL) in a screw cap NMR tube in a N2-filled drybox. The 
tube was sealed with a Teflon-lined cap and removed from the drybox. The 
kinetics of carboxylate exchange were studied by 1H NMR spectroscopy at 60 ºC 
by monitoring the disappearance of the most downfield resonance and the most 
upfield aromatic resonance of each complex. The rates of disappearance from 
these peaks were averaged. The data are summarized in Table 2.6.11.1. The 









Table 2.6.11.1 Data for Hammett Plot of Arylpyridine Electronics 
 
Compound 
 kobs (s-1 x 
105) σpara 
*OMe 3.08 –0.27 
Me 4.81  –0.14 
H 20.0  0.00 
F 3.64  0.15 
Cl 36.9  0.24 
*CF3 323 1.4 
* These complexes were studied but clean samples were not obtained. 



























2.6.12 General Procedure for Rigidity Kinetics and C-O vs. C-C Product 
Formation 
















Effect of Ligand Rigidity on Rate of Reductive Elimination. The PdIV complex 
(0.0076 mmol) was dissolved in CDCl3 containing 5% by volume pyridine-d5 (0.5 
mL) in a screw cap NMR tube in a N2-filled drybox. The tube was sealed with a 
Teflon-lined cap and removed from the drybox. The kinetics of reductive 
elimination was studied by 1H NMR spectroscopy at 50 ºC by monitoring the 
disappearance of the most downfield resonance associated with each PdIV 
complex. Two trials were run and the rates of disappearance from the runs were 
averaged. The data are summarized in Table S6.  
Table 2.6.12.1 Data for Ligand Rigidity Kinetics 
Substrate  kobs (s-1 x 105) krel 
62 1.96 ± 0.1 1.9 
63 1.06 ± 0.1 1.0 
64 N/A ~0.1* 
* The slow reaction rate along with competing C–C bond-formation prevented 
quantitative rate measurement in this system. 
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2.6.13 Competing C–C and C–O Bond-Forming Reductive Elimination  
 
Observation of Competing C–O and C–C Bond-Forming Reductive 
Elimination from 64. Complex 64 (0.0076 mmol) was dissolved in CHCl3 
containing 5% by volume pyridine (0.5 mL) in a 4 mL vial in a drybox. The vial 
was sealed with a Teflon-lined cap, removed from the drybox, and heated at 50 
ºC for 4 d. The solvent was removed under vacuum, and the resulting residue 
was taken up in CH2Cl2 (1 mL) and filtered through a plug containing 25% poly-4-
vinylpyridine and 75% Celite. The plug was washed with CH2Cl2 (10 mL), the 
solvent was removed under vacuum, and the reaction was analyzed by 1H NMR 
spectroscopy in CDCl3. The ratio of C–O to C–C products for reductive 
elimination from 64 was determined by integration of signals at 8.54 ppm for 65 
(C–O) and at 7.74 ppm for 66 (C–C). The results listed below represent the 













Table 2.6.13.1 Competing C–O and C–C Bond-Forming Reductive 

















yield 65 : yield 
66 
64 24% : 76% 
average of two trials 
2.6.14 Effect of Solvent on the Ratio of C–C versus C–O Bond-Forming 
Reductive Elimination  
 
Complex 67 (6.1 mg, 0.0076 mmol) was dissolved in the appropriate solvent (0.5 
mL) in a 4 mL vial in a drybox. The vial was sealed with a Teflon-lined cap, 
removed from the drybox, and heated at 80 ºC for 4 h. The solvent was removed 
under vacuum, and the resulting residue was taken up in CH2Cl2 (1 mL), and 
filtered through a plug containing 25% poly-4-vinylpyridine and 75% Celite. The 
plug was washed with CH2Cl2 (10 mL), the solvent was removed under vacuum, 
and the reaction was analyzed by 1H NMR spectroscopy in acetone-d6. The ratio 
of C–C to C–O products was determined by integration of signals at 8.93 ppm for 
68 (C–O) and at 7.98-8.08 ppm for 66 (C–C). The results listed below represent 
the average of two trials. 
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Table 2.6.14.1 Effect of Solvent on the Product Ratio of Reductive 
Elimination from 67 
 
Solvent Ratio 66 : 68 
CH3CN 0.25 : 1.0 
CHCl3 0.77 : 1.0 
nitrobenzene 2.2 : 1.0 
DMSO 3.3 : 1.0 
acetone 13 : 1.0 
benzene > 20 : 1 
* average of two trials 
2.6.15 Effect of Carboxylate on the Ratio of C–C versus C–O Bond-Forming 
Reductive Elimination  
 
Scheme 2.6.15.1 Effect of Carboxylate on the Ratio of C–C versus C–O 















(70) (66)  
 
 89 
Complex 69 (11.3 mg, 0.0076 mmol) was dissolved in the appropriate solvent 
(0.5 mL) in a 4 mL vial in a drybox. The vial was sealed with a Teflon-lined cap, 
removed from the drybox, and heated at 80 ºC for 8 d. The solvent was removed 
under vacuum, and the resulting residue was taken up in CH2Cl2 (1 mL), and 
filtered through a plug containing 25% poly-4-vinylpyridine and 75% Celite. The 
plug was washed with CH2Cl2 (10 mL), the solvent was removed under vacuum, 
and the reaction was analyzed by 1H NMR spectroscopy in acetone-d6. In all 
cases, the sole product observed was 66 (C–C). 
 
Table 2.6.15.1 Solvent Effects on Product Distribution of Reductive 








2.6.16 Effect of Additives on the Relative Rates of C–C versus C–O Bond-
Forming Reductive Elimination 
 
Additive = AcOH. Complex 67 (6.1 mg, 0.0076 mmol, 1.0 equiv) was dissolved 
in acetone (0.5 mL) in a 4 mL vial in a drybox. AcOH (2.2 µL, 0.038 mmol, 5 
equiv) was added, and then the vial was sealed with a Teflon-lined cap, removed 
from the drybox, and heated at 80 ºC for 3 h. The solvent was removed under 
vacuum, and the resulting residue was taken up in CH2Cl2 (1 mL), and filtered 
through a plug containing 25% poly-4-vinylpyridine and 75% Celite. The plug was 
washed with CH2Cl2 (10 mL), the solvent was removed under vacuum, and the 
reaction was analyzed by 1H NMR spectroscopy in acetone-d6. The ratio of C–C 
to C–O products was determined by integration of signals at 8.93 ppm for 68 (C–
O) and at 7.98-8.08 ppm for 66 (C–C). The results listed below represent the 
average of two trials. 
 
Additive = AgOTf. AgOTf was transferred to a 4 mL vial as a stock solution in 
THF (15.5 µL of a 50 mM stock solution, 0.20 mg, 0.00078 mmol, 0.1 equiv). The 
THF was removed under vacuum and then this vial was taken into the glove box. 
Complex 67 (6.1 mg, 0.0076 mmol, 1.0 equiv) and acetone were added to the 
vial, which was then sealed with a Teflon-lined cap, removed from the drybox, 
and heated at 80 ºC for 3 h. The solvent was removed under vacuum, and the 
resulting residue was taken up in CH2Cl2 (1 mL), and filtered through a plug 
containing 25% poly-4-vinylpyridine and 75% Celite. The plug was washed with 
CH2Cl2 (10 mL), the solvent was removed under vacuum, and the reaction was 
analyzed by 1H NMR spectroscopy in acetone-d6. The ratio of C–C to C–O 
products was determined by integration of signals at 8.93 ppm for 68 (C–O) and 
at 7.98-8.08 ppm for 66 (C–C). The results shown in Table S10 represent the 
average of two trials. 
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Table 2.6.16.1 Effect of Acidic Additives on the Product Ratio of Reductive 


















Entry Additive Ratio 66 : 68 
1 none 13 : 1 
2 AcOH (5.0 equiv) 3.6 : 1 
3 AgOTf (0.1 equiv) 0.10 : 1 
* average of two trials 
 
 
Additive = NBu4X. Complex 67 (6.1 mg, 0.0076 mmol, 1.0 equiv) was dissolved 
in CH3CN (0.5 mL) in a 4 mL vial in a drybox. BuN4X (0.0076 mmol, 1.0 equiv) 
was added. The vial was sealed with a Teflon-lined cap, removed from the 
drybox, and heated at 80 ºC for 3 h. The solvent was removed under vacuum, 
and the resulting residue was taken up in CH2Cl2 (1 mL), and filtered through a 
plug containing 25% poly-4-vinylpyridine and 75% Celite. The plug was washed 
with CH2Cl2 (10 mL), the solvent was removed under vacuum, and the reaction 
was analyzed by 1H NMR spectroscopy in acetone-d6. The ratio of C–C to C–O 
products was determined by integration of signals at 8.93 ppm for 68 (C–O) and 
at 7.98-8.08 ppm for 66 (C–C). The results listed in Table S11 represent the 
average of two trials. 
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Table 2.6.16.2 Effect of NBu4(O2CC9H19) on the Product Distribution for 




















Entry Additive  Ratio 66 : 
68 
1 none 0.2 : 1 
2 Bu4N(O2CC9H19) 2 : 1 
3 Bu4N(PF6) 0.2 : 1 
* average of two trials 
 
2.6.17 Study of the Reductive Elimination from 71 with AgBF4 
 
















(74) Ratio 0.5 1.0  
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(71) 0.211.0  
 



















Complex 71 (4.2 mg, 0.0076 mmol, 1.0 equiv) or complex 74 (4.4 mg, 0.0076 
mmol, 1.0 equiv) was dissolved in acetone (0.5 mL) in a 4 mL vial. The vial was 
sealed with a Teflon-lined cap and heated at 80 ºC for 3 h. The solvent was 
removed under vacuum, and the resulting residue was taken up in CH2Cl2 (1 
mL), and filtered through a plug containing 25% poly-4-vinylpyridine and 75% 
Celite. The plug was washed with CH2Cl2 (10 mL), the solvent was removed 
under vacuum, and the reaction was analyzed by 1H NMR spectroscopy in 
CDCl3. The ratio of C–C to C–O products was determined by integration of 
signals at 7.61 ppm for 68 (C–O) and at 7.98-8.08 ppm for 66 (C–C). The 
 94 
hydrolysis product was observed in varying quantities after workup, when this 
was the case the integral at 8.84 ppm (for the OH product) was added to the 
peak for product 68.  The ratios listed represent the average of two trials. 
 
Complex 73 (4.2 mg, 0.0076 mmol, 1.0 equiv) was dissolved in acetone (0.5 mL) 
in a 4 mL vial. AgBF4 (1.5 mg, 0.0076 mmol, 1.0 equiv) was added to the vial and 
then, was sealed with a Teflon-lined cap and heated at 80 ºC for 3 h. The solvent 
was removed under vacuum, and the resulting residue was taken up in CH2Cl2 (1 
mL), and filtered through a plug containing 25% poly-4-vinylpyridine and 75% 
Celite. The plug was washed with CH2Cl2 (10 mL), the solvent was removed 
under vacuum, and the reaction was analyzed by 1H NMR spectroscopy in 
CDCl3. The ratio of C–C to C–O products was determined by integration of 
signals at 7.61 ppm for 68 (C–O) and at 7.98-8.08 ppm for 66 (C–C). The 
hydrolysis product was observed in varying quantities after workup, when this 
was the case the integral at 8.84 ppm (for the OH product) was added to the 
peak for product 68.  The ratios listed represent the average of two trials. 
 
2.6.18 Observation of C–C Bond-Forming Reductive Elimination at 
Phenylpyridine Complex 16 
 
Scheme 2.6.18.1 C–C Bond-Forming Reductive Elimination at 















– [PdII] (32) (4)
Ratio:         1.6       :        1  
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Complex 16 (6.8 mg, 0.0080 mmol, 1.0 equiv) was dissolved in DMSO (0.5 mL) 
in a 4 mL vial in a drybox. Bu4N(O2C(p-CF3C6H4)) (19 mg, 0.039, 5.0 equiv) was 
added. The vial was sealed with a Teflon-lined cap, removed from the drybox, 
and heated at 80 ºC for 5 h. The solvent was removed under vacuum, and the 
resulting residue was taken up in CH2Cl2 (2 mL), and filtered through a plug 
containing 25% poly-4-vinylpyridine and 75% Celite. The plug was washed with 
CH2Cl2 (12 mL), the solvent was removed under vacuum, and the reaction was 
analyzed by 1H NMR spectroscopy in acetone-d6. The ratio of C–C to C–O 
products was determined by integration of signals at 8.48 ppm for 32 (C–O) and 
at 8.36 ppm for 4 (C–C). The results listed below represent the average of two 
trials. 
 
Table 2.6.18.1 Data for C-C vs. C-O Product Formation with Additive 
 
Trial Ratio 32 : 4 
Additive 1.0 : 1.6 
No Additive 0.0 : 1.0 
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kinetics over greater than three half-lives. Qualitative time studies showed that 
added pyridine had little effect on the relative rate in each of the solvents studied. 
29. Carboxylate exchange in toluene progressed too slowly to measure 
quantitatively at –38 °C (i.e., no observable exchange occurred after 6 h).  
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30. More investigation is needed to understand why the entropy of activation is 
so small in this system. See ref. 36 for a possible explanation. 
31. Exner, O. Correlation Analysis of Chemical Data; Plenum Press: New York, 
1988. 
32. Reductive elimination reactions from (Phpy)2PdIV(O2CAr)2 have the added 
complication that these complexes contain two different carboxylate ligands. If 
mechanism A were operating, these two ligands would serve two very different 
roles in the first step of the reaction – one would dissociate to form an anion 
(stabilized by electron withdrawing groups), while the other would remain bound 
to cationic intermediate II (stabilized by electron donating groups).  
33. Calculations on C–O bond-forming reductive elimination reactions from 15 
(ref. 22) suggested that mechanisms A and B are relatively close in energy (ΔG‡ 
= 31.4 kcal/mol and 26.4 kcal/mol, respectively). In contrast, mechanism C was 
calculated to have a much larger activation energy of 44.3 kcal/mol. 
34. While the observed solvent effects and activation parameters are somewhat 
unexpected for a system involving ionic intermediates, they may result from an 
unusually early or late transition state that has relatively little charge buildup. 
35. Only C–O coupled products were observed in this reaction; however, both 
acetoxylated product 73 and the corresponding phenol (presumably formed by 
ester hydrolysis under the reaction conditions) were observed.  
36. Jolliet, P.; Gianini, M.; von Zelewsky, A.; Bernardinelli, G.; Stoeckli-Evans, H. 
Inorg. Chem. 1996, 35, 4883-4888. 
37. Espenson, J. H. Reversible and Concurrent Reactions. Chemical Kinetics 
and Reaction Mechanisms, Second Edition; Speer J. B., Morriss, J. M., Eds.; 








Chapter 3: Investigations of Reactivity and Mechanism 




The development of new transition metal-catalyzed methods for 
incorporating sp3-C−heteroatom (C−X) bonds into organic molecules is a 
challenging feat in organic synthesis.1 The widespread importance of sp3-C−X 
bonds in pharmaceuticals, argochemicals and commodity chemicals make novel 
methodology for the facile construction of these functionalities particularly 
interesting.1 Over the past several years, there has been significant progress 
made in the development of catalytic reactions that incorporate sp3-C−X bonds 
into molecules through C−H activation/functionalization manifolds.2 Elegant 
methodology has been developed for the installation of sp3-C−X bonds (C−O, 
C−I), while advances for the incorporation of sp3-C−Cl, C−F and C−N bonds still 
remain limited.2 These reactions are typically thought to involve high oxidation 
state Pd intermediates and proceed via PdII/IV catalytic systems. The final step of 
the aforementioned PdII/IV catalytic reactions hinges on reductive elimination from 
high oxidation state Pd as the key transformation for the product release step to 
generate the sp3-C−X bonds. Scheme 3.1.1 depicts an example of a catalytic 
reaction that converts a sp3-C−H (I-1) bond directly to a sp3-C−OAc (I-3) bond via 
reductive elimination from a proposed PdIV intermediate (I-2).3 Despite the limited 
reports of sp3-C−Cl, C−F and C−N bond formation from PdIV, high oxidation state 
Pd catalysis remains an attractive means for constructing challenging kinds of 
 102 
bonds because of the large thermodynamic driving force for the reduction of PdIV 
to PdII.4 
 
Scheme 3.1.1 Proposed PdIV Intermediate in a Catalytic Alkane C−H 
















Studying reactivity directly at a PdIV center is critical to understanding how 
the product release occurs to afford sp3-C−X bonds. Ultimately, knowledge of 
reactivity at a PdIV center that furthers the understanding of how the formation of 
sp3-C−X bonds proceeds can lead to the improvement of known reactions as well 
as launch innovative advancement of catalytic reactions in this area.6 Our group 
as well as the Ritter group have conducted extensive mechanistic investigations 
at monomeric PdIV and dimeric PdIII for sp2-C−O, C−Cl, C−F and C−CF3 bond 
formation from characterized and observable/isolable complexes.7,8,9 The results 
have provided valuable insights into how catalytic reactions might be improved or 
broadened. In all of these cases, reversible dissociation of a ligand from an 
octahedral PdIV compound (I-4) to generate a five coordinate PdIV species (I-5) 
preceded bond-forming reductive elimination to afford either sp2-C−O2CR, C−F or 
C−CF3 bonds (I-6). This type of dissociative mechanism (whether of an ionic or 
neutral ligand) was favored over a concerted reductive elimination from a 
coordinately saturated PdIV complex (Scheme 3.1.2).  
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Scheme 3.1.2 General Depiction of Proposed Mechanisms for sp2-C−O2CR, 






















However, while many advances have been made in the development of 
PdIV systems to study sp2-C−X reductive elimination, there have not been 
rigorous mechanistic studies of analogous sp3-C−X bond formation from PdIV.10 
There are several distinct mechanistic questions to be addressed in this area that 
could impact the advancement of catalytic PdII/IV catalysis. For instance, if a 
dissociative mechanism is at play, sp3-C−X bond formation from PdIV could 
potentially proceed via two different pathways. As depicted in Scheme 4.1.3, 
after a pre-equilibrium dissociation occurred to generate a five coordinate 
intermediate (I-8), reductive elimination from this species might occur through a 
concerted reductive elimination (I) or, alternatively, by an SN2 type attack (II) of 
X– on the σ-alkyl ligand. Pathway (II) for sp3-C−X bond formation differs from the 
possible reaction routes for sp2-C−X bond formation. Typically, SN2 mechanisms 
are not thought to be feasible for sp2-C−X reductive elimination because there 
are not available orbitals for the nucleophile to participate in backside attack.11 If 
pathway (II) were operative for sp3-C−X reductive elimination, it would be 
particularly intriguing to probe if an external nucleophile could be used to install a 
functional group into the product instead of being constrained to the functionality 
derived from the oxidant. Therefore, understanding the mechanism of sp3-C−X 
reductive elimination reactions might allow for cheaper/alternative oxidants and 
reagents to be considered for catalytic reactions.  
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Secondly, it would be appealing to explore the competition between sp2 
versus sp3-C−X reductive elimination from PdIV complexes. If one could develop 
a stoichiometric system to allow for this competition to take place for a variety of 
C−X reductive elimination reactions, this might allow for predictions of reactivity 
in catalytic reactions. In 2004 studies by Canty examined C–Se bond formation 
from the mixed alkyl/aryl PdIV complex (bpy)PdIV(CH3)(p-CH3OC6H4)(p-
ClC6H4Se)2 (I-11).12 Complex I-11 allowed for direct comparison of the relative 
rates of sp2 versus sp3 C–Se coupling. As shown in Scheme 3.1.4, only CH3–
Se(p-ClC6H4) (I-12) was detected, demonstrating that sp3-C–Se coupling is 
considerably faster in this system. Canty’s result, however, is in contrast to what 
has been observed for reductive elimination reactions from PdII, which typically 
exhibit significantly faster aryl–X reductive elimination compared to alkyl–X bond 
formation.35 Thus, it would be useful to identify other sp2/sp3-C–X systems that 
would allow us to further explore if a preference for sp3-C–X over sp2-C–X 




Scheme 3.1.4 Study of Competitive sp3 versus sp2-C–Se Bond Formation 











(I-11) (I-12)  
 
 
For the decision of what type of complex might satisfy the desired design 
criteria for the observation and study of sp3-C–X bond formation from PdIV, we 
examined the types of sp3-C–X reductive elimination reactions have been 
observed from PdIV complexes previously. In the literature there are limited 
examples of sp3-C−X bond formation (C–I, C–Cl, C–S and C–Se) from 
observable PdIV complexes, and most proceed in low yield.10 For example, in 
1994 Elsevier reported CH3−I formation from (p-Tol-BIAN)PdIV(CH3)3I (p-Tol-
BIAN= bis(p-tolylimino)acenaphthene) at 20 ºC in 15 % yield.13 The major 
product in this system was ethane, resulting from C–C coupling (80-90%). Canty 
also reported C–I reductive elimination from (bpy)PdIV(C4H8)(CH2CH3)I to 
generate iodohexane  in low yield (9%).14 Most recently, Canty and coworkers 
demonstrated that the oxidation of (bpy)PdII(CH3)2 (I-13) with I2 at –50 ºC in 
acetone-d6 affords the diorgano PdIV complex (bpy)PdIV(I) 2 (CH3)2 (I-14).15 This 
species was too unstable to isolate, and, upon warming to –10 ºC, it underwent 
clean and highly selective C–I bond-forming reductive elimination to generate 
CH3I (I-16) and (bpy)PdII(CH3)(I) (I-15) (Scheme 3.1.5). Additionally, Canty also 
reported an example of sp3-C–Se and also C–S bond formation from 
TpPdIV(CH3)2(SePh) (Tp = tris(pyrazol-1-yl)borate). The corresponding 
thiophenolate was also synthesized and underwent reductive elimination to afford 
CH3-SePh (40%) and CH3-SPh (52%).16 Lastly, Vincente reported the only 
example of sp3-C−Cl bond formation, which was from a bimetallic PdIV-PdIV 
species at –25 ºC.17 
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(I-14)(I-13) (I-15) (I-16)  
 
Target Complex. This chapter aims to identify isolable/observable 
complexes that react to afford various types of sp3-C–X bonds via reductive 
elimination. Ideally, these reactions should proceed cleanly so that their 
mechanism maybe investigated. Lastly, it would be interesting to identify a 
system to directly compare sp3 versus sp2 reductive elimination from PdIV. A 
common feature of the aforementioned known complexes by Canty and Elsevier 
that yield sp3-C–I, C–S and C–Se reductive elimination is that they contain a N~N 
bidentante or N~N~N tridentante ligand to stabilize the PdIV complexes. 
Therefore, we hypothesized that either 2,2’-bipyridine (bpy) or 2,2’-bis(4-tert-
butylbipyridine (dtbpy) ligand would be effective supporting ligands for our target 
complex. We began studies with the PdII precursor used by Carmona and co-
workers (I-18). However, instead of replacing COD (1,5-cyclooctadiene) with the 
Tp ligand, we utilized an N~N bidentante ligand (I-19, I-20) (Scheme 3.1.6). 
Importantly, compound I-18 is easily accessible via the reaction of (COD)PdIICl2 
with the commercial Grignard reagent C6H4C(CH3)2CH2MgCl. 
 


















The following Sections (3.2–3.7) describe the reactivity of PdIV complexes 
derived from I-19 and I-20 (Scheme 3.1.7). These undergo selective sp3-C–F, C–
N, C–O2CR, C–Cl and C–C bond-forming reductive elimination. Also, this work 
reports the first detailed mechanistic studies of sp3-C–X bond formation from 
PdIV.  









(I-19, I-20) (I-21)  
 
3.2 Study of sp3 C−F Bond Forming Reductive Elimination from PdIV 
 
Introduction. The development of transition-metal catalyzed reactions for 
C–F bond formation has been an area of intense research over the past 
decade.18 Traditionally, the C–F coupling step of these sequences has proven 
challenging due to the high kinetic barrier for C–F bond-forming reductive 
elimination from most transition metal centers.19 The approach in the Sanford 
laboratory to address this has been through the use of PdII catalysts in 
conjunction with F+-based oxidants. As shown in Scheme 3.2.1, we were able to 
fluorinate 8-methylquinoline at the benzylic position with 10 mol % of Pd(OAc)2 
and N-fluoro-2,4,6-trimethylpyridinium tetrafluoroborate (NFTPB).  Since 2006, a 
variety of other PdII-catalyzed reactions with F+ reagents have been developed 
that introduce fluorine at both sp2- and sp3-carbon centers.20-23 These 
transformations have been proposed to proceed via C–F bond-forming reductive 
















A detailed understanding of the high valent Pd intermediates involved in 
the key C–F bond-forming step has lagged considerably behind catalytic reaction 
development. In particular, the feasibility of sp3-C–F bond formation from PdIV (a 
crucial step in Pd-catalyzed benzylic/alkyl C-H fluorination21c as well as olefin 
fluorination reactions)22 has not yet been established. Several recent reports 
have described detailed investigations of related sp2-C–F bond-forming reductive 
elimination from PdIV(F)(Aryl) complexes.24 In addition, both Vigalok25 and 
Gagne26 have demonstrated that related PtII alkyl complexes react 
stoichiometrically with F+ reagents to form alkyl fluorides. Both groups proposed 
sp3-C–F bond-forming reductive elimination from a high valent Pt center as a key 
step; however, no intermediates were isolated in either of these transformations. 
Our goal was to design a system where we could access PdIV alkyl fluoride 
complexes and directly study their reactivity towards C–F bond-forming reductive 
elimination.27 We report herein the first direct observation of this important 
transformation from a group 10 metal center.  
 
Results. We targeted the cyclometalated bipyridine PdII complex 128 as a 
precursor to stable PdIV alkyl fluoride adducts. The oxidation of 1 with N-fluoro-
2,4,6-trimethylpyridinium triflate (NFTPT)29 afforded the PdIV product 2 in 94% 
yield. The triflate ligand of 2 was highly labile and could be displaced by pyridine 
or water to generate the cationic products 3 and 4, respectively (Scheme 3.2.2). 
The PdIV products 2-4 were all formed as a single detectable stereoisomer (as 
determined by 1H NMR spectroscopic analysis). Notably, unlike most other 
palladium-fluoride complexes,30 2-4 are not sensitive to water. They were 
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routinely synthesized under ambient conditions and could be stored on the bench 
top for several hours (and in a –35 ºC freezer for several weeks) without 
noticeable decomposition. The fluoride ligand of 2-4 appears as a sharp doublet 
at –336.17 ppm (J = 15 Hz) in the 19F NMR spectrum. In all cases, the fluoride is 
coupled to one of the α-hydrogens of the σ-alkyl ligand. The sharpness of this 19F 
NMR signal as well as the insensitivity of the complex to adventitious moisture 
both suggest against interactions of the fluoride ligand with H2O in solution. The 
result demonstrates that the triflate counter ion is not essential component for the 
stablization of these cationic PdIV complexes.  
 
 





























X-ray quality crystals of 4 were obtained by slow diffusion of pentane into 
a solution of 3 in wet acetone at –35 °C. The crystal structure of 4 shows that the 
σ-alkyl group of the cyclometalated ligand is trans to the labile H2O ligand, while 
the σ-aryl and fluoride are trans to the bipyridine (Figure 3.2.1). The Pd–F bond 
length of complex 4 (1.979 Å) is shortened in comparison to bond lengths 
reported for other known PdIV–F complexes (1.983, 1.999 and 2.040 Å).23,37 
Notably, in contrast to complex 4, these complexes display water sensitivity 
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suggesting a possible correlation between the reduced Pd–F bond length 
observed for 4 and its remarkable water stability.  
 
 




Thermal ellipsoids are drawn at 50 % probability, and hydrogen atoms are 
omitted for clarity.  Selected bond lengths (Å): Pd−F(1) 1.979(5), Pd−C(11) 
2.008(9), Pd−N(1) 2.015(7), Pd−C(18) 2.025(9), Pd−N(2) 2.151(8), Pd−O(1) 
2.229(6), C(11)−C(16) 1.383(13), C(17)−C(18) 1.522(13) Selected bond angles 
(deg): F(1) −Pd−C(11) 85.9(3), F(1) −Pd−N(1) 175.8(3), C(11) −Pd−N(1) 98.3(3), 
F(1)−Pd−C(18) 89.2(3), F(1)−Pd−N(2) 96.1(2), F(1)−Pd−O(1) 90.1(2), C(11) 
−Pd−O(1) 100.6(3), N(1)−Pd−O(1) 89.8(2). 
The triflate ligand of 2 could also be readily replaced with fluoride. For 
example, the treatment of 1 with NFTPT for 15 min followed by the addition of 1.6 
equiv of NMe4F afforded the difluoride complex 5 in 93% yield (Scheme 3.2.3). 
The 19F NMR spectrum of 5 shows two distinct fluorine resonances, a doublet at 
–201.42 ppm and a doublet of doublets at –336.73 ppm. Complex 5 could also 
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be prepared in high yield by the direct reaction of PdIV triflate complex 2 with 1.6 
equiv of NMe4F. 
















The difluoride PdIV complex 5 displayed very different properties than 2-4. 
Complex 5 was extremely sensitive to water, and attempts to synthesize 5 
without rigorous exclusion of moisture resulted in the formation of complex 
mixtures of unidentified products. Given the strong trans influence of the σ-alkyl 
ligand, the trans-fluoride of 5 is likely labile and highly susceptible to interactions 
with H2O.  
We next sought to study the reactivity of these PdIV fluoride complexes 
towards C–F bond-forming reductive elimination. There are several potential 
challenges to consider for these transformations. First, 2-5 all contain both sp2-C 
and sp3-C ligands; thus, it was not clear that selectivity could be achieved in the 
reductive elimination processes. Second, sp3-C-heteroatom bond-forming 
reductive eliminations from PdIV generally proceed by outer-sphere mechanisms 
involving SN2-type attack of a nucleophile on the sp3-C–PdIV bond.30 However, it 
is well-known in organic chemistry that fluoride is a poor nucleophile for SN2 
reactions,31 suggesting that such a pathway might not be viable in these 
systems. In addition, the high degree of β-substitution at the sp3-C–Pd bond in 2-
5 was expected to further disfavor SN2-type processes.   
We were pleased to find that, despite these potential challenges, both 3 
and 5 underwent clean C–F bond-forming reductive elimination at 80 ºC. Heating 
3 for 30 min at 80 ºC produced 6 in 93% yield (Scheme 3.2.4 a); 3-BF4 showed 
similar reactivity, forming 6-BF4 in 58% yield. Similarly, 5 converted cleanly to 7 
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upon heating at 80 ºC for 15 min (87%) (Scheme 3.2.4 b).32 These are the first 
directly observable examples of sp3-C–F bond-forming reductive elimination from 
palladium(IV). Remarkably, the reactions were both highly selective for sp3-C–F 
coupling, and the analogous aryl fluorides 6-b and 7-b was not detected under 
any conditions examined. This is a reversal of the ‘normal’ selectivity of reductive 
elimination. For example, at PdII and most other metal centers sp2-C ligands are 
typically much more reactive towards reductive elimination than their sp3-C 
analogues.34 This result highlights an important and complementary feature of 
PdIV-mediated fluorinations20-22 compared to analogous transformations at PdII 
centers.19 
 






















































A 19F NMR array for the conversion of 3-BF4 to 6-BF4 is shown in Figure 
4.2.2. The disappearance of starting material proceeded with clean first order 
kinetics (kobs = 3.5 x 10–4 s–1 at 45 ºC), and no intermediates were detected in this 
reaction. The rate of C–F bond-forming reductive elimination from 3-BF4 slowed 
dramatically upon the addition of pyridine. For example, in the absence of added 
pyridine, reductive elimination was complete after 30 min at 80 ºC. In contrast, 
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under analogous conditions but with 50 equiv of added pyridine, no reaction was 
observed. A quantitative study of kobs versus [pyridine] was conducted. As shown 
in Figure 3.2.3, an excellent linear fit was observed for a plot of kobs versus 
1/[C5D5N].  
 

























Figure 3.2.3 Plot of kobs Versus 1/[C5D5N] for Reductive Elimination from 3-



















Mechanistic Discussion. On the basis of these studies, we propose that 
C–F bond-forming reductive elimination proceeds by the mechanism shown in 
Scheme 4.2.5. The inverse 1st order dependence on [pyridine] implicates 
dissociation of the pyridine ligand prior to the rate-determining step. Following 
this dissociation, C–F coupling could potentially occur either by direct reductive 
elimination from 8 (shown in Scheme 3.2.5, (a)) or via dissociation of fluoride 
from 8 to generate a PdIV dication followed by SN2-type attack of F– on the σ-alkyl 
ligand (Scheme 3.2.5, (b)). While we cannot definitively distinguish these 
possibilities at this time, we favor the direct reductive elimination pathway for 
several reasons. First, as discussed above, fluoride is generally a poor 
nucleophile for SN2 reactions, and SN2 is typically very slow in systems with high 
degrees of β-substitution.32 Second, dissociation of fluoride to generate a 
dicationic PdIV species is expected to be highly unfavorable, particularly in the 
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non-polar solvent CH2Cl2.35 Finally, stereochemical studies have implicated direct 
sp3-C–F bond-forming reductive elimination (with retention of configuration at 
carbon) at related PtIV and AuIII centers.26,27 
 



































In this Section, we demonstrated the synthesis of a series of PdIV fluoride 
complexes, including several (2-4) that are remarkably insensitive to water. 
Additionally, we report the first directly observable example of sp3-C–F bond 
formation from a group 10 metal center. This reaction proceeds with exquisite 
selectivity for sp3-C–F bond formation despite the potential for competing sp2-C–
F coupling. Preliminary studies are consistent with a mechanism involving direct 
C–F bond-formation rather than SN2-type attack on the PdIV-alkyl. We anticipate 
that further investigations of this and related systems will inform the development 





3.3 Study of sp3 C−N Bond Forming Reductive Elimination from PdIV 
 
Introduction.  As discussed in the previous section, C–F bond formation 
from transition metal complexes is difficult to achieve.  First, fluorine is a poor 
nucleophile and, also, it is highly electronegative and thus, forms highly polarized 
bonds with Pd. Both of these attributes contribute to the attenuated ability of 
fluorine to undergo reductive elimination reactions.33 Although we were able to 
identify conditions to promote C–F bond formation from complexes 3, 3-BF4 and 
5, we now sought to utilize the mitigated reactivity of the PdIVF complexes to 
achieve sp3-C–N bond formation, another challenging transformation.  
One of the obstacles of generating C–N bonds from PdIV complexes is that 
there are limited accounts of oxidants that can oxidize PdII to PdIV with delivery of 
a nitrogen containing ligand. Although NBS (N-bromosuccinimide) and NCS (N-
chlorosuccinimide) have been shown to stoichiometrically generate PdIV from 
PdII, incorporation of a succinimide moiety into the organic product limits the 
generality of the kinds of C–N bonds that can be formed through such a 
method.38 The exploration of other ways for achieving C–N bonds from PdIV 
remains underdeveloped.  
 Another challenge for incorporating C–N bonds into molecules by PdII/IV 
catalysis arises from competitive reductive elimination reactions with other 
nucleophiles that preferentially form C–X bonds over the desired C–N bond.39 
These other “X” type groups that compete with C–N bond formation are typically 
delivered to the metal center via an oxidant. Therefore, we thought that we might 
be able to exploit the reduced reactivity of fluorine and attain C–N bond formation 
by using NFTPT as an oxidant and delivering a F– ligand, which is a poor 
nucleophile for reductive elimination. Yu has achieved catalytic success for 
intramolecular C–N amination with this strategy.40 As shown in Scheme 3.3.1, he 
was able to demonstrate the use 2.0 equiv of NFTPT with phenyltriflamide (9) 
and 10 mol% of Pd(OAc)2 to afford functionalized indoline (10) with no 
observation of the possible aryl fluorination products (11) and (12). 
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 It would be useful to explore this approach directly at an isolated PdIV 
center so that the catalytic methodology might be expanded to include 
intermolecular versions of Yu’s reaction. By understanding how this reactivity 
takes place, we might be able to understand the factors and reaction pathways 
that control C–N versus C–F reductive elimination from PdIV.  
If we could design a system to study sp3-C–N bond formation from PdIV 
this would add significantly to the known accounts of this type of reaction from a 
group 10 metal center. Not only are examples of C–N bond formation from 
characterized PdIV complexes exceptionally rare, but also, the demonstration of 
sp3-C–N bond formation from group 10 metals is extremely limited. Our group 
documented the only report of sp2 C−N bond formation from a well defined PdIV 
complex. Dr. Salena Whitfield reported that thermolysis of  (2-
phpy)2PdIVCl(succinimide) (13) in C5H5N to afforded dimer 16 in 81% yield along 
with 6% of 2-phpy-Cl (C−Cl) (14) and 8% of 2-phpy-suc (C−N) (15).38 


























As mentioned above, accounts of sp3-C−N reductive elimination from late 
transition metal centers remain even scarcer. In 2007 Goldberg described the 
first well characterized illustration of this type of reaction. She reported the 
formation of N-methylsulfonamides (20) and ethane via the thermolysis of the 
isolated PtIV complexes with the general structure fac-(dppbz)PtMe3(NHSO2R) 
(dppbz = o-bis(diphenylphosphino)benzene (18).41 The amide ligand was 
delivered to Pt via reaction with complex 17 and the appropriate amide with 
generation of water as a by-product (Scheme 3.3.2). The mechanism of C−N 
bond formation from the PtIV complexes was proposed to involve a pre-
equilibrium dissociation of the sulfamide ligand, followed by nucleophilic SN2 
attack of the dissociated amide on a methyl ligand (Scheme 3.3.2, pathway (b)). 
Additionally, it was shown that the C−C reaction to yield ethane proceeded 
through the same intermediate (19), but reductive elimination occurred directly 
from the five coordinate intermediate (pathway (a)). The authors were able to 
inhibit C−C bond formation and generate C−N coupled products in high yields 
(65%) by adding excess of the sulfonamide anion under thermolysis conditions in 
benzene. A similar mechanism to the one that is outlined in Scheme 4.3.2 
(pathway (b)) has also been observed for C−O42 and C−I43 reductive elimination 
reactions from related PtIV species. Thus the authors propose that this type of 
reaction pathway might be ‘general’ for alkyl C−X reductive elimination reactions 

























































Additionally, Hillhouse has reported oxidatively-induced alkyl C−N bond 
formation from NiII to produce cyclic amines in high yields. Analogous reactions 
of acyclic NiII complexes have also been disclosed, but proceeded in low yields.44 
Mechanisms involving sp3-C–N reductive elimination from transient NiIII 
intermediates were proposed. Reports of RhIII porphyrin complexes that undergo 
intramolecular nucleophilic attack of an amino group on an alkyl ligand of the 
porphyrin have been reported.45 Most recently in 2010, Hartwig described sp3-C–
N bond-formation from PdII benzyl amido complexes.46 It was determined that 
reductive elimination was slightly influenced by the electronic properties of the 
amido group and that electron donating groups on the amido ligand reacted 
faster than electron poor groups.  
Since there are limited accounts of this type of reaction, it would be 
valuable to develop and study PdIV systems that undergo alkyl C−N bond 
formation.  
 Results. We demonstrated in Section 4.2 that complex 2 could be 
synthesized from the reaction of 1 with NFTPT and that the triflate ligand could 
be readily displaced (Scheme 3.2.2).  Next, we wanted to investigate replacing 
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the triflate ligand of complex 2 with an amide in order to explore sp3-C–N bond 
formation from PdIV. The amides that we tested for this reaction were 
benzenesulfonamide and 2,2,2-trifluoroacetamide. These substrates are 
particularly interesting because electron deficient amides are difficult to install via 
Pd0/II catalysis47 and, also alkylsulfonamide linkages are easily deprotected to 
reveal free amines.33  
 













 For the next series of studies we decided to synthesize and use 
complexes 21 and 22 because of the increased solubility of dtbpy-ligated 
complexes. Complex 21 readily reacted with NFTPT to yield PdIV complex 22 in 
96% yield (Scheme 3.3.3).  To screen for sp3 C–N reductive elimination, we first 
combined PdII complex 21 (1.0 equiv) with NFTPT (1.0 equiv) and 
benzenesulfonamide  (2.0 equiv) and allowed the reaction mixture to stir at 25 °C 
for 12 h in MeOH. This resulted in an unidentifiable array of products along with 
unreacted benzenesulfonamide. We hypothesized that complex 21 and NFTPT 
react to generate 22 in situ, although as we observed with complex 3 in Section 
4.2, the decomposition of complex 22 was perhaps the source of the intractable 
mixtures of compounds. This result was suggestive that benzenesulfonamide 
was not binding to the PdIV complex and that a base stronger than MeOH might 
be necessary to deprotonate the amide and faciliate reactivity. 
 
Therefore, we decided to use Cs2CO3 to facilitate deprotonation of the 
amide in MeCN (both benzenesulfonamide and 2,2,2-trifluoroacetamide are 
soluble in MeCN and the Cs2CO3 is semi-soluble). Thus, we stirred 
benzenesulfonamide (4.0 equiv) with Cs2CO3 (4.0 equiv) at 65 °C in MeCN for 1 
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h, then, added 21 and NFTPT to the reaction mixture. The reaction was heated 
for 12 h and afforded 23 in 71% yield (Scheme 3.3.4 (a)). Furthermore, the 19F 
NMR spectra displayed no fluorine peaks corresponding to sp3 or sp2-C-F 
products. This same system also worked for 2,2,2-trifluoroacetamide and 
produced the C–N product 24 in 29% yield (Scheme 3.3.4 (b)). Compounds 23 
and 24 are unusual examples of products derived from sp3-C-N reductive 
elimination. Notably, there was not a fluorine ligand on the isolated product 
perhaps indicative of the known lability of PdII fluorides. 
 





































65 °C, 1 hCs2CO3 +
MeCN














After identifying reaction conditions to achieve sp3-C–N bond formation 
without any apparent competitive C–F products, we sought to investigate if we 
could observe PdIV intermediates in this system. Since PdIV complexes containing 
monodentate amido ligands are extremely rare, we wanted to understand if C–N 
bond formation in this system was derived from a PdIV complex that contained an 
amide ligand or if the product was obtained through an external attack without 
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direct displacement of the triflate. Thus, we combined 3.0 equiv of the 
sulfonamide and 3.0 equiv of Cs2CO3 and allowed the reagents to stir in MeCN 
for 1 h at 65 °C to facilitate deprotonation. The solution was cooled and complex 
22 was added to the reaction. Gratifyingly, complexes 25 and 26 were isolated 
from the reaction mixture in 45% and 32% isolated yield, respectively (Scheme 
3.3.5). Purification/isolation of these complexes proved challenging due to the 
removal of the excess amide. In order to test if this was the cause of the low 
yields, we carried out the reaction of 22 with Cs2CO3/NH2R via 1H NMR 
spectroscopy with an internal standard. Within 5 min at 25 °C, both reactions 
proceeded in high yields to affording 25 in 82% yield and 26 in 79% yield as 
determined by 1H NMR spectroscopic analysis. 
These complexes were fairly robust and could be isolated on the bench 
top under ambient conditions as well as stored in the freezer at –35 °C for up to a 
month without observable decomposition. Characterization via 1H NMR and 19F 
NMR spectroscopy proved diagnostic for complexes 25 and 26.  For example in 
the 1H NMR spectra, complex 25 showed a broad singlet at 3.53 ppm for the 
hydrogen of the sulfonamide, a distinct doublet of doublets (J = 15 Hz, 7 Hz) for 
one of the methylene protons at 3.97 ppm, and a multiplet at 3.02 ppm for the 
other methylene proton. The 15 Hz coupling constant is reflected in the 19F NMR 
spectrum where the PdIV–F resonance appears as a doublet (J = 15 Hz) at –
339.66 ppm. Similar 1H NMR and 19F NMR spectrum were observed for complex 
26.  
 




1 h, 65 °C to 25°C
PdIV F
NHRMeCN
(25, R = SO2Ph, 45%)
3.0 equiv H2NR










Interestingly, thermolysis of the isolated complexes (25 and 26) afforded 
mixtures of both C–N and C–F reductive elimination products in an approximately 
0.5: 1.0 ratio at 65 °C within 15 min. Although the reductive elimination products 
in Scheme 4.3.6 were not isolated, the coupling constants and splitting patterns 
in the 1H and 19F NMR spectra are consistent with two products that each contain 
either a sp3-C–F or sp3-C–N bond. Further, studies are underway to definitively 
characterize these products.  This result was drastically different than the clean 
C–N bond formation that we observed in Scheme 3.3.4. However, the reaction in 
Scheme 3.3.4 contained both excess amide and Cs2CO3, which might account 
for the difference in reactivity observed upon the thermolysis of the isolated 
complexes.  
 














15 min, 65 °C +









To further investigate what might be contributing to the distribution of C–N 
and C–F products in Scheme 3.3.6, we followed the reaction of 22 with amide 
and Cs2CO3 via 1H NMR spectroscopy. The amide and Cs2CO3 were heated at 
65 °C in MeCN for 1 h, then complex 22 was added to a cooled solution and 
within 5 min at 25 °C complex 25 was formed. After 2 h complex 25 reacted 
cleanly to afford the C–N reductive elimination product 23 in 70% (Scheme 3.3.7) 
(similar results were observed from the formation of 24 (48%)). Not only did this 
reaction with excess amide and Cs2CO3 provide a different product distribution 
than the reaction in Scheme 4.3.4, it also proceeded much slower. For example, 
the reaction in Scheme 3.3.7 took 2 h at 65 °C for the complete decomposition of 
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25 or 26 as compared to the reaction shown in Scheme 3.3.6, which took 15 
mins at 65 °C for the disappearance of complex 25 or 26. As shown in Figure 
3.3.1, thermolysis of 25 with excess amide and Cs2CO3 at 65 °C proceeded with 
a clean first order decay (kobs = 1.1x 10-4 s-1) to afford the C–N reductive 
elimination product 23. This reaction is the first demonstration of sp3 C–N bond 
formation from a characterized PdIV complex and the only example of high 
yielding C–N reductive elimination from PdIV.  
 
Scheme 3.3.7 Reaction of 25 with Excess Cs2CO3 and Benzenesulfonamide 
 
PdIV F






















(25, R = SO2Ph)
 
 


























3.4 Reactivity of Complex X to Form sp3 C–Cl and C–O Bonds and General 
Insights into sp3 C–X Reductive Elimination from PdIV-F Complexes 
 
Introduction. As demonstrated in sections 3.2 and 3.3, we identified 
systems to study unprecedented sp3-C–F and C–N reductive elimination from 
PdIV. Next, we wanted to explore if this ligand systems could be used to explore 
other types of C–X reductive elimination from PdIV.    
Replacement of Triflate with Cl and OAc. Our first goal was to replace 
the triflate ligand of complex 2 with Cl– or AcO– to observe either sp3-C–Cl and 
C–OAc reductive elimination from PdIV. Gratifyingly, complex 2 reacted cleanly 
with NBu4OAc and NBu4Cl to afford 28 and 29 (Scheme 3.4.1). These complexes 
were formed in high yield (91% and 90%, respectively), but could not be isolated 
due to their low stability in solution (vide infra). Based on Figure 3.2.1, we 
reasoned that the new ligand (AcO– or Cl–) was incorporated onto the complex in 
the position that is trans to the σ-alkyl ligand, replacing the labile triflate ligand. 
Complexes 28 and 29 underwent thermal decomposition via C–X bond-forming 
reductive elimination. This transformation was highly selective for sp3-C–X bond 
formation; furthermore, the group trans to the σ-alkyl ligand reacted selectivity. 
The formation of compound 30 is the first reported example of sp3-C–O bond 
formation from high oxidation state Pd. Additionally, the decomposition of 29 to 
31 documents the first sp3-C–Cl reductive elimination from a monometallic PdIV 
species. Notably, complexes 28 and 29 were significantly less stable than 
complexes 5, 3 and 3-BF4, suggestive that sp3-C–Cl and C–OAc reductive 
elimination is significantly more facile than sp3-C–F coupling from PdIV. 
 











(28, X = OAc)
Bu4NX
(29, X = Cl) (30, X = OAc)









Analysis of Reactivity of PdIV Complexes for sp3-C–X Reductive 
Elimination. Compounds 5, 25, 28-dtbpy and 29-dtpy provide an excellent 
series of complexes to compare and contrast four types of sp3-C–X (F, NHR, 
OAc, Cl) reductive elimination reactions from PdIV. Regardless of the X type 
ligand at the PdIV center, sp3-C–X reductive elimination occurs exclusively from 
all of these complexes. Also, the type of ligand on the complex in this series 
appears to control the relative stability of complexes. These reactions were 
carried out with in situ generation of the desired PdIV complexes, since 
complexes 28-dtbpy and 29-dtbpy were unstable to isolation. Additionally, 3.0 
equiv of excess nucleophile delivered via NBu4OAc, NBu4NCl, 
C6H7NO2S/Cs2CO3 or NMe4F was used because those conditions resulted in 
clean formation of 23 from 25 without any competing sp3-C–F coupling.  Complex 
22 was subjected to 3.0 equiv of either NBu4OAc, NBu4NCl, C6H7NO2S/Cs2CO3 
or NMe4F in MeCN and the relative rates of reductive elimination were 
monitored. The PdIV compound 28-dtbpy was most reactive, with complete 
conversion to sp3 reductive elimination product 30 in 1 h at 25 °C. Next, 29-
dtbpy fully reacted to afford 31 in 2 h at 25 °C. After 2 h at 25 °C, complexes 5 
and 25 appeared mostly unreacted, so they were heated to 65 °C. Within 45 min 
at 65 ºC, 5 converted to completely 7. Finally, complex 25 required 2 h at 65 ºC 
to generate the reductive elimination product 23. The reactivity of complexes 5, 
25, 28-dtbpy, 29-dtbpy shows the following trend: sp3 C–O > C–Cl > C–F > C–
N. Interestingly, this observation also tracks with the catalytic development in the 
area of PdII/IV catalysis with C–O and C–Cl bond forming reactions being more 
prevalent in the literature than C–N and C–F bond forming reactions. 
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Scheme 3.4.2 Relative Stability of Complexes that undergo Sp3 C–X 




















(25-dtbpy) (26-dtbpy) (5) (25)
 
 
A general mechanism for sp3-C–O, C–Cl and C–N bond formation is 
proposed. Bond-forming reductive elimination from complexes 25, 26, 28 and 29 
is most consistent with a mechanism involving pre-equilibrium dissociation of a 
ligand followed by nucleophilic SN2 attack of the dissociated ligand on the σ-alkyl 
carbon of the complex (Scheme 3.4.3).   
Scheme 3.4.3 General SN2 Mechanism for Reactivity from Complexes 25, 














X = O2CR, Cl, NHR  
 
Alternatively, C–F reductive elimination from complexes 3 and 3-BF4, most 
reasonably occurs via dissociation of pyridine followed by concerted reductive 
elimination from PdIV to form sp3-C–F reductive elimination products. This 
mechanism is similar to what Goldberg observed for sp3-C–C bond formation 
from PtIV complexes.48 Additionally, reductive elimination from complex 5 to 
afford C–F bond formation might occur by either the pathway in Scheme 3.4.3 or 
3.4.4 or potentially both.  
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Scheme 3.4.4 General Concerted Mechanism for Reactivity from 













F+ Y– + Y– + Y–
 
As discussed in the introduction (Scheme 3.1.2) the studies that have 
been done for sp2-C–F, C–CF3 and C–O reductive elimination from PdIV involve a 
pre-equilibrium dissociation of a ligand followed by bond formation from a five 
coordinate intermediate. Therefore, the data in the literature and the results 
presented in this chapter suggest that the favored pathway for both sp2 and sp3-
C–X bond formation from an octahedral PdIV complex involves dissociation of a 
ligand prior to reductive elimination. The new reactions presented in this 
document substantially add to the known examples of sp3-C–X reductive 
elimination from characterized PdIV complexes, as results are the first examples 
of high yielding sp3 C–X bond formation from PdIV.  
Oxidation with Iodosylbenzene. Lastly, our results in this section 
suggest that the functionality of the C–X reductive elimination products do not 
need to be derived directly from the oxidant. This is because of the preference for 
sp3-C–X coupling to proceed via a SN2 mechanism and also due to the lability of 
ligands observed at PdIV complexes. Therefore, we sought to investigate using 
PhIO as an oxidant with nucleophiles such as Cl– or AcO– delivered via 
tetrabutylammonium salts to achieve sp3-C–Cl and C–OAc products from 21. We 
combined 2.0 equiv of either NBu4Cl or NBu4OAc with complex 21 in CH2Cl2 and 
then added 1.0 equiv of PhIO. After 12 h at 65 °C we observed formation of 32 
(49%) and 33 (75%). Alternatively under analogous conditions, sp3-C–F and C–N 
products were not observed by this method. This result is interesting because it 
implies that we are able to achieve products where the functionality in the 
product comes from an external nucleophile.  
 129 










(32, X = OAc)
(33, X = Cl)
O
Bu4NX
X = Cl, OAc
 
 
3.5 Reactivity of Complex 1 and 21 with Non-Fluorine Containing Oxidants 
 
Oxidation of  21 with PhI(X)2. Next, we wanted to explore the oxidation of 
21 with various oxidants that do not deliver a fluorine ligand to the metal. 
Typically, fluorine is thought to stabilize high oxidation state metals since fluorine 
forms a highly polarized bond with the metal and also it is a relatively poor 
nucleophile for reductive elimination. Therefore, we thought that it would be 
interesting to explore the reactivity of complexes that did not contain a fluorine 
ligand. We wanted to explore whether complex 21 would react with other 
oxidants to form stable/isolable complexes. Since these complexes might be 
more reactive, we sought to explore whether these complexes would undergo 
sp2 or sp3 or mixtures of C–X reductive elimination reactions.  
Thus, we carried out several reactions of PdII complex 21 with oxidants of 
the general structure PhI(X)2. The first reaction explored was the oxidation of 
complex 21 with 1 equiv of PhI(OAc)2. Upon combining the reagents an 
immediate color change from dark to light yellow occurred. Analysis of the 
reaction mixture by 1H NMR spectroscopy indicated clean formation of one 
product that contained an unsymmetrical ligand environment for the dtbpy ligand 
as well as two distinct acetate resonances. The methylene protons of the carbon 
ligand appeared as two doublets at 5.41 and 4.48 ppm with J = 10 Hz. Given the 
instability of complex 28, we reasoned that the isolated compound was most 
likely the PdII reductive elimination product (32) as opposed to the PdIV diacetate 
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complex (I) (Scheme 3.5.1). If this were the case, the 1H NMR spectrum 
suggested that sp3-C–OAc reductive elimination was the only product formed in 
this reaction.  
X-ray quality crystals of 32-bpy (the reaction of 1 with PhI(OAc)2 was used 
for the isolation of 32-bpy to facilitate crystallization) were obtained by slow 
diffusion of pentanes into a DCE solution of this compound at −35 °C. The crystal 
structure confirmed that 32 is the PdII product of sp3-C–OAc bond-forming 
reductive elimination  (Figure 3.5.1). Based on the previous results, we 
postulated that PhI(OAc)2  oxidized complex 1 to intermediate I (Scheme 3.5.1), 
which underwent facile sp3-C–O reductive elimination at 25 °C to yield product 
(32). Next, we sought to examine whether this reactivity was general for a series 
of hypervalent iodine reagents oxidants.  As depicted in Table 3.5.1, oxidants 
with electron rich and electron deficient carboxylate substituents gave similar 
results of high yielding sp3 C–O reductive elimination products (34-37) in 92-61% 
yield. Additionally, PhI(Cl)2 displayed similar reactivity with sp3-C–Cl bond 
formation occurring rapidly to afford complex 33 (98% yield).  



























Figure 3.5.1 ORTEP Plot of 32 
 











































Next, we chose to investigate if a PdIV intermediate could be observed via 
low temperature NMR spectroscopy. The reaction of 21 with PhI(Cl)2 was studied 
at temperatures as low as −60 °C. A possible PdIV intermediate was observed, 
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but within several minutes complete conversion to 33 occurred. Next, the 
reaction of 21 with PhI(OAc)2 was investigated at low temperature. However, 
even at −60 °C no intermediate was observed. Additionally, at 10 °C the 
conversion of 21 to 32 occurred within 10 min without any observable 
intermediates.  
Taking into consideration the work we conducted in Chapter 2 on the 
mechanism of sp2-C–O bond formation from PdIV complexes, we hypothesized 
that reacting 21 with an oxidant that contained an electron deficient carboxylate 
might allow for the observation of a PdIV intermediate. We showed in Chapter 2 
that PdIV complexes with electron deficient ligands undergo slower rates of 
reductive elimination than complexes with electron rich carboxylates. Therefore, 
we combined 21 with PhI(O2CC9F19)2 to observe a possible PdIV intermediate (II). 
At –30 °C, only unreacted starting material 21 was detected. However, at –10 °C 
a mixture of 38 and 35 was observed. Furthermore, after 30 min at 0 °C, 38 
completely converted to 35. Thus, this result gives support that a PdIV complex 
(II) is formed prior to reductive elimination from 21 for products 32-37.  



















Oxidation with CH3I. Next, we were intrigued by the reaction of CH3I with 
complex 1. There have been studies involving competitive C–I (CH3I) and C–C 
(ethane) reductive elimination from di and trimethyl PdIV  and PtIV  complexes. It 
has been shown by Goldberg that complex fac-L2Pt(CH3)3I (L2 = 
bis(diphenylphosphino)ethane) (39) reacts to undergo C–I reductive elimination 
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yielding CH3I as the kinetic product.43 This is thought to be formed via a 
mechanism involving a reversible dissociation of I– followed by SN2 attack of I–  
on an alkyl group of the PtIV complex (40). C–C reductive elimination from this 
complex to produce ethane is the thermodynamic product with the same initial 
first step of reversible dissociation of I– followed by concerted C–C coupling from 
the PtIV complex (40). One key piece of data in their mechanistic analysis was 
the observation of significant rate inhibition of formation of the C–C product with 
added NaI. Additionally, Canty has studied the reductive elimination reaction of 
bpyPdIV(CH3)3I and bpyPdIV(CH3)2(I)2. He showed that bpyPdIV(CH3)3I underwent 
exclusive C–C reductive elimination while the di-methyl complex 
(bpyPdIV(CH3)2(I)2)  afforded C–I reductive elimination.49 






































Thus, we were curious about whether competitive C–C and C–I reductive 
elimination from complex 21 upon reaction with CH3I would be observed and how 
the mechanism of these transformations would compare to the reported reaction 
from fac-L2Pt(CH3)3I. When CH3I was combined with complex 21, the yellow 
solution immediately turned light red with concurrent consumption of the starting 
material to form compound 43 in 81% yield (Scheme 3.5.3). This reaction was 
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once again selective for sp3 bond formation over sp2 and interestingly, C–C 
reductive elimination completely out-competed C–I reductive elimination.  
If reductive elimination in this system is occurring via a similar mechanism 
to the complexes previously discussed in this chapter, a pre-equilibrium 
dissociation of a ligand prior to reductive elimination is probable. Since 
dissociation of a CH3 group seems unlikely, we hypothesized a pre-equilibrium 
dissociation of I– followed by a concerted reductive elimination from a five 
coordinate PdIV intermediate might be taking place. This mechanism would imply 
that the concerted C–C reductive elimination takes place faster than an SN2 
nucleophilic attack by the dissociated iodide, which is similar to what Goldberg 
observed for ethane formation from fac-L2Pt(CH3)3I (L2 = 
bis(diphenylphosphino)ethane). This theory was tested by studying kobs for the 
consumption of 21 with 1.0 equiv of CH3I at 5 °C in the presence of varying 
equivalents of NBu4I. An excellent linear fit was observed for an inverse 
dependence on the concentration of [I–]. Thus C-C bond formation in this reaction 
most likely occurs via the mechanism outlined in Scheme 4.5.4, where 21 is 
oxidized to (III) and dissociation of I– to generate the five coordinate intermediate 
(IV) proceeds concerted sp3 C–C reductive elimination. 



























Figure 3.5.2 Plot of kobs verse 1/[NBu4I] for reductive elimination from 21 to 





























(III) (IV)  
 
In conclusion this chapter demonstrated the first high yielding examples of 
sp3-C–X bond formation from PdIV complexes. Interestingly, it was determined 
that in certain cases an SN2 mechanism is feasible for reductive elimination from 
a PdIV center. Given this observation we were able to demonstrate that the 
nucleophile that participates in the reductive elimination reaction can be derived 
from sources other than the oxidant. Additionally, it is important to note that 
complexes that contained a fluoride ligand were remarkably more stable than 
complexes that contained other X type ligands.  
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3.6 Experimental Data and Characterization of Complexes 
 
General Procedures 
NMR spectra were obtained on a Varian vnmrs 700 (699.76 MHz for 1H; 175.95 
MHz for 13C), a Varian Inova 400 (399.96 MHz for 1H; 376.34 MHz for 19F; 100.57 
MHz for 13C), a Varian vnmr500 (500.09 MHz for 1H; 470.56 MHz for 19F; 125.75 
MHz for 13C), or a Varion MR400 (400.53 MHz for 1H; 376.87 MHz for 19F; 100.71 
MHz for 13C) spectrometer. 1H, 19F and 13C chemical shifts are reported in parts 
per million (ppm) relative to TMS, with the residual solvent peak used as an 
internal reference. 19F NMR spectra are referenced on a unified scale, where the 
single primary reference is the frequency of the residual solvent peak in the 1H 
NMR spectrum. 1H and 19F multiplicities are reported as follows: singlet (s), 
doublet (d), doublet of doublets (dd), quartet (q), multiplet (m), and broad 
resonance (br). Mass spectral data were obtained on a Micromass magnetic 
sector mass spectrometer or on a Micromass LCT mass spectrometer in 
electrospray ionization mode. 
 
Materials and Methods 
Bipyridine (bpy) and 2-methyl-2-phenylpropyl magnesium chloride were obtained 
from Aldrich. 1-Fluoro-2,4,6-trimethylpyridinium triflate (NFTPT) and 1-fluoro-
2,4,6-trimethylpyridinium tetrafluoroborate (NFTPB) were obtained from TCI 
America. Unless otherwise noted, all reagents were used as received. NMR 
solvents were obtained from Cambridge Isotope Laboratories. All other solvents 
were obtained from Fisher Chemicals. Tetrahydrofuran was purified using an 
Innovative Technologies (IT) solvent purification system consisting of a copper 
catalyst, activated alumina, and molecular sieves.  
 137 
Section 3.2 Characterization and Experimental Procedures 
 







Complex 1. PdII(CH2CMe2-o-C6H4)(COD) (720 mg, 2.08, 1.0 equiv) was 
combined with 2,2′-bipyridine (325 mg, 2.08 mmol, 1.0 equiv) in CH2Cl2 (200 
mL), and the reaction mixture allowed to stir for 30 min. The solution was 
concentrated under vacuum (to 5 mL), and hexanes (30 mL) was added to 
precipitate the product. Complex 1 was isolated as a bright yellow solid (737 mg, 
90% yield). 1H NMR (500 MHz [D3]chloroform, 25 °C): δ = 9.25 (d, J = 5 Hz, 1H), 
8.80 (d, J = 5 Hz, 1H), 8.07-8.05 (multiple peaks, 2H), 7.99-7.93 (multiple peaks, 
2H), 7.56-7.53 (multiple peaks, 2H), 7.47 (t, J = 7 Hz, 1H), 7.01-6.99 (multiple 
peaks, 2H), 6.87 (t, J = 5 Hz, 1H), 2.46 (s, 2H), 1.43 (s, 6H).  13C NMR (125 MHz 
[D3]chloroform, 25 °C): δ = 168.71, 158.54, 154.73, 154.21, 150.43, 149.37, 
137.11, 134.35, 128.18, 125.42, 125.13, 123.72, 122.76, 121.34, 121.04, 121.00, 
46.96, 44.97, 33.35 (two overlapping carbons).  HRMS-electrospray (m/z): [M + 















Complex 2. Compound 1 (70 mg, 0.18 mmol, 1.0 equiv) and NFTPT (52 mg, 
0.18 mmol, 1.0 equiv) were combined in CH2Cl2 (15 mL), and this mixture was 
stirred for 15 min. The solvent was removed by rotary evaporation, and the 
resulting yellow oil was washed with diethyl ether (15 mL). The solid material was 
then dissolved in CH2Cl2 (1 mL), and diethyl ether (10 mL) was added to 
precipitate the product. The precipitate was collected and dried under vacuum to 
afford 2 as a light yellow solid (96 mg, 94% yield). 1H NMR (400 MHz 
[D3]acetonitrile, 25 °C): δ = 8.96 (d, J = 5 Hz, 1H), 8.58-8.56 (multiple peaks, 2H), 
8.43 (t, J = 8 Hz, 1H), 8.34 (t, J = 8 Hz, 1H), 8.03-7.99 (multiple peaks, 2H), 7.78 
(d, J = 8 Hz, 1H), 7.61 (t, J = 6 Hz, 1H), 7.34 (d, J = 8 Hz, 1H), 7.29 (d, J = 8 Hz, 
1H), 7.13 (d, J = 8 Hz, 1H), 4.80 (dd, J J = 15, 5 Hz, 1H), 4.24 (app. br. s, 1H), 
1.45 (s, 3H), 1.12 (s, 3H). 19F NMR (376 MHz [D3]acetonitrile, 25 °C): δ = –79.11 
(s, 3F), –336.17 (d, J = 15 Hz, 1F). 13C NMR data could not be obtained due to 
the instability of the complex over the timescale required for the experiment. 








Complex 3. Compound 1 (120 mg, 0.3 mmol, 1.0 equiv), NFTPT (88 mg, 0.3 
mmol, 1.0 equiv), and C5H5N (49 µL, 0.6 mmol, 2.0 equiv) were combined in 
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CH2Cl2 (15 mL), and this mixture was stirred for 15 min. The solvent was 
removed by rotary evaporation, and the resulting yellow oil was washed with 
diethyl ether (10 mL). The solid material was then dissolved in CH2Cl2 (2 mL), 
and diethyl ether (25 mL) was added to precipitate the product. The precipitate 
was collected and dried under vacuum to afford 3 as an off-white solid (125 mg, 
63% yield). 1H NMR (700 MHz [D2]dichloromethane, 25 °C): δ = 8.93-8.91 
(multiple peaks, 2H), 8.72 (d, J = 8 Hz, 1H), 8.48 (t, J = 8 Hz, 1H), 8.29 (t, J = 8 
Hz, 1H), 8.24 (app. br. s, 2H), 8.07 (d, J = 6 Hz, 1H), 7.88 (t, J = 8 Hz, 1H), 7.77 
(t, J = 6 Hz, 1H), 7.64 (t, J = 6 Hz, 1H), 7.47-7.44 (multiple peaks, 2H), 7.24 (t, J 
= 7 Hz, 1H), 7.05 (d, J = 8 Hz, 1H), 7.01 (t, J = 8 Hz, 1H), 6.66 (d, J = 8 Hz, 1H), 
4.72 (dd, J = 15, 6 Hz, 1H), 3.89 (app. br. s, 1H), 1.50 (s, 3H), 1.13 (s, 3H). 19F 
NMR (376 MHz [D2]dichloromethane, 25 °C): δ = –78.97 (s, 3F), –324.80 (d, J = 
15 Hz, 1F). 13C NMR data could not be obtained due to the instability of the 
complex over the timescale required for the experiment. HRMS-ESI  (m/z): [M + 








Complex 4. Compound 2 (11 mg, 0.02 mmol) was dissolved in acetone (1.5 mL) 
in a 3 mL vial. The vial was then placed in a 20 mL vial containing pentane and 
sealed with a Teflon-lined cap. The vial was placed in a –35 ºC freezer until 
yellow crystals formed. The solvent was decanted, and the crystals were washed 
with pentanes (3 mL), CH2Cl2 (3 mL), and acetone (3 mL). The crystals were 
then collected and dried under vacuum to afford 4 as a bright yellow solid (5.2 
mg, 53% yield). 1H NMR (500 MHz [D6]dimethyl sulfoxide, 25 °C): δ = 9.04 (d, J = 
5 Hz, 1H), 8.91-8.89 (multiple peaks, 2H), 8.56 (t, J = 8 Hz, 1H), 8.47 (t, J = 8 Hz, 
1H), 8.10 (t, J = 6 Hz, 1H), 7.86 (d, J = 7 Hz, 1H), 7.78 (t, J = 6 Hz, 1H), 7.72 (d, 
J = 7 Hz, 1H), 7.31 (d, J = 8 Hz, 1H), 7.27 (d, J = 8 Hz, 1H), 7.14 (d, J = 7 Hz, 
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1H), 4.61 (dd, J = 15, 5 Hz, 1H), 4.23 (d, J = 5 Hz, 1H), 3.31 (broad s) 1.45 (s, 
3H), 1.13 (s, 3H). 19F NMR (376 MHz [D6]dimethyl sulfoxide, 25 °C): δ = –77.91 
(s, 3F), –328.96 (d, J = 15 Hz, 1F). 13C NMR data could not be obtained due to 
the instability of the complex over the timescale required for the experiment. 









Complex 3-BF4. Compound 1 (552 mg, 1.4 mmol, 1.0 equiv), NFTPB (259 mg, 
1.4 mmol, 1.0 equiv), and C5H5N (225 µL, 2.8 mmol, 2.0 equiv) were combined in 
CH2Cl2 (50 mL), and this mixture was stirred for 15 min. The solvent was 
removed by rotary evaporation, and the resulting yellow oil was washed with 
diethyl ether (20 mL). The solid material was then dissolved in CH2Cl2 (3 mL), 
and diethyl ether (25 mL) was added to precipitate the product. The precipitate 
was collected and dried under vacuum to afford 3-BF4 as an off-white solid (486 
mg, 58% yield). 1H NMR (400 MHz [D2]dichloromethane, 25 °C): δ = 8.91 (d, J = 
5 Hz, 1H), 8.79 (d, J = 8 Hz, 1H), 8.62 (d, J = 8 Hz, 1H), 8.47 (d, J = 8 Hz, 1H), 
8.29 (d, J = 8 Hz, 1H), 8.23 (app. br. s, 2H), 8.07 (d, J = 6 Hz, 1H), 7.88 (t, J = 8 
Hz, 1H), 7.77 (t, J = 5 Hz, 1H), 7.64 (t, J = 7 Hz, 1H), 7.45 (t, J = 7 Hz, 2H), 7.24 
(t, J = 7 Hz, 1H), 7.05 (d, J = 7 Hz, 1H), 7.01 (t, J = 8 Hz, 1H), 6.65 (d, J = 8 Hz, 
1H), 4.72 (dd, J = 15, 6 Hz, 1H), 3.88 (app. br. s, 1H), 1.49 (s, 3H), 1.13 (s, 3H). 
19F NMR (376 MHz [D2]dichloromethane, 25 °C): δ =  –152.48 (s, 4F), –324.80 
(d, J = 15 Hz, 1F). 13C NMR data could not be obtained due to the instability of 
the complex over the timescale required for the experiment. HRMS-ESI  (m/z): 








Complex 5. Compound 2 (310 mg, 0.54 mmol, 1.0 equiv) and Me4NF (52 mg, 
0.86 mmol, 1.6 equiv) were combined in dry CH2Cl2 (15 mL), and this mixture 
was stirred for 15 min in the glovebox. The solution turned dark orange with a 
dark solid precipitate. The reaction was filtered through celite, and the solvent 
was removed under vacuum. The resulting yellow oil was dissolved in DCE (4 
mL), and pentane (30 mL) was added to precipitate the product. The precipitate 
was collected and dried under vacuum to afford 5 as a light yellow solid (190 mg, 
77% yield, along with 19 % Me4NBF4 as determined by 1H NMR). 1H NMR (500 
MHz [D2]dichloromethane, 25 °C): δ = δ 9.06 (d, J = 5 Hz, 1H), 8.43 (d, J = 8 Hz, 
1H), 8.40 (d, J = 8 Hz, 1H), 8.14-8.08 (multiple peaks, 2H), 8.01 (t, J = 8 Hz, 1H), 
7.95 (d, J = 8 Hz, 1H), 7.74 (d, J = 6 Hz, 1H), 7.31 (t, J = 6 Hz, 1H), 7.24-7.16 
(multiple peaks, 2H), 6.95 (d, J = 8 Hz, 1H), 4.11 (m, 1H), 3.51 (dd, J = 6, 3 Hz, 
1H), 1.39 (s, 3H), 1.02 (s, 3H). 19F NMR (470 MHz [D2]dichloromethane, 25 °C): 
δ = –201.42 (d, J = 51 Hz, 1F), –336.71 (dd, J = 51, 14 Hz, 1F). HRMS-ESI  
(m/z): [M – F]+ calcd for C20H20FN2Pd 413.0645; Found, 413.0640. 
 








Complex 6. Compound 3 (30 mg, 0.06 mmol) was dissolved CH2Cl2 (10 mL). 
The reaction was stirred for 30 min at 80 °C. The solvent was removed by rotary 
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evaporation, and the resulting yellow oil was dissolved in CH2Cl2 (1 mL), and 
precipitated with pentane (15 mL). The precipitate was collected and dried under 
vacuum to afford 6 as a tacky yellow solid (28 mg, 93% yield). 1H NMR (500 MHz 
[D3]chloroform, 25 °C): δ = 8.88 (d, J = 8 Hz, 2H), 8.56 (d, J = 8 Hz, 1H), 8.53 (d, 
J = 8 Hz, 1H), 8.22 (t, J = 8 Hz, 1H), 8.16 (t, J = 8 Hz, 1H), 8.04-7.99 (multiple 
peaks, 2H), 7.77 (d, J = 5 Hz, 1H), 7.68-7.61 (multiple peaks, 2H), 7.56 (d, J = 6 
Hz, 1H), 7.32 (t, J = 6 Hz, 1H), 7.22 (t, J = 8 Hz, 1H), 7.11-7.08 (multiple peaks, 
2H), 4.69 (dd, J = 48, 9 Hz, 1H), 4.53 (dd, J = 48, 9 Hz, 1H), 1.68 (s, 3H), 1.61 (s, 
3H). 19F NMR (470 MHz [D3]chloroform, 25 °C): δ = –78.99 (s, 1F), –217.01 (t, J 
= 48 Hz, 1F). 13C NMR (125 MHz [D3]chloroform, 25 °C): δ = 156.40, 153.70, 
152.45, 152.25, 150.41, 148.29, 148.13, 141.10, 140.82, 139.70, 132.91, 128.34, 
128.07, 126.94, 126.86, 126.48 (q, J = 322 Hz, 1C), 126.38, 125.27, 124.04, 
124.01, 92.21 (d, J = 177 Hz, 1C), 40.91, 40.76, 27.60. HRMS-ESI  (m/z): [M – 






Complex 8. Compound 7 (20 mg, 0.04 mmol, 1.0 equiv) was dissolved in dry 
CH2Cl2 (6 mL) under N2. The reaction was stirred for 15 min at 80 ºC. The 
solvent was removed by rotary evaporation, the resulting yellow oil was dissolved 
in CH2Cl2 (1 mL), and the product was precipitated with pentane (15 mL). The 
precipitate was collected and dried under vacuum to afford 8 as a tacky yellow 
solid (18 mg, 90% yield). 1H NMR (700 MHz [D2]dichloromethane, 25 °C): δ = 
9.16 (d, J = 5 Hz, 1H), 8.75 (d, J = 5 Hz, 1H), 8.15-8.13 (multiple peaks, 2H), 
8.06-8.01 (multiple peaks, 2H), 7.61 (t, J = 5 Hz, 1H), 7.53 (d, J = 6 Hz, 1H), 7.51 
(d, J = 8 Hz, 1H), 6.99 (t, J = 7 Hz, 1H), 6.95 (t, J = 8 Hz, 1H), 6.86 (d, J = 7 Hz, 
1H), 4.54 (dd, J = 49, 9 Hz, 1H), 4.51 (dd, J = 49, 9 Hz, 1H), 1.39 (s, 3H), 1.38 (s, 
3H). 19F NMR (376 MHz [D2]dichloromethane, 25 °C): δ = –151.89 (s, 1F), –
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214.87 (t, J = 49 Hz, 1F). 13C NMR (175 MHz [D3]chloroform, 25 °C): δ = 163.45, 
160.98, 155.59, 155.19, 151.02, 150.11, 138.42, 138.37, 135.29, 126.46, 126.24, 
125.22, 123.63, 123.25, 122.27, 122.20, 95.39 (d, J = 176 Hz, 1C), 36.62, 36.60, 










Complex 6-BF4. Compound 3-BF4 (30 mg, 0.05 mmol) dissolved combined in 
CH2Cl2 (10 mL). The reaction was stirred for 30 min at 80 °C. The solvent was 
removed by rotary evaporation, and the resulting yellow oil was dissolved in 
CH2Cl2 (1 mL), and precipitated with pentane (15 mL). The precipitate was 
collected and dried under vacuum to afford 6-BF4 as a tacky yellow solid (26 mg, 
87% yield). 1H NMR (700 MHz [D2]dichloromethane, 25 °C): δ = 8.85-8.83 
(multiple peaks, 2H), 8.48-8.45 (multiple peaks, 2H), 8.16-8.11 (multiple peaks, 
2H), 8.01-7.96 (multiple peaks, 2H), 7.75 (d, J = 5 Hz, 1H), 7.63 (d, J = 7 Hz, 
1H), 7.62-7.58 (multiple peaks, 2H), 7.52 (d, J = 6 Hz, 1H), 7.27 (t, J = 6 Hz, 1H), 
7.19 (d, J  = 8 Hz, 1H), 7.08-7.05 (multiple peaks, 2H), 4.68 (dd, J = 48 Hz, J = 9 
Hz, 1H), 4.50 (dd, J = 48 Hz, J = 9 Hz, 1H), 1.64 (s, 3H), 1.40 (s, 3H). 19F NMR 
(376 MHz [D3]chloroform, 25 °C): δ = –152.42 (s, 1F), –216.08 (t, J = 48 Hz, 1F). 
13C NMR (125 MHz [D3]chloroform, 25 °C): δ = 156.03, 153.23, 151.87 (two 
overlapping carbon’s), 150.16, 147.91, 140.67, 140.49, 139.35, 132.58, 127.94, 
127.74, 126.60 (two overlapping carbon’s), 126.42, 126.00, 124.87, 123.55, 
123.47, 93.31 (d, J = 176 Hz, 1C), 40.53, 40.40, 27.19. HRMS-ESI (m/z): [M – 




Determining Order in Pyridine with 3-BF4 at 45 °C in CD2Cl2 
Complex 3-BF4 (4.4 mg, 0.00758 mmol, 1.0 equiv) and C5D5N (0.001895 to 
0.0114 mmol, 3.8 mM to 20.0 mM) were combined in a screw cap NMR tube and 
dissolved in CD2Cl2 (0.5 mL). An internal standard (2-nitrobenzotrifluoride) was 
added (20 µl of a stock solution in CD2Cl2, 0.00758, 1 equiv) and the tube was 
sealed with a Teflon®-lined cap. The tube was immediately placed in an NMR 
spectrometer with the temperature pre-equilbrated to 45 °C, and the reaction was 
allowed to equilibrate for 2 min. The rate of reductive elimination was monitored 
by 19F NMR spectroscopy by monitoring the disappearance of the starting 
material. The reaction was followed to between 2-3 half lives, and the data was 
plotted as –ln[3-BF4/3-BF4º] versus time. A representative kinetics run is shown 

































equiv C5D5N [C5D5N] [1/C5D5N] kobs 
0.25 0.001895 528 2.75 x 10–4 
0.5 0.00379 264 1.6 x 10–4 
0.75 0.00568 176 5.51 x 10–5 
1 0.00758 132 8.02 x 10–5 














Figure 3.6.1. Representative Rate Data (Reductive Elimination from 3-BF4 in 








X-ray Crystallography Details 
 Yellow cubes of 4 were grown from an acetone/pentanes solution at –35 °C.  A 
crystal of dimensions 0.10 x 0.10 x 0.10 mm was mounted on a Bruker SMART APEX 
CCD-based X-ray diffractometer equipped with a low temperature device and fine focus 
Mo-target X-ray tube (l = 0.71073 A) operated at 1500 W power (50 kV, 30 mA). The X-
ray intensities were measured at 85(1) K; the detector was placed at a distance 5.055 
cm from the crystal. A total of 4717 frames were collected with a scan width of 0.5° in w 
and 0.45° in phi with an exposure time of 30 s/frame. The integration of the data yielded 
a total of 119486 reflections to a maximum 2q value of 56.64° of which 7429 were 
independent and 7186 were greater than 2s(I).  The final cell constants (Table 1) were 
based on the xyz centroids of 9866 reflections above 10s(I). Analysis of the data 
showed negligible decay during data collection; the data were processed with SADABS 
and corrected for absorption. The structure was solved and refined with the Bruker 
SHELXTL (version 2008/4) software package, using the space group Pca2(1) with Z = 4 
for the formula C33H26BN3F4Cl2Pd. All non-hydrogen atoms were refined anisotropically 
with the hydrogen atoms placed in idealized positions. Full matrix least-squares 
refinement based on F2 converged at R1 = 0.0219 and wR2 = 0.0533 [based on I > 
2sigma(I)], R1 = 0.0232 and wR2 = 0.0542 for all data. Additional details are presented 
in Table S2 and are available in the corresponding CIF file (deposited in the Cambridge 
Structural Database: CCDC 852596). 
 
Sheldrick, G.M. SHELXTL, v. 2008/4; Bruker Analytical X-ray, Madison, WI, 2008. 
 
Saint Plus, v. 7.60A, Bruker Analytical X-ray, Madison, WI, 2009. 
 
Sheldrick, G.M. SADABS, v. 2008/1.  Program for Empirical Absorption Correction of 




Table 3.6.2  Crystal data and structure refinement for 5. 
  
Empirical formula  C21 H22 F4 N2 O4 Pd S 
Formula weight            580.87 
Temperature               85(2) K 
Wavelength                  1.54178 A 
Crystal system, space group       Triclinic,  P-1 
Unit cell dimensions               a = 9.3652(2) A   alpha = 94.404(7) deg. 
b = 11.5602(3) A    beta = 108.848(8) deg. 
c = 11.9928(8) A   gamma = 111.654(8) deg. 
Volume                             1113.33(8) A^3 
Z, Calculated density              2,  1.733 Mg/m^3 
Absorption coefficient             8.196 mm^-1 
F(000)                              584 
Crystal size                       0.18 x 0.12 x 0.09 mm 
Theta range for data collection   4.00 to 68.17 deg. 
Limiting indices                   -11<=h<=11, -13<=k<=13, -11<=l<=12 
Reflections collected / unique     16877 / 3453 [R(int) = 0.0504] 
Completeness to theta = 68.17  84.7 % (96% complete to 0.86 A). 
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Absorption correction              Semi-empirical from equivalents 
Max. and min. transmission        0.686 and 0.557 
Refinement method                  Full-matrix least-squares on F^2 
Data / restraints / parameters     3453 / 0 / 375 
Goodness-of-fit on F^2             1.261 
Final R indices [I>2sigma(I)]      R1 = 0.0688, wR2 = 0.2137 
R indices (all data)               R1 = 0.0699, wR2 = 0.2141 





















Complex 21. (COD)PdII(CH2CMe2-o-C6H4) (104 mg, 0.30, 1.0 equiv) was 
combined with 4,4′-di-tert-butylbipyridine (80 mg, 0.30 mmol, 1.0 equiv) in CH2Cl2 
(120 mL) and allowed to stir for 30 min at rt. The reaction was concentrated 
under vacuum to 5 mL and ~30 mL of hexanes was added to precipitate the 
product. 21 was isolated as a bright yellow solid (147 mg, 97% yield). 1H NMR 
(CDCl3): δ 9.11(d, J = 6 Hz, 1H), 8.55 (d, J = 6 Hz, 1H), 7.98-7.97 (multiple 
peaks, 2H), 7.55 (d, J = 8 Hz, 1H), 7.53 (d, J = 6 Hz, 1H), 7.43 (d, J = 6 Hz, 1H), 
7.00 (app. t, 2H), 6.87 (d, J = 8 Hz, 1H), 2.43 (s, 2H), 1.44 (s, 6H), 1.43 (s, 9H), 
1.42 (s, 9H). 13C NMR (CDCl3): δ 169.09, 161.95, 161.87, 159.24, 155.35, 
154.86, 150.38, 149.32, 134.79, 123.92, 122.90, 122.78, 122.54, 121.58, 117.94, 
117.84, 47.27, 44.84, 35.19, 35.17, 33.76, 31.07, 30.30, 30.27. HRMS-







Complex 22. Compound 21 (510 mg, 1.01 mmol, 1.0 equiv) and NFTPT (291 
mg, 1.01 mmol, 1.0 equiv) were combined in CH2Cl2 (15 mL), and this mixture 
was stirred for 15 min. The solvent was removed by rotary evaporation, and the 
resulting yellow oil was washed with diethyl ether (30 mL). The solid material was 
then dissolved in CH2Cl2 (5 mL), and diethyl ether (25 mL) was added to 
precipitate the product. The precipitate was collected and dried under vacuum to 
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afford 22 as a light yellow solid (644 mg, 94% yield). 1H NMR (CD3CN): δ 8.80 (d, 
J = 6 Hz, 1H), 8.52 (s, 1H), 8.48 (s, 1H), 7.95 (d, J = 6 Hz, 1H), 7.83 (d, J = 6 Hz, 
1H), 7.66 (d, J = 6 Hz, 1H), 7.54 (d, J = 7 Hz, 1H), 7.32 (t, J = 7 Hz, 1H), 7.25 (t, 
J = 8 Hz, 1H), 7.09 (d, J = 8 Hz, 1H), 4.72 (dd, J = 15, 6 Hz, 1H), 4.12 (app. br. s, 
1H), 1.52 (s, 9H), 1.43 (s, 9H), 1.41 (s, 3H), 1.09 (s, 3H).. 19F NMR (CD3CN): δ –
79.56 (s, 3F), –335.43 (d, J = 15 Hz, 1F). 13C NMR data could not be obtained 
due to the instability of the complex over the timescale required for the 














Complex 23. Cs2CO3 (24 mg, 0.074 mmol, 2.0 equiv) and benzenesulfonamide 
(12 mg, 0.074 mmol, 2.0 equiv) were combined in MeCN (3.0 mL) at 65 °C and 
allowed to stir for 1 h. The solution was allowed to cool and complex 22 (25 mg, 
0.037 mmol, 1.0 equiv) was added to the reaction mixture. The reaction was 
heated at at 65 °C for 12 h. The solvent was removed by rotary evaporation and 
diethyl ether was added to the yellow sticky solid. The solution was decanted and 
the solvent was removed by rotary evaporation. The yellow solid was dissolved in 
2 mL of diethyl ether and precipitated with pentanes (~ 6 mL). Compound 23 
solid was collected as a yellow solid. (14 mg, 46% yield). 1H NMR (CD3CN): δ 
9.16 (d, J = 6 Hz, 1H), 8.39 (d, J = 6 Hz, 1H), 8.30 (d, J = 6 Hz, 1H), 7.88-7.84 
(multiple peaks, 2H), 7.75 (d, J = 6 Hz, 1H), 7.63-7.55 (multiple peaks, 3H), 7.51 
(d, J = 6 Hz, 1H), 7.31 (d, J = 6 Hz, 1H), 7.14 (d, J = 7 Hz, 1H), 7.06-7.03 
 152 
(multiple peaks, 2H), 6.84 (t, J = 8 Hz, 1H), 6.80 (t, J = 6 Hz, 1H), 6.73 (d, J = 8 
Hz, 1H), 5.65 (br. s, 2H), 2.80 (d, J = 11, 1H), 2.36 (d, J = 11, 1H), 1.45 (s, 9H), 
1.43 (s, 3H), 1.38 (s, 9H), 1.24 (s, 3H). 13C NMR (CD3CN): δ 164.50, 164.38, 
156.82, 153.74, 153.48, 151.66, 150.99, 149.57, 143.57, 135.73, 132.86, 129.86, 
129.61(overlapping carbons, 2C), 128.06, 127.92, 126.45, 125.41, 124.06, 
123.65, 123.35, 121.21, 120.69, 119.55, 57.16, 44.30, 35.97, 35.90, 32.32, 
30.05, 29.86, 27.27. HRMS-ESI (m/z): [M – C6H6NO2S]+ calcd for 









Complex 24. Cs2CO3 (36 mg, 0.111 mmol, 3.0 equiv) and 2,2,2-
trifluoroacetamide (13 mg, 0.111 mmol, 3.0 equiv) were combined in MeCN (4.0 
mL) at 65 °C and allowed to stir for 1 h. The solution was allowed to cool and 
complex 22 (25 mg, 0.037 mmol, 1.0 equiv) was added to the reaction mixture. 
The reaction was heated at 65 °C for 12 h. The solvent was removed by rotary 
evaporation and diethyl ether was added to the white solid. The solution was 
decanted and the solvent was removed by rotary evaporation (2X). The white 
solid was dissolved in 2 mL of diethyl ether and precipitated with pentanes (~ 6 
mL). Complex 24 was collected as a white solid. (6 mg, 23% yield). 1H NMR 
(CD3CN): δ 8.47 (d, J = 6 Hz, 1H), 8.39 (d, J = 5 Hz, 1H), 8.36-8.35 (multiple 
peaks, 2H), 7.70 (d, J = 6 Hz, 1H), 7.59 (d, J = 6 Hz, 1H), 7.40-7.39 (multiplet, 
1H), 7.09-7.05 (multiple peaks, 3H), 3.62 (d, J = 13, 1H), 3.02 (d, J = 13, 1H), 
2.30 (s, 3H), 2.18 (s, 1H), 1.48 (s, 3H), 1.47 (s, 9H), 1.45 (s, 3H), 1.44 (s, 9H). 
13C NMR (CD3CN): δ 164.42, 164.25, 160.98 (q, J = 31 Hz, 1H), 156.00, 153.27, 
153.16, 150.96, 149.62, 148.83, 135.73, 133.72, 125.38, 123.88, 123.60, 123.51, 
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121.80, 120.20 98 (q, J = 289 Hz, 1H), 120.41, 119.72, 42.87, 35.50, 35.44, 
29.46, 29.32, 27.38. HRMS-ESI (m/z): [M – CH3CN]+ calcd for C30H37F3N3OPd 
618.1929; Found, 618.1929. At this time the counterion on this complex has not 
been determined. 
 






















Complex 25. Cs2CO3 (22 mg, 0.066 mmol, 2.0 equiv) and benzenesulfonamide 
(10 mg, 0.066 mmol, 3.0 equiv) were combined in MeCN (2.0 mL) at 65 °C and 
allowed to stir for 1 h. The solution was allowed to cool and complex 22 (15 mg, 
0.022 mmol, 1.0 equiv) was added to the reaction mixture. The reaction was 
shaken for ~ 1 min and then filtered over a pipette filled with celite. The filtrate 
was collected and the solvent was removed by rotary evaporation. Diethyl ether 
(2 mL) was added to the yellow solid and decanted into a vial. The solvent was 
removed by rotary evaporation. Diethyl ether (2 mL) was added to the yellow 
solid and decanted into a vial.  The solvent was removed by rotary evaporation.  
The solid was dissolved in (0.5 mL) CH2Cl2 and allowed to crystalize by diffusion 
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with pentanes at -35 °C. The yellow solid was collected (7 mg, 45% yield). 1H 
NMR (CD3CN): δ 8.56 (d, J = 6 Hz, 1H), 8.40-8.38 (multiplet, 1H), 8.07 (s, 1H), 
8.03 (s, 1H), 7.91-7.88 (multiple peaks, 3H), 7.68 (d, J = 6 Hz, 1H), 7.57 (d, J = 8 
Hz, 1H), 7.43 (d, J = 7 Hz, 1H), 7.24-7.22 (multiple peaks, 2H), 6.98-6.95 
(multiple peaks, 3H), 3.97 (dd, J = 15, 7 Hz, 1H), 3.35 (s, 1H), 3.02 (d, J = 7 Hz, 
1H), 1.48 (s, 9H), 1.43 (s, 9H), 1.46 (s, 3H), 1.33 (s, 3H). 19F NMR (CD3CN): δ –
335.43 (d, J = 15 Hz, 1F). HRMS-ESI (m/z): [M – C6H4NO2S]+ calcd for 










Complex 26. Cs2CO3 (29 mg, 0.089 mmol, 3.0 equiv) and 2,2,2-
trifluoroacetamide (10 mg, 0.089 mmol, 3.0 equiv) were combined in MeCN (2.5 
mL) at 65 °C and allowed to stir for 2 h. The solution was allowed to cool and 
complex 22 (20 mg, 0.03 mmol, 1.0 equiv) was added to the reaction mixture. 
The reaction was shaken for ~ 1 min and then filtered over a pipette filled with 
celite. The filtrate was collected and the solvent was removed by rotary 
evaporation. CH2Cl2 (2 mL) was added to the off white solid and decanted into a 
vial. The solvent was removed by rotary evaporation and petroleum ether (3 mL) 
was added to the vial and the solution was decanted. The solvent was removed 
by rotary evaporation and the solid was dissolved in (0.5 mL) chlorobenzene and 
allowed to crystalize by diffusion with pentanes at -35 °C. The filtrate was 
removed from the solid/crystals and the solvent was removed by rotary 
evaporation to afford an off white solid (6 mg, 32% yield). 1H NMR (CD3CN): δ 
8.73 (d, J = 6 Hz, 1H), 8.43 (s, 1H), 8.38 (s, 1H), 7.93 (d, J = 6 Hz, 1H), 7.85 (d, J 
= 6 Hz, 1H), 7.72 (d, J = 8 Hz, 1H), 7.54 (d, J = 7 Hz, 1H), 7.40 (d, J = 6 Hz, 1H), 
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7.22 (t, J = 7 Hz, 1H), 7.16 (d, J = 8 Hz, 1H), 7.02 (d, J = 8 Hz, 1H), 4.72 (dd, J = 
15, 7 Hz, 1H), 4.12 (d, J = 7 Hz, 1H), 3.02 (s, 1H), 1.52 (s, 9H), 1.43 (s, 9H), 1.41 
(s, 3H), 1.09 (s, 3H). 19F NMR (CD3CN): δ –79.56 (s, 3F), –339.67 (d, J = 15 Hz, 
1F). 13C NMR data could not be obtained due to the instability of the complex 
over the timescale required for the experiment. HRMS-ESI (m/z): [M – 
C2HF3NO]+ calcd for C28H36FN2Pd 525.1897; Found, 525.1901. HRMS-ESI (m/z): 







Complex 28. Compound 2 (4.3 mg, 0.008 mmol, 1.0 equiv) was dissolved in 
CD3CN (0.25 mL) and frozen with liquid nitrogen in a screw cap NMR tube 
sealed with a Teflon-lined cap. A solution of Bu4NOAc (2.3 mg, 0.008 mmol, 1.0 
equiv) in CD3CN (0.25 mL) with CH2Cl2 as an internal standard was added to the 
NMR tube and frozen with liquid nitrogen. The reaction mixture was allowed to 
warm to room temperature in the NMR probe. After 5 min, a spectrum was 
acquired. The reaction was repeated three times and the yield is an average of 
the three trials. Yield: 90% as determined by 1H NMR spectroscopic analysis of 
the crude reaction mixture. 1H NMR (CD3CN): δ 8.89 (d, J = 5 Hz, 1H), 8.52 
(multiple peaks, 2H), 8.37-8.29 (multiple peaks, 2H), 7.95 (multiple peaks, 2H), 
7.76 (t, J = 6 Hz, 1H), 7.55 (t, J = 8 Hz, 1H), 7.29-7.18 (multiple peaks, 2H), 7.07 
(t, J = 7 Hz, 1H), 4.74 (dd, J = 15, 6 Hz, 1H), 4.17 (multiplet, 1H), 2.18 (s, 3H), 
1.58 (s, 3H), 1.33 (s, 3H). 19F NMR (CD3CN): δ  –329.56 (d, J = 15 Hz, 1F). 13C 
NMR data could not be obtained due to the instability of the complex over the 








Complex 29. Compound 2 (4.3 mg, 0.008 mmol, 1.0 equiv) and Bu4NCl (2.1 mg, 
0.008 mmol, 1.0 equiv) were dissolved in CD3CN (0.5 mL) with CH2Cl2 as an 
internal standard. After 5 minutes at 25 °C the reaction was analyzed by 1H NMR 
spectroscopy. The reaction was repeated three times, and the yield is an 
average of the three trials. Yield: 91% as determined by 1H NMR spectroscopic 
analysis of the crude reaction mixture. 1H NMR (CD3CN): δ 8.95 (d, J = 5 Hz, 
1H), 8.50-8.47 (multiple peaks, 2H), 8.32 (t, J = 6 Hz, 1H), 8.29 (t, J = 6 Hz, 1H), 
8.20 (t, J = 8 Hz, 1H), 7.99 (d, J = 6 Hz, 1H), 7.87 (d, J = 5 Hz, 1H), 7.47 (t, J = 7 
Hz, 1H), 7.26-7.16 (multiple peaks, 2H), 7.03 (d, J = 7 Hz, 1H), 4.58 (dd, J = 15, 
6 Hz, 1H), 3.84 (multiplet, 1H), 1.05 (s, 3H), 0.70 (s, 3H). 19F NMR (CD3CN): δ–
337.49 (d, J = 15 Hz, 1F). 13C NMR data could not be obtained due to the 







Complex 30. Compound 2 (4.3 mg, 0.008 mmol, 1.0 equiv) and Bu4NOAc (2.3 
mg, 0.008 mmol, 1.0 equiv) were dissolved in CD3CN (0.5 mL) with CH2Cl2 as an 
internal standard. This reaction was stirred for 2 h to yield compound 30. The 
reaction was repeated three times and the yield is an average of the three trials. 
Yield: 77% as determined by 1H NMR spectroscopic analysis of the crude 
reaction mixture. 1H NMR (CD3CN): δ 8.43 (d, J = 5 Hz, 1H), 8.28 (d, J = 8 Hz, 
1H), 8.23 (d, J = 8 Hz, 1H), 8.16 (t, J = 8 Hz, 1H), 8.04 (t, J = 8 Hz, 1H), 7.97 (d, 
J = 7 Hz, 1H), 7.64 (t, J = 6 Hz, 1H), 7.48 (d, J = 6 Hz, 1H), 7.28 (t, J = 7 Hz, 1H), 
7.16 (d, J = 8 Hz, 1H), 6.95 (t, J = 7 Hz, 1H), 6.87 (t, J = 8 Hz, 1H), 5.17 (d, J = 
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11 Hz, 1H), 4.55 (d, J = 11 Hz, 1H), 1.84 (s, 3H), 1.64 (s, 3H), 1.76 (s, 3H). 19F 
NMR (MeCN) –30 °C: δ –146.54 (broad s, 1F). This compound could not be 
isolated cleanly from the mixture without decomposition. Therefore it was 







Complex 31. Compound 2 (4.3 mg, 0.008 mmol, 1.0 equiv) and Bu4NCl (2.1 mg, 
0.008 mmol, 1.0 equiv) were dissolved in CD3CN (0.5 mL) with CH2Cl2 as an 
internal standard. This reaction was stirred for 2 h at 25 ºC to yield compound 31. 
The reaction was repeated three times and the yield is an average of the three 
trials. Yield: 63% as determined by 1H NMR spectroscopic analysis of the crude 
reaction mixture. 1H NMR (CD3CN): δ 9.15 (d, J = 5 Hz, 1H), 8.36-8.25 (multiple 
peaks, 2H), 8.19 (t, J = 8 Hz, 1H), 8.10 (t, J = 8 Hz, 1H), 7.78 (d, J= J = 8 Hz, 
1H), 7.72 (t, J = 7 Hz, 1H), 7.55 (d, J = 7 Hz, 1H), 7.36 (t, J = 5 Hz, 1H), 7.26 (d, 
J = 8 Hz, 1H), 6.99 (t, J = 8 Hz, 1H), 6.92 (t, J = 8 Hz, 1H), 4.58 (d, J = 11 Hz, 
1H), 4.10 (d, J = 11 Hz, 1H), 1.85 (s, 3H), 1.70 (s, 3H). This compound could not 
be isolated cleanly from the mixture without decomposition. Therefore it was 
converted to compound S2 for complete characterization. 
 
Scheme 3.6.2 Synthesis and Characterization of Complexes S1 and S2 




























Complex S1. Compound 2 (50 mg, 0.09 mmol, 1.0 equiv) and LiOAc (7.6 mg, 
0.12 mmol, 1.3 equiv) were combined in THF (10 mL), and this reaction mixture 
was stirred for 1 h at 25 ºC. The reaction mixture was filtered through celite, and 
the solvent was removed by rotary evaporation. The resulting yellow oil was 
dissolved in MeCN (5 mL) and TMSI (13 µL, 0.09 mmol, 1.0 equiv) was added. 
The solvent was removed by rotary evaporation. The yellow oil was washed with 
diethyl ether (10 mL), dissolved in CH2Cl2 (2 mL), and then the product was 
precipitated with pentane (15 mL). The resulting solid was collected, and MeCN 
(1 mL) was added. The solid was collected and dried under vacuum to afford S1 
as a tacky yellow solid (18 mg, 35% yield). 1H NMR (CD2Cl2): δ 9.65 (d, J = 5 Hz, 
1H), 8.11-8.05 (multiple peaks, 2H), 8.03 (t, J = 8 Hz, 1H), 8.00 (t, J = 7 Hz, 1H), 
7.78 (d, J = 8 Hz, 1H), 7.58 (t, J = 5 Hz, 1H), 7.32-7.30 (multiple peaks, 2H), 7.24 
(d, J = 8 Hz, 1H), 6.94 (t, J = 7 Hz, 1H), 6.83 (t, J = 7 Hz, 1H), 4.73 (d, J = 11 Hz, 
1H), 4.51 (d, J = 11 Hz, 1H), 1.80 (s, 3H), 1.69 (s, 3H), 1.59 (s, 3H). 13C NMR 
(CDCl3): δ 171.05, 158.97, 153.28, 153.10, 150.07, 138.35, 137.17, 127.77, 
127.14, 126.74, 126.05, 125.10, 124.75, 124.14, 123.26, 121.67, 121.39, 74.25, 









Complex S2. Compound 2 (50 mg, 0.09 mmol, 1.0 equiv) and LiCl (4.9 mg, 0.12 
mmol, 1.3 equiv) were combined in THF (10 mL), and this reaction mixture was 
stirred for 1 h at 25 ºC. The reaction was filtered through celite, and the solvent 
was removed by rotary evaporation. The resulting yellow oil was dissolved in 
MeCN (5 mL), and TMSI (13 µL, 0.09 mmol, 1.0 equiv) was added. The solvent 
was removed by rotary evaporation. The yellow oil was washed with diethyl ether 
(10 mL), dissolved in CH2Cl2 (2 mL), and then the product was precipitated with 
pentane (15 mL). The solid was collected, and MeCN (1 mL) was added After 
filtration over a small pad of celite, the filtrate was collected and the solvent was 
removed by rotary evaporation. The solid was collected and dried under vacuum 
to afford S2 as a tacky yellow solid (24 mg, 48% yield). 1H NMR (CD2Cl2): δ 9.58 
(d, J = 5 Hz, 1H), 8.03-8.00 (multiple peaks, 2H), 7.97 (t, v = 8 Hz, 1H), 7.92 (t, J 
= 8 Hz, 1H), 7.72 (d, J = 8 Hz, 1H), 7.51 (t, J = 5 Hz, 1H), 7.29 (d, J = 8 Hz, 1H), 
7.24 (t, J = 6 Hz, 1H), 7.17 (d, J = 8 Hz, 1H), 6.87 (t, J = 7 Hz, 1H), 6.77 (t, J = 8 
Hz, 1H), 4.22 (d, J = 11 Hz, 1H), 3.91 (d, J = 11 Hz, 1H), 1.70 (s, 3H), 1.67 (s, 
3H). 13C NMR (CD2Cl2): δ 157.62, 155.83, 154.62, 151.87, 150.55, 144.13, 
140.40, 140.34, 138.87, 129.62, 128.40, 128.05, 125.80, 124.86, 123.58, 123.38, 
59.29, 42.40, 30.80 (two overlapping carbon’s). HRMS-ESI (m/z): [M – I]+ calcd 




























Complex 32. Compound 21 (200 mg, 0.395, 1.0 equiv) was combined with 
PhI(OAc)2 (127 mg, 0.395 mmol, 1.0 equiv) in CH2Cl2 (100 mL), and the reaction 
mixture allowed to stir for 15 min. The solution was concentrated under vacuum 
to ~2 mL and diethyl ether (20 mL) was added to precipitate the product. 
Complex 32 was isolated as a pale yellow solid (130 mg, 53% yield). 1H NMR 
(MeCN): δ 8.33 (d, J = 6 Hz, 1H), 8.29 (s, 1H), 8.23 (s, 1H), 7.98 (d, J = 6 Hz, 
1H), 7.69 (d, J = 6 Hz, 1H), 7.38-7.30 (multiple peaks, 2H), 7.18 (d, J = 8 Hz, 
1H), 6.97 (t, J = 7 Hz, 1H), 6.87 (t, J = 7 Hz, 1H), 5.41 (d, J = 10 Hz, 1H), 4.48 (d, 
J = 10 Hz, 1H), 1.86 (s, 3H), 1.76 (s, 3H), 1.65 (s, 3H), 1.64 (s, 3H), 1.47 (s, 9H), 
1.38(s, 9H).  13C NMR (CDCl3): δ 176.38, 171.18, 165.07, 164.60, 156.75, 
154.02, 152.07, 151.87, 150.49, 148.72, 136.42, 127.01, 124.37, 124.34, 124.31, 
123.93, 120.90, 120.40, 74.52, 40.17, 36.12, 36.10, 30.19, 29.99, 28.12, 27.69, 
23.90, 20.80. HRMS-electrospray (m/z): [M - OAc]+ calcd for C30H39N2O2Pd, 








Complex 33. Compound 21 (200 mg, 0.394 mmol, 1.0 equiv) and PhICl2 (110 
mg, 0.394 mmol, 1.0 equiv) were combined in CH2Cl2 (40 mL), and the resulting 
solution was stirred for 15 min. The reaction mixture was concentrated to ~4 mL, 
and hexanes (~30 mL) was added to precipitate the product. The precipitate was 
collected and dried under vacuum to afford 33 was isolated as a bright yellow 
solid (223 mg, 98% yield). 1H NMR (CDCl3): δ 9.16 (d, J = 6 Hz, 1H), 7.95 
(multiple peaks, 2H), 7.84 (d, J = 8 Hz, 1H), 7.54 (d, J = 6 Hz, 1H), 7.46 (d, J = 6 
Hz, 1H), 7.26-7.19 (multiple peaks, 2H), 6.96 (t, J = 7 Hz, 1H), 6.90 (t, J = 7 Hz, 
1H), 4.76 (d, J = 11 Hz, 1H), 3.93 (d, J = 11 Hz, 1H), 1.81 (s, 3H), 1.78 (s, 3H), 
1.43 (s, 9H), 1.37 (s, 9H). 13C NMR (CDCl3): δ 163.59, 163.16, 155.76, 153.49, 
151.53, 149.36, 148.79, 148.03, 134.97, 127.42, 124.85, 123.55 overlapping 
carbons, 2C), 123.52, 118.36, 117.80, 57.88, 41.28, 35.55 (2C, overlapping), 
30.46, 30.27, 29.03, 28.81. HRMS-EI (m/z): [M+]+ calcd for C29H39Cl2N2Pd, 









Complex 34. Compound 21 (80 mg, 0.158, 1.0 equiv) was combined with 
PhI(O2CCF3)2 (68 mg, 0.158 mmol, 1.0 equiv) in CH2Cl2 (50 mL), and the 
reaction mixture allowed to stir for 15 min. The solution was concentrated under 
vacuum. Then, ~1 mL CH2Cl2 was added to the yellow oil and diethyl ether (20 
mL) was added to precipitate the product. Complex 21 was isolated as a pale 
yellow solid (72 mg, 61% yield). 1H NMR (acetone): δ 8.60 (s, 1H), 8.56 (s, 1H), 
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8.22 (d, J = 6 Hz, 1H), 7.96 (d, J = 8 Hz, 1H), 7.83 (d, J = 6 Hz, 1H), 7.44-7.38 
(multiple peaks, 2H), 7.13 (d, J = 8 Hz, 1H), 6.93 (t, J = 7 Hz, 1H), 6.83 (t, J = 7 
Hz, 1H), 5.42 (d, J = 11 Hz, 1H), 4.91 (d, J = 11 Hz, 1H), 1.76 (s, 3H), 1.68 (s, 
3H), 1.42 (s, 9H), 1.36 (s, 9H). 19F NMR (MeCN): δ −78.17(s, 3F), −78.73 (s, 3F). 











Complex 35. Compound 21 (30 mg, 0.059, 1.0 equiv) was combined with 
PhI(O2C10F19)2 (73 mg, 0.059 mmol, 1.0 equiv) in CH2Cl2 (40 mL), and the 
reaction mixture allowed to stir for 15 min. The solution was concentrated under 
vacuum. Then, ~1 mL CH2Cl2 was added to the yellow oil and pentanes (20 mL) 
was added to precipitate the product. Complex 35 was isolated as a pale yellow 
solid (74 mg, 81% yield). 1H NMR (CDCl3): δ 8.30 (d, J = 6 Hz, 1H), 7.97 (d, J = 8 
Hz, 1H), 7.95 (s, 1H), 7.92 (s, 1H), 7,53 (d, J = 6 Hz, 1H), 7.44 (d, J = 6 Hz, 1H), 
7.15 (d, J = 6 Hz, 1H), 7.09 (d, J = 7 Hz, 1H), 6.94 (t, J = 7 Hz, 1H), 6.88 (t, J = 8 
Hz, 1H), 5.47 (d, J = 11 Hz, 1H), 4.67 (d, J = 11 Hz, 1H), 1.75 (s, 3H), 1.69 (s, 
3H), 1.41 (s, 9H), 1.34 (s, 9H). 19F NMR (CD2Cl2): δ –82.49 to – 82.51 (multiple 
peaks, 6F), –117.35 (br. s, 2F), –120.08 (br. s, 2F),  –123.54 to –124.51 (multiple 
peaks, 24F), –127.90 (br. s, 4F). 13C NMR (CD2Cl2): δ 165.98, 165.65, 163.19 (t, 
J = 25  Hz, 1C), 159.56 (t, J = 30  Hz, 1C), 157.83, 154.71, 153.30, 150.07, 
149.61, 149.26, 138.99, 136.67, 126.08, 126.02, 125.53, 125.41, 120.61, 120.12, 
119.49 (t, J = 34  Hz, 1C), 117.85 (t, J = 27  Hz, 1C),  114.11-109.61 (b peaks, 
16 C), 41.29, 37.09, 36.99, 31.56, 31.35, 28.65, 28.30, 26.61. HRMS-
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Complex 36. Compound 21 (15 mg, 0.03, 1.0 equiv) was combined with 
PhI(O2CC6H4p-OMe)2 (15 mg, 0.03 mmol, 1.0 equiv) in CH2Cl2 (15 mL), and the 
reaction mixture allowed to stir for 15 min. The solution was concentrated under 
vacuum to ~2 mL and diethyl ether (20 mL) was added to precipitate the product. 
Complex 36 was isolated as a pale yellow solid (14 mg, 72% yield). 1H NMR 
(CDCl3): δ 8.41 (d, J = 6 Hz, 1H), 8.21 (d, J = 7 Hz, 1H), 8.00 (app. d, J = 8 Hz, 
2H), 7.89 (s, 1H), 7.81 (s, 1H), 7.72 (app. d, J = 8 Hz, 2H), 7.44 (d, J = 6 Hz, 1H), 
7.30-7.23 (multiple peaks, 2H), 6.98 (t, J = 6 Hz, 1H), 6.90 (t, J = 6 Hz, 1H), 6.83-
6.76 (multiple peaks, 3H), 6.60 (d, J = 6 Hz, 1H), 6.00 (d, J = 10 Hz, 1H), 4.49 (d, 
J = 10 Hz, 1H), 1.94 (s, 3H), 1.71 (s, 3H), 1.38 (s, 9H), 1.16(s, 9H).  13C NMR 
(CDCl3): δ 172.79, 165.93, 163.25, 163.10, 162.54, 161.10, 155.93, 153.20, 
151.69, 151.04, 149.30, 148.82, 135.73, 132.08, 131.54, 131.37, 129.32, 126.29, 
124.19, 123.79, 123.15, 123.11, 118.39, 117.80, 113.50, 112.55, 74.55, 55.44, 
55.22, 35.47, 35.17, 34.68, 30.39, 30.02, 28.34, 27.63. HRMS-electrospray 











Complex 37. Compound 21 (20 mg, 0.039, 1.0 equiv) was combined with 
PhI(O2CC6H4p-OMe)2 (17 mg, 0.039 mmol, 1.0 equiv) in CH2Cl2 (15 mL), and the 
reaction mixture allowed to stir for 30 min. The solution was concentrated under 
vacuum. Then, diethyl ether (5 mL) was added to the yellow oil and decanted. 
Pentanes (5 mL) was added to the reaction and decanted. Complex 37 was 
isolated as a pale yellow solid (28 mg, 83% yield). 1H NMR (MeCN): δ 8.28-8.27 
(multiple peaks, 2H), 8.17 (d, J = 2 Hz, 1H), 8.05 (dd, J = 7 Hz, J = 2 Hz, 1H), 
7.98-7.96 (multiple peaks, 2H), 7.79-7.78 (multiple peaks, 2H), 7.75 (d, J = 8 Hz, 
1H), 7.61 (dd, J = 6 Hz, J = 2 Hz, 1H), 7.35 (d, J = 6 Hz, 1H), 7.28 (dd, J = 8 Hz, 
J = 2 Hz, 1H), 7.18  (t, J = 8 Hz, 1H), 7.13-7.12 (multiple peaks, 2H), 7.01-6.97 
(multiple peaks, 3H), 6.88-6.86 (multiple peaks, 2H), 6.04 (d, J = 11 Hz, 1H), 4.61 
(d, J = 11 Hz, 1H), 2.27 (s, 3H), 2.25 (s, 3H), 1.80 (s, 1H), 1.77 (s, 1H), 1.43 (s, 
9H), 1.22 (s, 9H). NMR (MeCN): δ 171.57, 170.78, 170.05, 170.03, 169.68, 
166.54, 166.38, 165.78, 164.45, 156.57, 155.11, 153.95, 153.12, 152.00, 151.74, 
150.39, 148.54, 138.08, 136.29, 134.88, 131.29, 128.63, 127.09, 124.44, 124.42, 
124.13, 124.06, 122.67, 121.58, 120.99, 120.40, 75.34, 40.37, 36.16, 35.87, 
30.11, 29.81, 28.31, 28.22, 27.72, 20.96. HRMS-electrospray (m/z): [M + H]+ 









Complex 42. Compound 21 (50 mg, 0.0986, 1.0 equiv) was combined with MeI 
(6 µL, 0.0986 mmol, 1.0 equiv) in CH2Cl2 (20 mL), and the reaction mixture 
allowed to stir for 15 min. The solution was concentrated under vacuum to ~2 mL 
and pentane (10 mL) was added to precipitate the product. Complex 38 was 
isolated as a pale yellow solid (52 mg, 81% yield). 1H NMR (CD2Cl2): δ 9.50 (d, J 
= 6 Hz, 1H), 8.15 (d, J = 6 Hz, 1H), 7.94 (app. s, 2H), 7.47 (d, J = 6 Hz, 1H), 7.37 
(d, J = 6 Hz, 1H), 7.17  (d, J = 6 Hz, 1H), 6.96 (app. s, 3H), 2.73 (s, 2H), 2.71 (s, 
3H), 1.67 (s, 6H), 1.39 (s, 9H), 1.38 (s, 9H).  13C NMR (CD2Cl2): δ 162.09, 
162.00, 155.71, 153.02, 152.08, 149.49, 147.94, 136.90, 132.37, 125.65, 124.92 
(2 overlapping C’s), 123.28, 122.18, 118.06, 117.28, 120.90, 120.40, 41.66, 
34.98 (2 overlapping C’s), 33.58  (2 overlapping C’s), 30.04, 29.90, 26.39, 24.02. 


















































65 °C, 1 hCs2CO3 +
MeCN












Cs2CO3 (10 mg, 0.031 mmol, 4.0 equiv) and benzenesulfonamide (4.8 mg, 0.031 
mmol, 4.0 equiv) were combined in MeCN (0.5 mL) (with nitrotoluene as a 
standard) at 65 °C and allowed to stir for 1 h. The solution was allowed to cool 
and complex 21 (3.8 mg, 0.0075 mmol, 1.0 equiv) and NFTPT (2.2 mg, 0.0075 
mmol, 1.0 equiv) was added to the reaction mixture. The reaction was heated at 
65 °C for 12 h. The yield (71% an average of two trials) of 25 was determined by 
1H NMR spectroscopy. 
 
Cs2CO3 (10 mg, 0.031 mmol, 4.0 equiv) and 2,2,2-trifluoroacetamide (3.4 mg, 
0.031 mmol, 4.0 equiv) were combined in MeCN (0.5 mL) (with nitrotoluene as a 
standard) at 65 °C and allowed to stir for 1 h. The solution was allowed to cool 
and complex 21 (3.8 mg, 0.0075 mmol, 1.0 equiv)  and NFTPT (2.2 mg, 0.0075 
mmol, 1.0 equiv) was added to the reaction mixture. The reaction was heated at 
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65 °C for 12 h. The yield (29% an average of two trials) of 26 was determined by 
1H NMR spectroscopy. 
Scheme 3.6.5 1H NMR Reaction 22 with NFTPT, Cs2CO3 and Amide  
PdIV F
OTf
1 h, 65 °C to 25°C
PdIV F
NHRMeCN
(25, R = SO2Ph,)
3.0 equiv H2NR









Cs2CO3 (7.4 mg, 0.023 mmol, 3.0 equiv) and benzenesulfonamide (3.6 mg, 
0.023 mmol, 3.0 equiv) were combined in MeCN (0.5 mL) (with nitrotoluene as a 
standard) at 65 °C and allowed to stir for 1 h. The solution was allowed to cool 
and complex 22 (5.1 mg, 0.0076 mmol, 1.0 equiv) was added to the reaction 
mixture. The yield (82%) of 25 was determined by 1H NMR spectroscopy. 
 
Cs2CO3 (7.4 mg, 0.023 mmol, 3.0 equiv) and 2,2,2-trifluoroacetamide (2.6 mg, 
0.023 mmol, 3.0 equiv) were combined in MeCN (0.5 mL) (with nitrotoluene as a 
standard) at 65 °C and allowed to stir for 1 h. The solution was allowed to cool 
and complex 22 (5.1 mg, 0.0076 mmol, 1.0 equiv) was added to the reaction 
mixture. The yield (79%) of 26 was determined by 1H NMR spectroscopy. 
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Complex 25 (4.8 mg, 0.007 mmol) was dissolved in MeCN (0.5 mL) (with 
nitrotoluene as a standard) and heated at 65 °C for 15 min. The ratio of sp3-C–N 
and sp3-C–F reductive elimination products was determined by 1H NMR 
spectroscopy. Although the sp3-C–N and sp3-C–F products were not isolated 
from the reaction mixture, the products analyzed were determined to be either 
the sp3-C–N and sp3-C–F by the coupling constant and splitting pattern in the 1H 
NMR. 
 
Complex 26 (5.0 mg, 0.0075 mmol) was dissolved in MeCN (0.5 mL) (with 
nitrotoluene as a standard) and heated at 65 °C for 15 min. The ratio of sp3-C–N 
and sp3-C–F reductive elimination products was determined by 1H NMR 
spectroscopy. Although the sp3-C–N and sp3-C–F products were not isolated 
from the reaction mixture, the products analyzed were determined to be either 
the sp3-C–N and sp3-C–F by the coupling constant and splitting pattern in the 1H 
NMR. 
 




1 h, 65 °C to 25°C
PdIV F
NHRMeCN
(25, R = SO2Ph,)
3.0 equiv H2NR














2 h, 65 °C
 
 
Cs2CO3 (7.4 mg, 0.023 mmol, 3.0 equiv) and benzenesulfonamide (3.6 mg, 
0.023 mmol, 3.0 equiv) were combined in MeCN (0.5 mL) (with nitrotoluene as a 
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standard) at 65 °C and allowed to stir for 1 h. The solution was allowed to cool 
and complex 22 (5.1 mg, 0.0076 mmol, 1.0 equiv) was added to the reaction 
mixture. The reaction was heated at 65 °C for 2 h. The yield (70%) of 23 was 
determined by 1H NMR spectroscopy. 
 
Cs2CO3 (7.4 mg, 0.023 mmol, 3.0 equiv) and 2,2,2-trifluoroacetamide (2.6 mg, 
0.023 mmol, 3.0 equiv) were combined in MeCN (0.5 mL) (with nitrotoluene as a 
standard) at 65 °C and allowed to stir for 1 h. The solution was allowed to cool 
and complex 22 (5.1 mg, 0.0076 mmol, 1.0 equiv) was added to the reaction 
mixture. The reaction was heated at 65 °C for 2 h. The yield (48%) of 24 was 
determined by 1H NMR spectroscopy. 
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Complex 21 (3.8 mg, 0.0075, 1.0 equiv) was combined with iodosylbenzene (3.3 
mg, 0.0082, 1.1 equiv) and either NBu4OAc (6.3 mg, 0.021 mmol, 3.0 equiv) or 
NBu4Cl (6.2 mg, 0.021 mmol, 3.0 equiv) and heated at 65 °C for 2 h in CH2Cl2 
(0.5 mL) with DCE as an internal standard. For product 32 the peak at 9.05 ppm 
in the 1H NMR spectrum was integrated relative to the standard and two trials 
gave an average yield of 76%. For product 33 the peak at 9.09 ppm in the 1H 
NMR spectrum was integrated relative to the standard and two trials gave an 
average yield of 46%. 
 






















Complex 21 (3.8 mg, 0.0076, 1.0 equiv) was dissolved in (0.25 mL) of CD2Cl2 
and placed in a Teflon screw cap NMR tube and frozen with liquid nitrogen. 
PhI(O2CC9F19)2 (9.3 mg, 0.0076 mmol, 1.0 equiv) was dissolved in (0.25 mL) of 
CD2Cl2 and placed in a Teflon screw cap NMR tube and frozen on top of the 
solution of complex 21 with liquid nitrogen. The reaction was allowed to warm in 
the NMR spectrometer and monitored via 1H NMR spectroscopy. 















Determining Order in NBu4I with 21 and CH3I at 5 °C in CD2Cl2 
 
Complex 21 (3.8 mg, 0.0076 mmol, 1.0 equiv) and CH3I (0.43 µL, 0.0076 mmol, 
1.0 equiv) were combined in CD2Cl2 (0.25 mL) and placed in a screw cap NMR 
tube, then frozen with liquid nitrogen. NBu4I (0.0227 to 0.0834 mmol, 45 mM to 
167 mM) and CD2Cl2 (0.25 mL) were combined in the same screw cap NMR tube 
and frozen on top of the layer with complex 21 and CH3I. An internal standard 
(dichloroethane) was added (20 µl of a stock solution in CD2Cl2, 0.00758, 1 
equiv) and the tube was sealed with a Teflon®-lined cap. The NMR tube was 
allowed to thaw and then immediately placed in an NMR spectrometer with the 
temperature pre-equilbrated to 5 °C, and the reaction was allowed to equilibrate 
for 2 min. The rate of reductive elimination was monitored by 19H NMR 
spectroscopy by monitoring the disappearance of the starting material (21). The 
reaction was followed to between 2-3 half lives, and the data was plotted as –
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ln[21/21º] versus time. A representative kinetics run is shown in Figure 3.6.3. The 
values of kobs for each [pyridine] are reported in Table 3.6.2. 
 
Table 3.6.3 Rate as a Function of [NBu4I] at 5 °C 
 
equiv NBu4I [NBu4I] [1/NBu4I] kobs 
3.0 0.0227 44.05 1.22 x 10–2 
5.0 0.0379 26.38 5.8 x 10–3 
7.0 0.0531 18.83 4.6 x 10–3 
9.0 0.0682 14.66 2.6 x 10–3 
11.0 0.0834 11.99 1.9 x 10–3 
 
Figure 3.6.3 Representative Rate Data (Reductive Elimination from 21 with 
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Chapter 4: C−H Bond Activation at PalladiumIV Centers 
 
4.1 Introduction 
Over the past decade, high oxidation state palladium catalysis has found 
increasingly diverse applications in organic synthesis.1 The development of new 
transformations in this area has been guided by fundamental studies of PdIII and 
PdIV model complexes, which have provided key insights into the unique 
reactivity and mechanisms accessible at high valent palladium centers.1,2 To 
date, these model studies have primarily focused on reductive elimination from 
PdIII and/or PdIV species.1,2 In contrast, the possibility of other organometallic 
transformations at high oxidation state Pd has not been explored in detail. This is 
likely due to the assumption that reductive elimination occurs much faster than 
competing reactions.fr 
Very recently, several groups have proposed a new reaction – C–H 
activation at a transient PdIV intermediate – as a key step in catalysis.3-7 This 
novel mode of reactivity has been implicated in four different catalytic contexts: (i) 
the oxidative dimerization of 2-arylpyridine derivatives,3 (ii) the carboamination of 
olefins,4 (iii) the acetoxylation of allylic C–H bonds,5 and (iv) the C–H arylation of 
naphthalene.6,7  Remarkably, many of these catalytic reactions proceed under 
unusually mild conditions3-5 and/or exhibit unprecedented site selectivities 
(Scheme 4.1.1).3,4,6 These results suggest that harnessing C–H activation at PdIV 
could provide opportunities for achieving distinct and highly complementary 




Scheme 4.1.1 Catalytic Reactions in which C–H Activation at PdIV Proposed 































While the reports described above have proposed C–H activation at PdIV 
during catalysis, until this work there was no literature precedent for such a 
transformation. As such, my goal was to design model systems to demonstrate 
the viability of this reaction and to probe reactivity and site selectivity in this 
context.8,9 This work demonstrates that, with appropriate choice of supporting 
ligands, C–H activation at a PdIV center can proceed rapidly at temperatures as 
low as –40 ºC. Furthermore, we showed that the site selectivity of this 
transformation can be dramatically different than that at analogous PdII 
complexes. The results demonstrated in this chapter provide a novel platform for 
incorporating C–H activation at a PdIV center as a step in new catalytic 
processes. 
In order to observe and study C–H activation at PdIV, it was critical to slow 
competing C–X bond-forming reductive elimination (kRE) while increasing the 
relative rate of the desired C–H activation process (kC–H) (Scheme 4.1.2).  
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4.2 Initial Results  
 
  Our first attempt to observe C–H activation (intermolecular) at PdIV 
involved complexes of an analogous structure to the compounds that I 
synthesized and isolated in Chapter 2. I reasoned that PdIV complex 
(N~C)2PdIV(Cl)2 (I-1) (N~C = 2-phenylpyridine) might serve as an attractive 
target. I reasoned that the chloride ligands could serve two appealing purposes. 
First, complex I-1 been shown to require higher temperatures to undergo bond-
forming reductive elimination than related (N~C)2PdIV(OAc)2.10 Thus, I-1 might 
permit for the C–H activation event to out-compete reductive elimination. 
Secondly, the incorporation of chloride ligands onto the complex would allow for 
easy abstraction with a silver salt. This would open a coordination site on the 
metal and hopefully allow for the desired C–H activation reaction to take place.  
 Gratifyingly, the treatment of complex I-1 with 1.0 equiv of AgOTf and 2.0 
equiv of pyridine resulted in the successful synthesis and isolation of complex I-2 
(Scheme 4.2.1). Crystallization of complex I-2 was achieved by slow diffusion of 
hexanes into a chlorobenzene solution at −35 °C (Figure 4.2.1). The crystal 
structure shows a cationic PdIV center where the chloride substituent was 
replaced with a pyridine ligand at the site on the complex that is trans to the σ-
aryl carbon.   
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(I-1) (I-2)  
 
 




Unfortunately, when complex I-2 was screened for the intermolecular C–H 
activation reaction with various arenes (1,2-dimethoxybenzene, aniline, toluene, 
benzene, (trifluoromethyl)bezene, etc) over a range of temperatures and solvents 


































At this point, we considered the need for a more stable PdIV complex that 
would not undergo the undesired reductive elimination event so easily. 
Therefore, we searched the literature for a relatively stable cationic PdIV complex 
and found complex I-4, which had been previously synthesized by Campora and 
co-workers.11 The trispyrazolylborate ligand has been shown to impart significant 
stability to high oxidation state palladium, while we reasoned that the pyridine 
ligand might be easily replaced with an arene substrate. Complex I-4 was indeed 
highly stable towards reductive elimination. However, in the presence of various 
arene substrates, the complex was either unreactive or decomposed into a 
complex mixture of unidentifiable products (Scheme 4.2.3).  



















4.3 Results  
On the basis of the previous mentioned considerations and unsuccessful 
attempts at intermolecular C–H activation, we initiated investigations of 
oxidatively-induced intramolecular C–H activation at complex 1 (Scheme 4.3.1). 
This PdII starting material contains a rigid bidentate sp2 N-donor ligand [2,2’-di-
tert-butylbipyridine (dtbpy)] and a chloride. Both of these ligands are known to 
slow reductive elimination (kRE) from high valent Pd intermediates,13-15 often 
enabling detection/isolation of PdIII or PdIV species.1,2,13-15 In addition, the 
tethered aryl C–H bond could undergo sp2 C–H activation to afford a favorable 5-
membered palladacycle. The intramolecular nature of this C–H cleavage event is 
expected to increase kC–H.12 
We first examined the oxidation of 1 with PhICl2, since this reagent is 
known to react with PdII starting materials to yield isolable PdIV products.15 As 
shown in Scheme 4.3.1, the reaction produced two major inorganic compounds: 
PdIICl2(dtbpy) (2, 83% yield) and complex 3 (16% yield). Both 2 and 3 are PdII 
species rather than the desired PdIV products; however, 3 is remarkable in that it 
contains a σ-aryl rather than a σ-alkyl ligand bound to Pd. We hypothesized that 
2 and 3 might be formed from transient PdIV intermediate I, which could undergo 
competing sp3-C–Cl bond-forming reductive elimination (to liberate 2) and C–H 
activation/sp3-C–Cl bond-formation to generate 3. While these were promising 
initial results, complex 3 remained a minor side product under all conditions 
examined. Additionally, efforts to observe PdIV intermediates I and/or II were 












































The results in Scheme 4.3.1 suggest that kRE is significantly faster than kC–
H for intermediate I. We reasoned that this problem could be addressed by: (1) 
replacing the chloride with an X-type ligand that is less prone to reductive 
elimination and (2) limiting the conformational flexibility of the tethered C–H 
substrate. As such, guided by the work of my group member and co-author on 
this published manuscript, Dr. Nicholas Ball, we next targeted PdII(CF3)(2-
PhC6H4)(dtbpy) (4) as a PdII starting material. Dr. Nicholas Ball observed an 
interesting result when he treated complex 4 with N-fluoro-2,4,6-
trimethylpyridinium triflate (NFTPT) and hypothesized that C–H activation might 
be occurring on the ortho-phenyl ring of the complex.  The incorporation of the 
CF3 ligand was a particularly important design feature, since several recent 
reports have shown that PdIV(CF3)(Aryl) complexes can be stable to reductive 
elimination at or above room temperature.16 Complex 4 was prepared in 58% 
yield by the reaction of PdII(I)(2-PhC6H4)(dtbpy) with CsF/TMSCF3 in THF. 
 The treatment of 4 with 1 equiv of PhICl2 in MeCN at 25 °C for 35 min 
resulted in a color change from pale yellow to dark yellow along with the 
formation of products 5-Cl, 6, and 7 in 81%, 12%, and 11% yield as determined 
by 1H NMR spectroscopic analysis of the crude reaction mixture (Scheme 3.3.2). 
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Complex 5-Cl was isolated in 77% yield by recrystallization from CH2Cl2/Et2O. 
Characterization of 5-Cl by NMR spectroscopy, mass spectrometry, and X-ray 
crystallography (of a close analogue, vide infra) revealed that this is an 
octahedral PdIV complex containing a cyclometalated biphenyl ligand. This 
indicates that the desired C–H activation event has occurred. 
 























In order to gain insights into the mechanism of the C–H activation process, 
we monitored the reaction of 4 with d5-PhICl2 at –30 ºC in CD3CN (Scheme 
4.3.3). 1H and 19F NMR analysis showed fast consumption of starting material, 
and the formation of a transient intermediate 8.17 Upon warming to RT, this 
intermediate decayed over 35 min with 1st order kinetics to form a mixture of 5-Cl 
and 6 (final ratio of 5-Cl : 6 = 1.0 : 0.27 under these conditions). Intermediate 8 
shows resonances associated with 15 aromatic protons, and a 1H-1H COSY 
allowed assignment of five distinct protons on the pendant phenyl ring.18 This 
indicates that this ring is not yet cyclometalated (and also shows that rotation 
about the aryl-aryl bond is slow on the NMR timescale). 19F-13C HMBC further 
confirmed that 8 contains a single σ-aryl ligand, as the CF3 fluorines showed only 
one correlation with an aromatic carbon. In contrast, two 19F-13C HBMC 
correlations were observed for the cyclometalated product 5-Cl. Finally, a DOSY 
experiment showed that 5-Cl and 8 have nearly identical diffusion coefficients at 
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–15 ºC, indicating that these complexes have similar hydrodynamic radii. This is 
consistent with the formulation of 8 as a monomeric octahedral complex.  
Mass spectrometry experiments provided further insights into the 
molecular structure of 8. ESI-MS showed a peak at 631.1312, which corresponds 
to the mass of [Pd(CF3)(2-PhC6H4)(Cl)(dtbpy)]+. Notably, electrospray ionization 
commonly results in loss of one X-type ligand from PdIV complexes.2g For 
example, ESI-MS of 5-Cl affords a peak at 595.1560, corresponding to the mass 
of [5-Cl–Cl]+. MALDI, a softer ionization technique, resulted in a peak at 667.1, 
which corresponds to [Pd(CF3)(2-PhC6H4)(Cl)2(dtbpy)+H]+. 
 





















All of the NMR and MS data presented above are consistent with 
formulation of intermediate 8 as a PdIV complex of general structure PdIV(CF3)(2-
PhC6H4)(Cl)2(dtbpy). The diamagnetic nature of this complex clearly indicates 
that it is not a monomeric PdIII species. The NMR diffusion experiment along with 
MALDI MS data provide evidence against alternative formulations as a PdIII 
dimer or a square planar PdII complex.19 Overall, the characterization data are 
fully consistent with the C–H activation event occurring at PdIV intermediate 8, 
thereby representing the first demonstration that high oxidation state Pd can 
mediate this transformation.  
We next explored the reaction of 4 with other 2e– oxidants. While no 
reaction was observed with iodobenzene diacetate (PhI(OAc)2, Table 4.3.1, entry 
3),2g both iodobenzene bistrifluoroacetate PhI(TFA)2 and N-fluoro-2,4,6-
trimethylpyridinium triflate (NFTPT)16 reacted with 4 within 10 min at rt to afford 
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cyclometalated PdIV complexes where X = trifluoroacetate and triflate (5-TFA and 
5-OTf, respectively). The structure of the trifluoroacetate complex was confirmed 
by X-ray crystallography, and an ORTEP picture of 5-TFA is shown in Figure 
4.3.1. Consistent with the solution NMR data, the crystal structure shows an 
unsymmetrical ligand environment around the octahedral PdIV center, with the 
trifluoroacetate group trans to one σ-aryl ligand and the trifluoromethyl group 
trans to one N of the dtbpy (Figure 4.3.1). 
 

















Entry Oxidant X (Product) Yield (%) 















4 NFTPT OTf (5-OTf) 86 






Figure 4.3.1 ORTEP Plot of 5-TFA 
 
 
Substrate 9 was also examined in order to probe the accessibility of a six-
membered palladacycle (Scheme 4.3.4). In this case, reaction with PhICl2 for 10 
min at 25 ºC returned the ortho-chlorinated PdII product 10 in 95% yield. This 
result suggests that a 6-membered palladacycle was generated, but that the 
resulting PdIV intermediate underwent rapid C–Cl bond-forming reductive 
elimination under the reaction conditions.20 
















Finally, we conducted a series of experiments to compare this C–H 
activation at PdIV to analogous transformations at PdII centers. A σ-aryl ligand 
derived from 2-iodo-3,5’-dimethyl-1,1’-biphenyl (ligand abbreviated σ-DMB) was 
 189 
used, since it contains two sterically and electronically differentiated sites for C–H 
activation (HA and HB). As shown in Scheme 3.3.5, the treatment of σ-DMB 
complex 11 with NFTPT at rt in MeCN produced a 1.7 : 1 mixture of two isomeric 
products 12-OTf and 13-OTf in 64% yield.21,22 While 12-OTf/13-OTf could not be 
completely separated, the mixture was characterized using a variety of two-
dimensional NMR experiments (see section 4.4). In addition, treatment of 12-
OTf/13-OTf with NaCl afforded the corresponding chloride complexes (12-Cl/13-
Cl), and the structure of the major isomer was definitively established by X-ray 
crystallography. As shown in Figure 4.3.2, the X-ray structure confirms that 12-Cl 
(and by analogy 12-OTf) is the product of C–H activation at HA.  
 






















(1.7 : 1 isomer ratio)
 




For comparison, we examined an analogous cyclopalladation reaction at 
the PdII σ-DMB complex 14-F (Scheme 4.3.6), which was generated in situ by the 
treatment of 14-I with AgF. Cyclopalladation at 14-F was sluggish at room 
temperature and required heating to 60 ºC in benzene for 4 h to proceed to 
completion.  Furthermore, this reaction afforded >10 : 1 selectivity for activation 
of the less sterically hindered C–H bond (HA).23 This selectivity is similar to that 
observed in numerous other cyclopalladation reactions at PdII centers, but very 
different from that observed in Scheme 4.3.5 (1.7 : 1).24 The significant difference 
in both rate and selectivity for this C–H activation at PdII versus PdIV highlights 
the dissimilarity of these processes, and highlights the potential value of PdIV-
mediated C–H activation in catalysis.  
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4.3 Conclusions 
In summary, this chapter describes the first observation and study of C–H 
activation at PdIV. This transformation was achieved by designing model 
complexes in which the rate of reductive elimination is slowed relative to that of 
the desired competing C–H activation process. Remarkably, the C–H activation 
reaction can proceed under mild conditions and with different site selectivity than 
analogous transformations at PdII. Investigations are underway to elucidate the 
mechanism of C–H activation at PdIV and to identify further intra- and 
intermolecular examples of this new reaction. We anticipate that such studies will 
ultimately enable the rational incorporation of PdIV-mediated C–H activation into 





The palladium(II) complexes Pd(dba)2 [dba = dibenzylideneacetone],25 
(COD)Pd(Cl)2 [COD = 1,5-cyclooctadiene] and (COD)Pd(CH2CMe2-o-C6H4) were 
prepared according to literature procedures. (PPh3)2Pd(Cl)2 was purchased from 
Strem Chemicals. Aryl iodides, anilines and boronic acids were purchased from 
commercial sources. TMSCF3 was obtained from Matrix Chemicals. Di-tert-
butylbipyridine (dtbpy) and 2-methyl-2-phenylpropyl magnesium chloride were 
obtained from Aldrich. 1-Fluoro-2,4,6-trimethylpyridinium triflate (NFTPT) was 
obtained from TCI America. PhICl2 was prepared via a modification of a literature 
procedure.26 PhI(TFA)2 was purchased from Acros Organics. Unless otherwise 
noted, all reagents were used as received. NMR solvents were obtained from 
Cambridge Isotope Laboratories. All other solvents were obtained from Fisher 
Chemicals. Tetrahydrofuran was purified using an Innovative Technologies (IT) 
solvent purification system consisting of a copper catalyst, activated alumina, and 













4.4.1 Synthesis of Precursors to Organic Ligands 
 

















Compound S1. 2-Bromo-4-methylaniline (4.3 g, 18 mmol, 1.0 equiv), m-
tolyboronic acid  (4.1 g, 21 mmol, 1.2 equiv), (PPh3)2Pd(Cl)2 (0.270 g, 3.4 mmol, 
0.02 equiv), and a 2M solution of K2CO3 in water (45 ml) were combined in 
dimethoxyethane (200 mL). The resulting biphasic reaction mixture was stirred 
overnight at 80 °C. The reaction mixture was cooled to room temperature and 
then extracted with ether (3 x 30 mL). The organic extracts were combined, dried 
over MgSO4, and filtered through a plug of Celite. The product was purified by 
column chromatography to afford S1 as a yellow oil (3.16 g, 89% yield, RF = 0.34 
in 1:9 ethyl acetate:hexanes). 1H NMR (CDCl3): δ 7.29 (t, J = 8 Hz, 1H), 7.24-
7.22 (multiple peaks, 2H), 7.13 (d, J = 8 Hz, 1H), 6.96-6.93 (multiple peaks, 2H), 
6.67 (d, J = 8 Hz, 1H), 3.62 (br s, 2H), 2.38 (s, 3H), 2.26 (s, 3H). 13C NMR 
(CDCl3): δ 140.94, 139.60, 138.39, 130.92, 129.79, 128.89, 128.62, 127.87 (2 
overlapping C’s), 127.80, 126.05, 115.74, 21.47, 20.42. HRMS-electrospray 
(m/z): [M+H]+ calcd for C14H15N, 198.1277; Found, 198.1276.  
 
Compound S2. Aniline S1 (2.36 g, 7.73 mmol, 1.0 equiv) was dissolved in 
ethanol (40 mL). A solution of NaNO2 (2.36 g, 7.73 mmol, 1.0 equiv) in water (4 
mL) was added slowly over 10 min. The reaction mixture was cooled to 0 ºC, and 
concentrated HCl (10 mL) was added over 30 min. A solution of KI (2.30 g, 14.0 
mmol, 1.8 equiv) in water (4 mL) was then added, and the reaction mixture was 
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removed from the ice bath and allowed to stir at 25 °C for 2 h. The reaction 
mixture was extracted with ethyl acetate (3 x 45 mL), and the organic extracts 
were washed with a saturated solution of NaHSO3 (2 x 60 mL). The organic layer 
was separated and dried over MgSO4. The product was purified by column 
chromatography to afford S2 as a colorless oil (1.02 g, 43% yield, RF = 0.23 in 
hexanes). 1H NMR (CDCl3): δ 7.78 (d, J = 8 Hz, 1H), 7.29 (t, J = 8 Hz, 1H), 7.18 
(d, J = 8 Hz, 1H), 7.12-7.11 (multiple peaks, 3H), 6.84 (d, J = 8 Hz, 1H), 2.39 (s, 
3H), 2.31 (s, 3H). 13C NMR (CDCl3): δ 146.51, 144.18, 139.21, 138.05, 137.52, 
131.05, 129.94, 129.69, 128.26, 127.77, 126.36, 94.48, 21.49, 20.91. HRMS-
electrospray (m/z): [M]+ calcd for C14H13I, 308.0062; Found, 308.0065.  
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4.4.2 Synthesis of Palladium(II) Starting Materials 
 













Complex S3. S3 was prepared using a modification of a literature procedure.11 
To a –78 ºC solution of (COD)Pd(Cl)2 (3.5 g, 12.2 mmol, 1.0 equiv) in Et2O (60 
mL) was added 2-methyl-2-phenylpropyl magnesium chloride (24.5 mL of a 2.0 
M solution in Et2O, 12.2 mmol, 1.0 equiv). The reaction mixture was stirred for 12 
h at 25 ºC. The solvent was removed via rotary evaporation, the black solids 
were dissolved in CH2Cl2 (100 mL), and this suspension was filtered through a 
plug of Celite. The resulting yellow solution was concentrated to ~6 mL, and 
petroleum ether (~60 mL) was added to precipitate a yellow solid.  The 
precipitate was collected and dried under vacuum to afford S3 as an off-white 
solid (3.69 g, 79% yield). 1H NMR (CDCl3): δ 7.56 (d, J = 8 Hz, 2H), 7.33 (t, J = 8 
Hz, 2H), 7.21 (t, J = 8 Hz, 1H), 5.84 (br s, 2H), 4.39 (br s, 2H), 2.56 (s, 2H), 2.25 
(s, 4H) 2.24 (s, 4H), 1.55 (s, 6H). 13C NMR (CDCl3): δ 151.52, 128.32, 126.03, 
125.82, 125.12, 101.16, 47.57, 42.13, 32.41,31.34, 31.34, 31.06, 27.1. Anal. 
Calc. for C18H25ClPd with ~15 % H2O as determined by 1H NMR: C, 55.99, H, 
6.61; Found: C, 55.97, H, 6.57. 
 
Complex 1. S3 (613 mg, 1.77 mmol, 1.0 equiv) and 4,4′-di-tert-butylbipyridine 
(473 mg, 1.77 mmol, 1.0 equiv) were combined in CH2Cl2 (120 mL), and the 
reaction mixture was allowed to stir for 30 min at rt. The solvent was 
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concentrated under vacuum to ~5 mL, and hexanes (~30 mL) was added to 
precipitate the product. The precipitate was collected and dried under vacuum to 
afford 1 as a bright yellow solid (893 mg, 93% yield). 1H NMR (CD2Cl2): δ 9.08 (d, 
J = 6 Hz, 1H), 7.95 (d, J = 6 Hz, 1H), 7.92 (s, 1H), 7.87 (s, 1H), 7.66 (app d, J = 8 
Hz, 2H), 7.53 (d, J = 8 Hz, 1H), 7.07 (d, J = 8 Hz, 1H), 7.02 (app t, J = 8 Hz, 2H), 
6.88 (d, J = 8 Hz, 1H), 2.24 (s, 2H), 1.55 (s, 6H), 1.39 (s, 9H), 1.35 (s, 9H). 13C 
NMR (CDCl3): δ 162.69, 161.64, 155.66, 152.83, 152.01, 149.06, 149.00, 
127.03, 126.76, 124.57, 123.17, 122.42, 117.80, 117.13, 41.47, 37.22, 35.26, 
35.08, 31.19, 30.30, 30.17, 30.07. HRMS-electrospray (m/z): [M–Cl]+ calcd for 
C28H37ClN2Pd, 507.1986; Found, 507.1999. 
 
4.4.3 Synthesis of Authentic Sample of 3 
 












authentic sample of 3  
 
Complex S4. (COD)PdII(CH2CMe2-o-C6H4) (104 mg, 0.30, 1.0 equiv) was 
combined with 4,4′-di-tert-butylbipyridine (80 mg, 0.30 mmol, 1.0 equiv) in CH2Cl2 
(120 mL) and allowed to stir for 30 min at rt. The reaction was concentrated 
under vacuum to 5 mL and ~30 mL of hexanes was added to precipitate the 
product. S4 was isolated as a bright yellow solid (147 mg, 97% yield). 1H NMR 
(CDCl3): δ 9.11(d, J = 6 Hz, 1H), 8.55 (d, J = 6 Hz, 1H), 7.98-7.97 (multiple 
peaks, 2H), 7.55 (d, J = 8 Hz, 1H), 7.53 (d, J = 6 Hz, 1H), 7.43 (d, J = 6 Hz, 1H), 
7.00 (app. t, 2H), 6.87 (d, J = 8 Hz, 1H), 2.43 (s, 2H), 1.44 (s, 6H), 1.43 (s, 9H), 
1.42 (s, 9H). 13C NMR (CDCl3): δ 169.09, 161.95, 161.87, 159.24, 155.35, 
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154.86, 150.38, 149.32, 134.79, 123.92, 122.90, 122.78, 122.54, 121.58, 117.94, 
117.84, 47.27, 44.84, 35.19, 35.17, 33.76, 31.07, 30.30, 30.27. HRMS-
electrospray (m/z): [M+H]+ calcd for C28H36N2Pd, 507.1986; Found, 507.2000. 
 
Complex 3. An authentic sample of 3 was prepared by the reaction of S4 with 
PhICl2 as described below. S4 (200 mg, 0.394 mmol, 1.0 equiv) and PhICl2 (110 
mg, 0.394 mmol, 1.0 equiv) were combined in CH2Cl2 (40 mL), and the resulting 
solution was stirred for 15 min. The reaction mixture was concentrated to ~4 mL, 
and hexanes (~30 mL) was added to precipitate the product. The precipitate was 
collected and dried under vacuum to afford 3 was isolated as a bright yellow solid 
(223 mg, 98% yield). 1H NMR (CDCl3): δ 9.16 (d, J = 6 Hz, 1H), 7.95 (multiple 
peaks, 2H), 7.84 (d, J = 8 Hz, 1H), 7.54 (d, J = 6 Hz, 1H), 7.46 (d, J = 6 Hz, 1H), 
7.26-7.19 (multiple peaks, 2H), 6.96 (t, J = 7 Hz, 1H), 6.90 (t, J = 7 Hz, 1H), 4.76 
(d, J = 11 Hz, 1H), 3.93 (d, J = 11 Hz, 1H), 1.81 (s, 3H), 1.78 (s, 3H), 1.43 (s, 
9H), 1.37 (s, 9H). 13C NMR (CDCl3): δ 163.59, 163.16, 155.76, 153.49, 151.53, 
149.36, 148.79, 148.03, 134.97, 127.42, 124.85, 123.55 (2 overlapping C’s), 
123.52, 118.36, 117.80, 57.88, 41.28, 35.55 (2 overlapping C’s), 30.46, 30.27, 
29.03, 28.81. HRMS-electrospray (m/z): [M]+ calcd for C29H39Cl2N2Pd, 591.1525; 
Found, 591.1518. 
 
4.4.4 Synthesis of Authentic Sample of 6 
 















Complex 6. HCl (40 µl of a 2 M solution in Et2O, 2.0 equiv) was added to a 
solution of Pd(CH3)(CF3)(dtbpy)27 (18 mg, 0.04 mmol, 1.0 equiv) in CH2Cl2 (10 
mL). The reaction was stirred for 5 min, and then the solvent was removed under 
reduced pressure. The yellow residue was taken up in CH2Cl2 (1 mL), and 
hexanes (~8 mL) was added to precipitate the product. The resulting solids were 
collected on a fritted filter and dried under vacuum to afford 6 as a light yellow 
solid (13 mg, 69% yield). 1H NMR (CD3CN): δ 9.08 (d, J = 7 Hz, 1H), 8.68 (d, J = 
7 Hz, 1H), 8.21 (s, 1H), 8.16 (s, 1H), 7.61-7.58 (multiple peaks, 2H), 1.36 (s, 9H), 
1.34 (s, 9H). 13C NMR (CDCl3): δ 164.68, 164.45, 156.05, 154.34 (q, J = 277 Hz), 
154.23, 152.48, 150.12, 124.15, 123.51, 118.85, 117.97, 35.62 (2 overlapping 
C’s), 30.35, 30.24. HRMS-electrospray (m/z): [M–Cl]+ calcd for C19H24ClF3N2Pd, 
443.0932; Found, 443.0926.  
4.4.5 General procedures for the synthesis of Pd(Aryl)(I)(dtbpy) and 
Pd(Aryl)(CF3)(dtbpy) 
 


















General Procedure: Under nitrogen, Pd(dba)2 (3.0 g, 5.23 mmol, 1 equiv) was 
weighed into a 250 mL round bottom flask and dissolved in THF (75 mL). The 
ligand dtbpy (3.7 g, 6.6 mmol, 2.6 equiv) was added, and the resulting mixture 
was stirred at 25 ºC for 15 min. The aryl iodide (14.6 mmol, 2.8 equiv) was 
added, and the reaction mixture was warmed to 60 °C for 3 h. In air, the reaction 
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mixture was filtered through a plug of Celite, and the solvent was removed under 
reduced pressure. The resulting solid was washed with hexanes (3 x 50 mL) and 
then with a 50:50 mixture of ether and hexanes (~400 mL) to completely remove 
residual dibenzylidene acetone. The product was then redissolved in CH2Cl2 (20 
mL) and stirred with activated charcoal for 30 min. This suspension was then 
filtered through a plug of Celite, and the solvent was removed in vacuo to yield 
the products. 
 
General procedure: Under N2, Pd(Aryl)(I)(dtbpy) (1.5-1.6 mmol, 1 equiv) and 
CsF (3 equiv) were dissolved in THF (0.145 M) in a 25 mL Schlenk flask. The 
resulting suspension was stirred for 10 min, and then Me3SiCF3 (2 equiv) was 
added. The reaction was stirred vigorously at 22 ºC for 3 h. The solvent was then 
removed under reduced pressure. CH2Cl2 (15 mL) was added to dissolve the 
product, and the resulting suspension was filtered through a plug of Celite. The 
plug was washed with of CH2Cl2 (2 x 5mL), the filtrate was concentrated under 
reduced pressure to (~2 mL), and hexanes (60 mL) was added to precipitate the 
product. The resulting solids was collected on a fritted filter, washed with 






Complex S5. S5 was prepared using the general procedure above and was 
isolated as an orange solid (1.6 g, 44% yield). 1H NMR (CDCl3): δ 9.48 (d, J = 6 
Hz, 1H), 8.01 (app s, 2H), 7.82 (s, 1H), 7.78 (s, 1H), 7.72 (d, J = 8 Hz, 1H), 7.47-
7.40 (multiple peaks, 2H), 7.25-7.18 (multiple peaks, 3H), 7.09-6.97 (multiple 
peaks, 4H), 1.38 (s, 9H), 1.33 (s, 9H). 13C NMR (CDCl3): δ 162.71, 162.62, 
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155.50, 153.60, 152.58, 149.28, 145.85, 145.69, 145.02, 138.73, 129.91, 129.10, 
127.11, 125.51, 124.73, 123.62, 123.45, 123.05, 117.83, 117.65, 35.25, 35.24, 
30.21, 30.06. HRMS-electrospray (m/z): [M+Na]+ calcd for C30H33IN2Pd, 






Complex 4. Complex 4 was prepared using the general procedure above and 
was isolated as a yellow solid (530 mg, 58% yield). 1H NMR (CDCl3): δ 8.97 (d, J 
= 6 Hz, 1H), 7.94-7.92 (mulptile peaks, 2H), 7.88 (s, 1H), 7.82-7.79 (multiple 
peaks, 2H), 7.53 (d, J = 6 Hz, 1H), 7.48 (d, J = 6 Hz, 1H), 7.31 (d, J = 8 Hz, 1H), 
7.19-7.05 (multiple peaks, 6H),1.40 (s, 9H), 1.32 (s, 9H). 19F NMR (CDCl3): δ –
20.00 (m, 3F). 13C NMR (CDCl3): δ 162.90, 162.83, 154.97, 154.14, 151.54 (q, J 
= 4 Hz), 150.10, 147.01, 146.27, 136.82, 135.33 (q, J = 364 Hz), 129.17, 128.25, 
127.08, 125.28, 124.80, 123.31, 123.19, 122.79, 117.81, 117.46, 35.21, 35.16, 
30.18, 30.08. HRMS-electrospray (m/z): [M+Na]+ calcd for C31H33F3N2Pd, 







Complex S6. S6 was prepared using the general procedure above, except that 
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the reaction was conducted at 50 ºC to minimize impurities. The product was 
isolated as a yellow solid (1.44 g, 92% yield). 1H NMR (CD3CN): δ 9.15 (d, J = 7 
Hz, 1H), 8.22 (app s, 2H), 7.67 (d, J = 6 Hz, 1H), 7.60 (d, J = 8 Hz, 1H), 7.57-
7.55 (multiple peaks, 2H), 7.48 (d, J = 6 Hz, 1H), 7.30 (d, J = 8 Hz, 1H), 7.28-
7.22 (multiple peaks, 3H), 7.13-7.11 (multiple peaks, 2H), 7.04 (t, J = 8 Hz, 1H), 
1.44 (s, 9H), 1.43 (s, 9H). 13C NMR (CDCl3): δ 200.65, 162.92, 162.91, 155.57, 
153.82, 152.31, 149.71, 149.40, 145.49, 139.10, 137.91, 131.39, 130.58, 129.22, 
129.08, 127.36, 123.38, 123.28, 121.99, 118.33, 117.87, 35.32, 35.24, 30.22, 
30.14. IR (thin film): n 2965.1, 1649.7, 1612.9, 1447.8, 1285.9, 921.5, 735.8, 
700.1, 633.7 cm-1. HRMS-electrospray (m/z): [M–I]+ calcd for C31H33IN2OPd, 







Complex 9. Complex 6 was prepared using the general procedure above and 
was isolated as a yellow solid (1.56 g, 96% yield). 1H NMR (CD3CN, 23 ºC): δ 
8.64 (br s, 1H), 8.22 (app br s, 2H), 7.80  (d, J = 8 Hz, 1H), 7.74-7.58 (br s, 1H) 
7.54-7.50 (multiple peaks, 3H), 7.44-7.39 (multiple peaks, 2H), 7.27 (t, J = 8 Hz, 
1H), 7.23 (t, J = 6 Hz, 1H) 7.12 (t, J = 7 Hz, 1H), 7.10-7.07 (multiple peaks, 2H), 
1.43 (br s, 18H). The broad resonances observed in the room temperature 1H 
NMR spectrum was considerably sharper at –30 ºC. 1H NMR (CD3CN, –30 °C): δ 
8.63 (1H, broad s), 8.26 (2H, multiple peaks), 7.80 (1H, broad s), 7.67 (1H, broad 
s), 7.61(1H, broad s), 7.54-7.52 (2H, multiple peaks), 7.40-7.36 (2H, multiple 
peaks), 7.29-7.25 (2H, multiple peaks), 7.15-7.08 (3H, multiple peaks), 1.44 (s, 
9H), 1.40 (s, 9H). 19F NMR (CD3CN, 23 ºC ): δ –21.18 (s, 3F). 13C NMR (CDCl3, 
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23 ºC): δ 201.51, 163.20, 161.39, 154.71 (br s, 2C), 150.70 (br s, 2C), 144.74, 
139.46, 139.34, 137.01, 134.29 (q, J = 365 Hz), 131.09, 130.11, 129.98, 129.11, 
129.03, 128.28, 127.95, 127.18 (2 overlapping C’s), 123.03, 121.97, 117.98, 
35.16 (2 overlapping C’s), 30.05, 29.96. 13C NMR (CDCl3 –30 °C): 201.51, 
163.20, 161.39, 154.71, 154.02, 150.70, 150.04, 144.74, 139.46, 139.34, 137.01, 
134.29 (q, J = 365 Hz), 131.09, 130.11, 129.98, 129.11, 129.03, 128.28, 127.95, 
127.18 (2 overlapping C’s), 123.03, 121.97, 117.98, 35.16 (2 overlapping C’s), 
30.05, 29.96. IR (thin film): ν 2966.5, 1658.0, 1612.6, 1480.9, 1449.6, 1090.2, 
736.2, 702.1 cm-1. HRMS-electrospray (m/z): [M–CF3]+ calcd for C32H33F3N2OPd, 






Complex S7. Complex S7 was prepared using the general procedure above and 
was isolated as a light orange solid (676 mg, 33% yield). 1H NMR (CD3CN): δ 
9.32 (d, J = 6 Hz, 1H), 8.17 (s, 1H), 8.11 (s, 1H), 7.79 (d, J = 8 Hz, 1H), 7.73 (s, 
1H), 7.61 (d, J = 6 Hz, 1H), 7.47-7.39 (multiple peaks, 4H), 7.07-7.04 (multiple 
peaks, 2H), 6.89 (d, J = 8 Hz, 1H), 6.83 (d, J = 8 Hz, 1H), 2.36 (s, 3H), 2.17 (s, 
3H), 1.40 (s, 9H), 1.35 (s, 9H). 13C NMR (CDCl3): δ 161.72, 161.58, 154.50, 
152.69, 151.58, 148.44, 144.64, 143.98, 139.99, 137.54, 135.27, 131.46, 129.70, 
129.07, 126.24, 125.97, 125.20, 124.89, 122.60, 122.04, 116.82, 116.71, 34.31 
(2 overlapping C’s), 29.30, 29.17, 20.28, 19.71. HRMS-electrospray (m/z): [M–I]+ 







Compound 11. Complex 11 was prepared using the general procedure above 
and was isolated as a yellow solid (82 mg, 39% yield). 1H NMR (CD3CN): δ 8.80 
(d, J = 6 Hz, 1H), 8.33 (s, 1H), 8.23 (s, 1H), 7.66 (d, J = 6 Hz, 1H), 7.63-7.61 
(multiple peaks, 2H), 7.48 (d, J = 8 Hz, 1H), 7.38 (d, J = 8 Hz, 1H), 7.31 (d, J = 6 
Hz, 1H), 6.98 (s, 1H), 6.88 (t, J = 6 Hz, 1H), 6.75 (t, J = 8 Hz, 1H), 6.70 (t, J = 8 
Hz, 1H), 2.21 (s, 3H), 2.05 (s, 3H), 1.33 (s, 9H), 1.23 (s, 9H). 19F NMR (CDCl3): δ 
–20.40 (s, 3F). 13C NMR (CDCl3): δ 162.80, 162.70, 154.78, 154.09, 151.28, 
149.97, 146.80, 146.03, 136.47, 136.02, 135.51 (q, J = 363 Hz), 131.85, 130.14, 
129.19, 128.97, 126.60, 125.77 (2 overlapping C’s), 123.06, 122.55, 120.87, 
117.62, 117.29, 35.12, 35.04, 30.03, 29.96, 21.07, 20.79. HRMS-electrospray 
(m/z): [M–H]+ calcd for C33H37F3N2Pd, 623.1865; Found, 623.1865. 
 
4.4.6 Reactions Discussed in Section 3.3 
 























Procedure: Complex 1 (4.1 mg, 0.00758 mmol, 1.0 equiv), PhICl2 (2.1 mg, 
0.00758, 1.0 equiv), and an internal standard (C2H4Cl2, 0.00758 mmol, added 
from a stock solution of C2H4Cl2 in CDCl3) were combined in CDCl3 (0.5 mL) at 
room temperature. This mixture was allowed to stand for 10 min and was then 
analyzed by 1H NMR spectroscopy. The yields of products 2 and 3 were 
determined by 1H NMR integration relative to the internal standard. As discussed 
above, an authentic sample of 3 was synthesized to confirm the identity of this 
product. Complex 2 was identified by comparison to literature data.28 The 
chlorinated organic product (1-chloro-2-methylpropan-2-yl)benzene was detected 
by GCMS after (1) evaporation of the reaction solvent under a stream of N2 
followed by (2) extracting the resulting residue with pentane (2 mL) to dissolve 
the organic materials.  
 
4.4.7 Procedure for the Reaction of 4 with PhICl2 to form 5-Cl, 6, and 7 
 























Complex 5-Cl (NMR-scale reaction). Complex 4 (9.1 mg, 0.015 mmol, 1.0 
equiv) and PhICl2 (4.2 mg, 0.015 mmol, 1.0 equiv) were combined in MeCN (0.5 
mL) with DCE (1.0 equiv) as the internal standard and this mixture was stirred for 
35 min at RT Analysis of the crude reaction mixture by 1H NMR spectroscopy 
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showed 81% yield of 5-Cl along with 12% yield of 6. The crude yield of 7 (11%) 
was determined from a separate reaction run in parallel. In this latter case, the 
volatiles were removed under vacuum, the resulting solids were sonicated with 
hexanes, and this mixture was filtered through a pipette plug of celite. The filtrate 
was collected, the solvent was removed under vacuum, and the yield of 7 was 
determined by 1H NMR spectroscopy.  
 
Complex 5-Cl (Isolation of product). Complex 4 (27 mg, 0.048 mmol, 1.0 
equiv) and PhICl2 (13 mg, 0.048 mmol, 1.0 equiv) were combined in MeCN (18 
mL), and this mixture was stirred for 35 min at RT. The solvent was removed by 
rotary evaporation. The resulting yellow solids were washed with pentanes (2 x 
20 mL). The residue was then dissolved in CH2Cl2 (2 mL), and ether (10 mL) was 
to precipitate the product. The precipitate was collected and dried under vacuum 
to afford 5-Cl as a light yellow solid (24 mg, 77% yield). 1H NMR (CD3CN): δ 9.21 
(d, J = 6 Hz, 1H), 8.50 (s, 1H), 8.42 (d, J = 8 Hz, 1H), 8.36 (s, 1H), 7.95 (d, J = 6 
Hz, 1H), 7.68 (d, J = 8 Hz, 1H), 7.57-7.54 (multiple peaks, 2H), 7.40-7.36 
(multiple peaks, 2H), 7.21 (t, J = 8 Hz, 1H), 7.08 (t, J = 6 Hz, 1H), 6.73 (t, J = 8 
Hz, 1H), 6.49 (d, J = 8 Hz, 1H), 1.54 (s, 9H), 1.34 (s, 9H). 19F NMR (CD3CN): δ –
21.37 (s, 3F). 13C NMR (CD2Cl2): δ 169.46 (q, J = 6 Hz), 167.19 (q, J = 6 Hz), 
165.12, 165.01, 153.75, 153.43, 150.66  (q, J = 5 Hz), 148.72, 148.63, 148.07, 
134.55, 129.82, 128.53, 127.77, 127.29, 126.66, 125.69, 124.94, 123.32 (q, J = 
365 Hz), 123.23, 123.11, 120.63, 120.46, 36.19, 36.01, 30.76, 30.55. HRMS-








4.4.8 Reaction of 4 with C6D5ICl2  and Characterization Data for 8 
 





















Complex 8. Complex 4 (9.1 mg, 0.015 mmol, 1 equiv) was dissolved in CD3CN 
(0.35 mL), and the resulting solution was added to an NMR tube and then frozen 
in LN2. A solution of C6D5ICl2 (4.1 mg, 0.015 mmol, 1 equiv) in CD3CN (0.25 mL) 
was then added to the NMR tube at LN2 temperature (such that it froze on top of 
the first solution). The sample was immediately placed into an NMR spectrometer 
where the probe temperature was set to 25 ºC, –15 ºC, –20 ºC or –30 ºC. The 
sample was allowed to equilibrate for 3 min and then data acquisition was 
initiated. The observed ratio of 8 : 5-Cl after 3 min depended on the probe 
temperature. This ratio was 1 : 1 at 25 ºC, 3 : 1 at –20 ºC and 3.3 : 1 at –30 ºC. 
For all the NMR characterization experiments described below, the NMR tube 
was warmed to 25 ºC before being placed in the spectrometer at low 
temperature, such that characterization was performed on a 1: 1 mixture of 8 : 5-
Cl.  
At –30 ºC, a 3.3 : 1 mixture of 8 : 5-Cl was observed at t=0. Compound 8 
is stable for at least 1 h at –30 ºC, and the ratio of 8 : 5-Cl did not change over 
this time. Therefore, it is most probable that the initially formed 5-Cl is not 
generated via intermediate 8. Instead, it appears to be formed from some other 
undetected intermediate in the oxidation reaction. 
Warming the mixture of 8/5-Cl to 0 ºC or 25 ºC resulted in the 
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disappearance of 8 and growth of 5-Cl and 6. The decay of 8 was first order, and 
plots of [8] versus time at 0 ºC and 25 ºC are shown in Figures 3.4.8.1 and 
3.4.8.2. 

















Fit to: f=y0+a*(1-exp(–b*x)) 
Parameter Value    StdErr    CV(%)        Dependencies 
y0  9.775e-1  1.360e-3  1.391e-1  0.9084933 
a -1.001e+0  1.006e-2  1.005e+0  0.9902510 







Figure 4.4.8.2 Decay of Intermediate 8 at 25 ºC ([8] versus time) 
 
time sec













Fit to: f=y0+a*(1-exp(–b*x)) 
Parameter  Value  StdErr      CV(%)    Dependencies 
y0  1.550e+0  6.530e-3  4.213e-1  0.9377485 
a -1.307e+0  6.219e-3  4.756e-1  0.8800414 
b  1.497e-3  2.051e-5  1.370e+0  0.8835136 
R2=0.998
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Characterization of 8. Complex 8 was characterized using a variety of NMR and 
mass spectroscopy techniques, which are described in detail below. 
 
HRMS-electrospray. Complex 4 (4.5 mg, 0.0076 mmol, 1 equiv) was dissolved 
in CH3CN (0.35 mL). This solution was added to a solution of C6H5ICl2 (2.1 mg, 
0.0076 mmol, 1 equiv) in CH3CN (0.25 mL). The resulting sample was 
immediately subjected to analysis via electrospray ionization mass spectrometry. 
HRMS-electropray (m/z): [M–Cl]+ calcd for C31H33ClF3N2Pd, 631.1319; Found, 
631.1312.  


































MALDI-TOF (IIN). Complex 4 (4.5 mg, 0.0076 mmol, 1 equiv) was dissolved in 
CH3CN (0.35 mL). This solution was added to a solution of C6H5ICl2 (2.1 mg, 
0.0076 mmol, 1 equiv) in CH3CN (0.25 mL). The resulting sample was 
immediately subjected to analysis via MALDI-TOF MS with dithranol as the 
matrix. MS (MALDI-TOF, IIN): 666.1 [M+H]+. 
 
NMR characterization – general information: In each case, the spectrum is 
shown below the characterization data.  Notably, in all cases, 8 was observed as 
a mixture with C–H activation product 5-Cl. Where relevant, accompanying text 
and/or figures are included to highlight important conclusions from each 
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experiment. 
19F NMR spectrum of 8 (CD3CN, 25 ºC): δ 19F NMR (CDCl3): δ –19.08 (s, 
3F), –20.34 (s, 3F). This spectrum shows the presence of a mixture of 
intermediate 8 and product 5-Cl. No starting material (–20.00  ppm) is observed. 





   
 Data Collected on:
   Te-vnmrs500
 Archive directory:
   
 Sample directory:
   
 FidFile: JMRXIII-36.002FNMR
Pulse Sequence: FLUORINE (s2pul)
Solvent: cd3cn
Data collected on: Jul  6 2011
 Temp. -20.0 C / 253.2 K
Operator: racowski
 Relax. delay 1.000 sec
 Pulse 30.0 degrees
 Acq. time 0.629 sec
 Width 208.3 kHz
 16 repetitions
OBSERVE  F19, 470.5563688 MHz
DATA PROCESSING
 Line broadening 1.5 Hz
FT size 262144
Total time 0 min 29 sec
3.05
1.00
   
 




1H NMR spectrum of 8 (CD3CN, 25 ºC): δ 9.00 (d, J = 6 Hz, 1H), 8.66 (d, J = 7 
Hz, 1H), 8.00 (d, J = 9 Hz, 1H), 7.94-7.92 (overlapping peaks with complex 5-Cl, 
2H), 7.67-7.65 (multiple peaks, 2H), 7.11 (t, J = 7 Hz, 1H), 7.07-7.01 (overlapping 
peaks with complex 5-Cl, 1H), 6.93 (t, J = 8 Hz, 1H), 6.56 (multiple peaks, 2H), 
6.43 (d, J = 8 Hz, 1H), 6.22 (d, J = 7 Hz, 1H), 6.14 (d, J = 8 Hz, 1H), 1.46 (app s, 
two overlapping signals, 18H). 
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   Sn.Chem.LSA.UMich.edu-inova500
 Archive directory:
   
 Sample directory:
   
 FidFile: JMRXIII-52.001
Pulse Sequence: PROTON (s2pul)
Solvent: cd3cn
Data collected on: Jul 18 2011
Operator: racowski
 Relax. delay 0.500 sec
 Pulse 45.0 degrees
 Acq. time 3.500 sec
 Width 7998.4 Hz
 16 repetitions
OBSERVE   H1, 499.9068982 MHz
DATA PROCESSING
 Line broadening 0.3 Hz
FT size 65536



























   
 Data Collected on:
   Sn.Chem.LSA.UMich.edu-inova500
 Archive directory:
   
 Sample directory:
   
 FidFile: JMRXIII-52.001
Pulse Sequence: PROTON (s2pul)
Solvent: cd3cn
Data collected on: Jul 18 2011
Operator: racowski
 Relax. delay 0.500 sec
 Pulse 45.0 degrees
 Acq. time 3.500 sec
 Width 7998.4 Hz
 16 repetitions
OBSERVE   H1, 499.9069073 MHz
DATA PROCESSING
 Line broadening 0.3 Hz
FT size 65536

























Complex 8-d5 was synthesized via an analogous procedure to 8, but with 4-d5 as 
starting material. This experiment confirmed the assignment of the intact phenyl 
ring resonances, since the peaks at 6.14, 6.22, 6.56 (two overlapping peaks) and 
6.93 are not observed.  



















(4-d5) (8-d5) (5-Cl-d4)  
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 Data Collected on:
   Sn.Chem.LSA.UMich.edu-inova500
 Archive directory:
   
 Sample directory:
   
 FidFile: JMRXIII-52.001
Pulse Sequence: PROTON (s2pul)
Solvent: cd3cn
Data collected on: Jul 18 2011
Operator: racowski
 Relax. delay 0.500 sec
 Pulse 45.0 degrees
 Acq. time 3.500 sec
 Width 7998.4 Hz
 16 repetitions
OBSERVE   H1, 499.9069073 MHz
DATA PROCESSING
 Line broadening 0.3 Hz
FT size 65536
Total time 1 min 12 sec

















   
 Data Collected on:
   Yb-vnmrs700
 Archive directory:
   
 Sample directory:
   
 FidFile: JMRXIII-81.001
Pulse Sequence: PROTON (s2pul)
Solvent: cd3cn
Data collected on: Aug  1 2011
Operator: racowski
 Relax. delay 0.500 sec
 Pulse 45.0 degrees
 Acq. time 3.500 sec
 Width 11261.3 Hz
 16 repetitions
OBSERVE   H1, 699.7603841 MHz
DATA PROCESSING
 Line broadening 0.3 Hz
FT size 131072
Total time 1 min 12 sec













1H-1H COSY (CD3CN, –15 ºC). This experiment allows assignment of 5 
resonances [at 6.14, 6.22, 6.56 (two overlapping peaks) and 6.93] as belonging 
to the intact phenyl ring of 8.  










 Relax. delay 1.000 sec
 Mixing 0.080 sec
 Acq. time 0.150 sec
 Width    11261.3 Hz
 2D Width 11261.3 Hz
 8 repetitions
 256 increments
OBSERVE   H1, 699.7604179 DATA PROCESSING
 Sq. sine bell 0.075 sec
F1 DATA PROCESSING
 Sq. sine bell 0.023 sec
FT size 4096 x 4096















Diffusion NMR (DOSY gradient compensated stimulated echo with spin lock and 
convection compensation) (CD3CN, –15 ºC). Plot below shows chemical shift 
(ppm) versus diffusion coefficient, D, (m2/s x 10–10). All of the aromatic peaks for 
both 8 and 5-Cl have very similar diffusion coefficients (D) between 7.0 and 8.0 x 
10–10 m2/s. This indicates that 8 and 5-Cl have similar hydrodynamic radii, which 


















Figure 4.4.8.8 Diffusion NMR of 8 and 5-Cl 
JMRXIII-78.dosytrial
Solvent: cd3cn





 Relax. delay 1.000 sec
 Pulse 90.0 degrees
 Acq. time 0.150 sec
 Width 5020.1 Hz
 16 repetitions
OBSERVE   H1, 699.7603847 DATA PROCESSING
 Gauss apodization 0.069 sec
FT size 4096













13C-19F HMBC (CD3CN, –30 ºC). This heteronuclear HMBC shows two cross-
peaks for complex 5-Cl, demonstrating correlations between the fluorines of the 
CF3 ligand and the two α-carbons of the cyclometalated ligand. In contrast, the 
analogous data for 8 show a single cross-peak, indicating that only one C of the 
σ-aryl ligand is bound to the metal. Additionally, a one bond correlation is seen 
between fluorine and the carbon of the CF3 group for both 8 and 5-Cl.  









 Relax. delay 1.000 sec
 Acq. time 0.144 sec
 Width    14204.5 Hz
 2D Width 15088.6 Hz
 8 repetitions
 2 x 256 increments
OBSERVE  F19, 470.5599334 DATA PROCESSING
 Sq. sine bell 0.072 sec
F1 DATA PROCESSING
 Gauss apodization 0.016 sec
FT size 4096 x 4096


















Stereochemistry of 8. Possible isomers of intermediate 8 are shown below. 
Complexes 8-a, 8-b, and 8-c are stereoisomers, while 8-b/8-b-rot and 8-c/8-c-rot 
are rotamers. Complexes 8-c/8-c-rot are highly unlikely, because they place the 
strongly donating σ-aryl and CF3 ligands trans to one another, which is typically 
strongly disfavored in PdIV complexes. 1H-1H ROESY and NOESY NMR 
experiments were conducted but did not show strong enough cross-peaks to 
definitively distinguish between 8-a and 8-b.  



































Two pieces of evidence lead me to favor isomer 8-b over isomer 8-a. First, 
the 1H NMR resonances for the non-cyclometalated ring are significantly shielded 
[appearing at 6.14, 6.22, 6.56 (two overlapping peaks) and 6.93]. This is 
consistent with an interaction of the protons on this ring with a pi-system in a 
structure like 8-b (see below, the aromatic ring is sitting below the dtbpy ligand). 
However, NOESY/ROESY NMR experiments did not provide strong enough nOe 
data to definitively confirm this assignment. 







protons on this 
ring shielded due 
to interaction with 
dtbpy pi-system  
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In addition, the stereochemistry of cyclometalation appears consistent with 
isomer 8-b. As discussed in detail above, at t=0 (25 ºC), complex 8 was formed 
as an ~1:1 mixture with 5-Cl. We believe that the initially formed 5-Cl is 
generated by a different pathway – ie, not from 8. With 4-d5 as the starting 
material, the initially formed 5-Cl-d4 was exclusively isomer I. Isomer II appeared 
only as 8-d5 decayed, suggesting that C–H activation at complex 8-d5 produces 
isomer II. The final ratio of 5-Cl-d4-I : 5-Cl-d4-II after 6 h at 25 ºC was ~1 : 1. The 
result suggests that 8 converts selectively to 5-Cl-d4-II, which is most consistent 
with isomer 8-b.  
Notably, isomerization of the initially formed 5-Cl-d4-I as the pathway to 5-
Cl-d4-II cannot be ruled out; however, I believe that this is unlikely. For example, 
the related unsymmetrical product 13-OTf (vide infra) does not isomerize under 























formed at t=0; ~50% yield
exclusively isomer I
C6D5ICl2






















(final mixture = ~1 : 1)
(initial mixture = ~1:1 ratio)
(4-d5)
(8-d5)















4.4.9 Procedures and Characterization of the Reactions of 4 with Oxidants 
 


















Complex 5-OTf. Complex 4 (137 mg, 0.23 mmol, 1.0 equiv) and NFTPT (66.5 
mg, 0.23 mmol, 1.0 equiv) were combined in MeCN (30 mL), and this mixture 
was stirred for 15 min. The solvent was removed by rotary evaporation, and the 
resulting yellow solids were dissolved in CH2Cl2 (20 mL). This solution was 
extracted with H2O (3 x 30 mL). The organic layer was separated and dried over 
MgSO4. The reaction was concentrated by rotary evaporation, and the remaining 
solid residue was washed with diethyl ether (2 x 40 mL). The solid material was 
then dissolved in CH2Cl2 (2 mL), and diethyl ether (10 mL) was added to 
precipitate the product. The precipitate was collected and dried under vacuum to 
afford 5-OTf as a light yellow solid (147 mg, 86% yield). 1H NMR (CD3CN): δ 
9.19 (d, J = 5 Hz, 1H), 8.55 (s, 1H), 8.41 (s, 1H), 8.03 (d, J = 6 Hz, 1H), 7.92 (d, J 
= 8 Hz, 1H), 7.75 (d, J = 8 Hz, 1H), 7.59-7.57 (multiple peaks, 2H), 7.51-7.45 
 222 
(multiple peaks, 2H), 7.30 (t, J = 8 Hz, 1H), 7.15 (t, J = 6 Hz, 1H), 6.76 (t, J = 8 
Hz, 1H), 6.38 (d, J = 8 Hz, 1H), 1.56 (s, 9H), 1.36 (s, 9H). 19F NMR (CD3CN): δ –
23.37 (s, 3F), –79.34 (s, 3F). 13C NMR (CD3CN): δ 170.00 (q, J = 5 Hz), 167.09, 
167.06, 163.01 (q, J = 5 Hz), 154.36, 153.59, 150.43  (q, J = 5 Hz), 148.58, 
148.18, 147.41, 131.52, 129.64, 129.36, 128.82, 128.47, 127.99, 125.60, 124.62, 
124.08, 123.86 (q, J = 365 Hz), 122.71, 122.43, 121.40 (CF3 for triflate; identified 
by 19F-13C HSQC, as resonance was in signal to noise), 36.42, 36.27, 30.07, 










Complex 5-TFA. Complex 4 (60 mg, 0.080 mmol, 1 equiv) and PhI(O2CCF3)2 
(25 mg, 0.080, 1.0 equiv) were combined in MeCN (15 mL), and this mixture was 
stirred for 15 min. The reaction mixture was filtered through a plug of Celite, and 
the Celite was washed with MeCN (5 mL). The solvent was removed by rotary 
evaporation. The resulting solids were then dissolved in CH2Cl2 (3 mL), and 
pentane (15 mL) was added to precipitate the product. The precipitate was 
collected and dried under vacuum to afford 5-TFA as a light yellow solid (41 mg, 
73% yield). 1H NMR (CD3CN): δ 9.32 (d, J = 5 Hz, 1H), 8.45 (s, 1H), 8.32 (s, 1H), 
7.97-7.92 (multiple peaks, 2H), 7.69 (d, J = 8 Hz, 1H), 7.57-7.53 (multiple peaks, 
2H), 7.42 (t, J = 7 Hz, 1H), 7.37 (d, J = 6 Hz, 1H), 7.26 (t, J = 8 Hz, 1H), 7.09 (t, J 
= 6 Hz, 1H), 6.71 (t, J = 8 Hz, 1H), 6.36 (d, J = 8 Hz, 1H), 1.53 (s, 9H), 1.32 (s, 
9H). 19F NMR (CD3CN): δ –26.15 (s, 3F), –75.80 (s, 3F). 13C NMR (CD2Cl2): δ 
169.96 (q, J = 6 Hz), 165.43, 165.36, 162.18 (q, J = 6 Hz), 160.91 (q, J = 35 Hz), 
154.54, 153.95, 151.73 (q, J = 6 Hz), 148.81, 148.15, 148.03, 130.85, 129.92, 
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128.61, 127.74, 127.68, 126.79, 125.07, 124.76, 123.33, 123.25 (q, J = 366 Hz), 
123.08, 120.01, 119.97, 117.14 (q, J = 293 Hz), 36.15, 35.98, 30.67, 30.44. IR 
(thin film): n 2968.9, 1690.3, 1411.9, 1195.6, 1090.9, 1017.9, 745.7, 606.1 cm–1. 
HRMS-electrospray (m/z): [M–O2CCF3]+ calcd for C33H32F6N2O2Pd, 595.1552; 
Found, 595.1563. 
4.4.10 Characterization of 10 
 
Scheme 4.4.10.1 Reaction of 9 with PhI(Cl)2 
 
PdII CF3











Complex 10. Complex 9 (25 mg, 0.4 mmol, 1.0 equiv) and PhICl2 (11 mg, 0.04 
mmol, 1.0 equiv) were combined in MeCN (5 mL), and the resulting solution was 
stirred for 10 min at rt. The solvent was removed under vacuum, the yellow 
residue was dissolved in CH2Cl2 (1 mL), and the product was precipitated with 
hexanes (10 mL). The precipitate was collected and dried under vacuum to afford 
10 as a light yellow solid (25 mg, 95% yield). 1H NMR (CD3CN): δ 9.14 (d, J = 6 
Hz, 1H), 8.62 (s, 1H), 8.53 (s, 1H), 8.32 (d, J = 8 Hz, 1H), 8.06-8.00 (multiple 
peaks, 2H), 7.97 (d, J = 6 Hz, 1H), 7.80-7.75 (multiple peaks, 3H), 7.62-7.59 
(multiple peaks, 3H), 7.54 (d, J = 6 Hz, 1H), 1.55 (s, 9H), 1.42 (s, 9H).  19F NMR 
(CD3CN): δ –21.05 (s, 3F). 13C NMR (CDCl3): δ 213.26, 173.84, 167.12, 166.91, 
153.64, 153.42, 149.67, 148.18, 142.11, 141.09, 138.91, 136.11, 133.13, 132.57, 
130.66, 129.68, 129.48, 128.40, 126.11, 125.03, 125.33 (q, J = 371 Hz), 122.33, 
122.02, 119.60, 35.99 (2 overlapping C’s), 30.23, 30.14. IR (thin film): ν 2963.2, 
1666.2, 1612.4, 1484.0, 1413.3, 1336.9, 1058.1, 1013.9, 849.5, 732.1, 604.5 cm–
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1. HRMS-electrospray (m/z): [M+H]+ C32H32F3N2OClPd, 659.1263; Found, 
659.1273. 
4.4.11 Procedures and Characterization data for 12-OTf/13-OTf and 12-
Cl/13-Cl 
 























Complexes 12-OTf/13-OTf. Complex 11 (162 mg, 0.29 mmol, 1.0 equiv) and 
NFTPT (83.8 mg, 0.29 mmol, 1.0 equiv) were combined in MeCN (30 mL), and 
this mixture was stirred for 15 min at rt. The solvent was removed by rotary 
evaporation, and the resulting yellow solids were dissolved in CH2Cl2 (20 mL). 
This solution was extracted with H2O (3 x 30 mL). The organic layer was 
separated and dried over MgSO4. The reaction was concentrated by rotary 
evaporation, and the remaining solid residue was washed with diethyl ether (2 x 
40 mL). The solid material was then dissolved in CH2Cl2 (2 mL), and diethyl ether 
(10 mL) was added to precipitate the product. A mixture of complexes 12-OTf 
and 13-OTf was obtained in a 1.7 : 1 ratio as a pale yellow solid (135 mg, 64% 






























Compounds 12-Cl/13-Cl. The mixture of isomers 12-OTf and 13-OTf (20 mg, 
0.026 mmol) was dissolved in CH2Cl2 (10 mL). This solution was extracted with a 
saturated aqueous solution of NaCl (10 mL). The organic layer was separated, 
dried over MgSO4, and concentrated under vacuum to afford an inseparable 
mixture of 12-Cl and 13-Cl as a pale yellow solid (16 mg, 93% yield). Complex 
12-Cl was synthesized independently as described below. 
 
NMR characterization and structural assignment of 12-OTf/13-OTf and 12-
Cl/13-Cl. A series of 2D NMR experiments (1H-1H COSY, 1H-13C HSQC, 19F-13C 
HSQC, 1H-13C HMBC and 19F-1H HOESY were conducted to completely 
characterize the mixtures of isomers 12/13. The major isomers 12-OTf and 12-Cl 
were synthesized and analyzed independently (vide infra). Complexes 13-OTf 
and 13-Cl (the minor regioisomers) were characterized as part of a mixture with 
12-OTf or 12-Cl, respectively. The most diagnostic resonances for 13-OTf and 
13-Cl were those corresponding to H23, H24 and H25. 19F-13C HSQC correlation 
was used to determine the 13C NMR shift for the CF3 peak of the minor isomers 
13-OTf and 13-Cl and for the triflate CF3 peak for 12-OTf and 13-OTf. 19F-1H 
HOESY was used to establish the geometry about the octahedral Pd center in 
12-Cl/13-Cl. This information was extrapolated to 12-OTf/13-OTf. This 
experiment showed a correlation between the fluorines of the CF3 ligand and H1, 
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consistent with the geometry shown. Based on the X-ray structure of 12-Cl, this 
proton is 3.157 Å from the closest fluorine.  
Scheme 4.4.11.3 Depiction of F-H Correlation Observed in 19F-1H HOESY 





















Independent synthesis of 12-Cl. Compound 11 (75 mg, 0.12 mmol, 1.0 equiv) 
and PhICl2 (33 mg, 0.12, 1.0 equiv) were combined in MeCN (20 mL), and this 
mixture was stirred for 10 min. The solvent was removed by rotary evaporation. 
The resulting solids were then dissolved in CH2Cl2 (2 mL), and hexanes (10 mL) 
was added to precipitate the product. The precipitate was collected and dried 
under vacuum to afford 12-Cl as a light yellow solid (61 mg, 77% yield, single 
isomer detected by 1H NMR spectroscopy). 1H NMR (CD2Cl2): δ 9.22 (H1, d, J = 
6 Hz, 1H), 8.24 (H16, d, J = 8 Hz, 1H), 8.21 (H6, s, 1H), 8.07 (H9, s, 1H), 7.79 
(H2, d, J = 6 Hz, 1H), 7.63 (H13, d, J = 6 Hz, 1H), 7.39 (H20, s, 1H), 7.30 (H23, 
s, 1H), 7.23 (H14, d, J = 6 Hz, 1H), 6.97 (H17, d, J = 9 Hz, 1H), 6.49 (H26, d, J = 
9 Hz, 1H), 6.32 (H27, d, J = 8 Hz, 1H), 2.43 (H25, s, 3H), 2.22 (H19, s, 3H), 1.49 
(H12, s, 9H), 1.30 (H5, s, 9H). 19F NMR (CD2Cl2): δ –20.97. 13C NMR (CD2Cl2): δ 
165.40 (C15), 164.50 (C10), 164.40 (C3), 163.48 (C28), 153.39 (C8), 153.11 
(C7), 150.73 (C1), 147.58 (C21), 147.63 (C14), 147.38 (C22), 135.30 (C24), 
133.77 (C16), 129.20 (C27), 128.81 (C17), 127.94 (C26), 125.52 (C2), 125.07 
(C18), 124.65 (C13), 123.56 (C20), 123.45 (C23), 122.78 (CF3) (q, J = 364 Hz), 
(120.23 (C6), 120.15 (C9), 35.49 (C4), 35.01 (C11), 30.39 (C12), 30.31 (C5), 
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21.25 (C25), 21.06 (C19). HRMS-electrospray (m/z): [M–Cl]+ calcd for 
C33H36ClF3N2Pd, 623.1860; Found, 623.1871. 
 




















































Independent synthesis of 12-OTf. Complex 12-Cl (30 mg, 0.045 mmol, 1 
equiv) and AgOTf (12 mg, 0.047 mmol, 1.05 equiv) were dissolved in MeCN (6 
mL), and the resulting suspension was stirred for 15 min at rt. The reaction 
mixture was filtered through a plug of Celite, and the filtrate was concentrated 
under vacuum. The resulting yellow residue was dissolved in CH2Cl2 (6 mL), and 
this solution was extracted with water (2 x 20 mL). The organic extracts were 
separated, dried over MgSO4, and concentrated to ~1 mL. Pentane was added to 
precipitate the product. The precipitate was collected and dried under vacuum to 
afford 12-OTf was obtained as a light yellow solid (32 mg, 92% yield). 1H NMR 
(CD3CN): δ 9.15 (H1, d, J = 6 Hz, 1H), 8.53 (H6, s, 1H), 8.38 (H6, s, 1H), 8.00 
(H2, d, J = 6 Hz, 1H), 7.75 (H16, d, J = 7 Hz, 1H), 7.59 (H20, s, 1H), 7.57 (H14, 
d, J = 7 Hz, 1H), 7.45 (H13, d, J = 6 Hz, 1H), 7.43 (H23, s, 1H), 7.09 (H17, d, J = 
7 Hz, 1H), 6.54 (H26, d, J = 8 Hz, 1H), 6.21 (H27, d, J = 8 Hz, 1H), 2.49 (H19, s, 
3H), 2.25 (H25, s, 3H), 1.55 (H5, s, 9H), 1.37 (H12, s, 9H). 19F NMR (CD3CN): δ 
–23.37 (s, 3F), –79.34 (s, 3F). 13C NMR (CD3CN): δ 167.04 (C3), 166.94 (C10), 
166.88 (C15), 159.83 (C28), 153.46 (C7), 153.18 (C8), 150.53 (C1), 148.19 
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(C22), 148.13 (C14), 147.02 (C21), 138.38 (C18), 137.86 (C24), 130.99 (C16), 
129.62 (C17), 129.28 (C27), 129.19 (C26), 126.47 (C2), 125.41 (C13), 125.40 
(C20), 124.65 (C23), 123.68 (CF3) (q, J = 364 Hz), 122.60 (C6), 122.47 (C9), 
120.90 (CF3 for triflate determined by HSQC (19F/13C)), 36.42 (C11), 36.30 (C4), 
30.11 (C5), 29.87 (C12), 20.80 (C19), 20.34 (C25). HRMS-electrospray (m/z): 
[M–OTf]+ C32H32F6N2O3SPd, 623.1880; Found, 623.1876. 



















































Characterization data for 13-OTf. Full spectral data for compound 13-OTf were 
not obtained due to the inability to resolve all of the peaks from 12-OTf. 
Importantly, the peaks that were well-resolved correspond to H23-25, which 
clearly show a triplet for H24 and a COSY relationship. Further characterization 
was achieved by converting this mixture to a mixture of 12-Cl and 13-Cl (for 
which all of the 1H and 13C NMR resonances were well-resolved and could be 
assigned by 2D NMR). 1H NMR (CD3CN): δ 9.19 (H1, d, J = 6 Hz, 1H), 8.00 (H6, 
s, 1H), 7.50 (H23, d, J = 7 Hz, 1H), 7.22 (H24, t, J = 7 Hz, 1H), 6.95 (H25, d, J = 
7 Hz, 1H), 2.33 (s, 1H). 19F NMR (CD3CN): δ –22.91 (s, 3F), –79.36 (s, 3F). 13C 
NMR (CD3CN): δ 150.58 (C1), 132.18 (C25), 128.27 (C24), 125.20 (C20), 124.20 
(C23), 124.01 (CF3), 122.44 (C3), 121.84 (C9), 120.90 (CF3 of triflate). HRMS-
electrospray (m/z): [M–OTf]+ C32H32F6N2O3SPd, 623.1880; Found, 623.1865. 
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Characterization data for 13-Cl. 1H NMR (CD2Cl2): δ 9.28 (H1, d, J = 6 Hz, 1H), 
8.36 (H16, d, J = 8 Hz, 1H), 8.16 (H6, s, 1H), 8.06 (H9, s, 1H), 7.71 (H2, d, J = 6 
Hz, 1H), 7.66 (H13, d, J = 6 Hz, 1H), 7.43 (H20, s, 1H), 7.37 (H23, d, J = 6 Hz, 
1H), 7.22 (H14, d, J = 6 Hz, 1H), 6.95 (H17, t, J = 8 Hz, 1H), 6.55 (H25, d, J = 8 
Hz, 1H), 6.90 (H24, d, J = 8 Hz, 1H), 2.42 (H27, s, 3H), 2.22 (H19, s, 3H), 1.50 
(H12, s, 9H), 1.30 (H5, s, 9H). 19F NMR (CD2Cl2): δ –19.84. 13C NMR (CD2Cl2): δ 
168.42 (C15), 165.75 (C28), 164.64 (C10), 164.30 (C3), 152.74 (C8), 153.24 
(C7), 151.95 (C1), 148.01 (C22), 147.90 (C14), 147.57 (C21), 136.16 (C18), 
134.67 (C16), 128.40 (C17), 127.61 (C26), 126.40 (C24), 125.84 (C25), 124.62 
(C2), 124.56 (C13), 123.59 (C20), 122.91 (CF3), 120.15 (C6), 120.03 (C23), 
120.01 (C9), 35.56 (C11), 34.84 (C4), 30.37 (C12), 30.40 (C5), 21.26 (C27), 
21.06 (C19). HRMS-electrospray (m/z): [M–Cl]+ calcd for C33H36ClF3N2Pd, 







































































4.4.12 Selectivity of Cyclometalation at 14-F 
 





















A solution of complex 14-I (50 mg, 0.063 mmol, 1 equiv) and AgF (5 
equiv) in benzene (12 mL) was sonicated for 4 h at 25 °C. The reaction mixture 
was filtered through a plug of Celite and the plug was washed with CH2Cl2 (15 
mL). The resulting solution was concentrated by rotary evaporation to ~2 mL, and 
ether/pentane (15 mL) was added to precipitate the product. The precipitate was 
collected and dried under vacuum to afford 15 as a yellow solid (31 mg, 89% 
yield). 1H NMR (CD2Cl2): δ 9.12 (d, J = 6 Hz, 2H), 8.05 (s, 2H), 7.58 (d, J = 6 Hz, 
2H), 7.32 (d, J = 7 Hz, 2H), 7.12 (s, 2H), 6.71 (d, J = 7 Hz, 2H), 2.29 (s, 6H), 1.43 
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(s, 18H). 13C NMR (CDCl3, 52 ºC): δ 163.67, 157.45, 155.48, 150.49, 136.37, 
135.37, 125.92, 122.97, 120.67, 119.31, 117.35, 35.42, 30.23, 21.19. HRMS-
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Chapter 5: Conclusions 
 
5.1 Conclusions and Future Directions 
Over the last two decades, numerous reagents have been utilized to 
oxidize PdII model complexes to PdIV species. Furthermore, a wide variety of 
supporting ligands have been shown to support and stabilize observable PdIV 
adducts. However, in the past, C–C bond-forming reductive elimination was the 
primary decomposition pathway of these systems. This has hampered efforts to 
conduct detailed mechanistic investigations of C–X bond formation at PdIV. In 
contrast, the examples discussed in Chapters 2 and 3 describe PdIV compounds 
that decompose via carbon-heteroatom bond-forming reductive elimination.  
The investigations presented in this thesis along with other recent studies 
in the field have begun to uncover the molecular mechanisms of carbon-
heteroatom bond-forming reductive elimination from PdIV centers. Together these 
studies have begun to address fundamental questions about C–X reductive 
elimination from PdIV, such as the electronic requirements of C–X coupling, the 
effects of ancillary ligands, the influence of solvent and additives, and the relative 
rates of competing transformations. All of these results lend support for the 
potential feasibility of C–X coupling from PdIV in the catalytic oxidation reactions 
presented in Chapter 1. 
The future of this field is bright, as there are still many outstanding 
mechanistic questions to be answered. For instance, now that systems have 
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been identified to investigate sp3-C–X bond-formation from PdIV in high yields 
(Chapter 3), it would be interesting to explore the stereochemical outcome 
(retention vs inversion) and stereospecificity of sp3-C–heteroatom reductive 
elimination from PdIV. These questions are crucial for developing well-controlled 
asymmetric catalytic transformations.  
Furthermore, many organometallic PdIV species that are present during 
catalytic processes contain different heteroatom X-type ligands. Therefore, 
designing approaches to understand what controls the relative rates of different 
C–X reductive elimination reactions is of critical importance to the field.  While an 
initial attempt to address this issue was made in Chapter 3, Scheme 3.4.2, there 
are still many questions to be addressed about competing C–heteroatom bond-
forming processes, such as the effect of solvent, the influence of ligand structure 
and complex geometry, and the role of additives.  
Additionally, studies of C–X reductive elimination from PdIV mono-organo 
complexes are important future targets, since such adducts more closely 
resemble putative catalytic intermediates than most of the complexes discussed 
herein. Efforts in all of these areas are bound to inform the development and 
optimization of novel catalytic transformations. 
Finally, the results presented in Chapter 4 discuss the first example of C–
H activation at a PdIV center. While the initial observation of intramolecular C–H 
at PdIV was very exciting, there are several important questions that arise from 
this result. For example, what is the mechanism and electronic requirements for 
C–H activation at PdIV?  We envision that the question of electronic requirements 
might be addressed by modifying the biphenyl ligand of the PdIV complex (1)  
(Scheme 5.1.1) with various electronically differentiated substituents to study the 
rate of C–H activation to form 2. Also, exploration of the effect of solvent on this 
transformation would be useful. Eyring analysis as well as determining the 
intramolecular kinetic isotope effect should also provide insight into the 
mechanism of C–H activation at PdIV. Additionally, extending the substrate scope 
of C–H activation at PdIV to intermolecular C–H activation, which more closely 
 238 
mimics catalytic processes, would provide valuable information for the 
development of new methodology.  
 
Scheme 5.1.1 Proposed Electronic Modification of 1 to Investigate the Rate 












(1) (2)  
 
Lastly and most excitingly, we believe that Chapter 4 lays the groundwork 
for debunking the assumption that PdIV is only relevant in reductive elimination 
reactions. The work in Chapter 4 represents the first report of an organometallic 
transformation other than bond-forming reductive elimination at PdIV. This result 
serves as motivation to explore other organometallic processes at PdIV, such as 
insertion reactions of π substrates or nucleopalladation of alkenes and alkynes. 
Excitingly, we obtained a very promising preliminary result when we investigated 
insertion reactions of π substrates. Reacting complex 3 in CH2Cl2 with CO for 15 
min resulted in the quantitative conversion of complex 3 to organic product 6. We 
hypothesize that compound 6 is generated via CO insertion at PdIV followed by 
C–C reductive elimination. More specifically, CO first replaces the triflate ligand 
of complex 3 to form intermediate 4. Then, insertion of CO into the sp3-carbon 
bond of complex 3 takes place (5), followed by bond-forming C–C reductive 
elimination to generate the organic product (4).  Notably, PdII complex 7 is 
unreactive for up to 48 h under the analogous conditions. We are optimistic that 
monitoring the reaction by react-IR might provide evidence to substantiate our 
mechanistic hypothesis. Moreover, the result in Scheme 5.1.2 motivates us to 
pursue further study of new organometallic transformations at PdIV. It is our hope 
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that these stoichiometric findings will guide the development of novel, innovative 
catalytic reactions.     
 





















Scheme 5.1.3 PdII Complex (7) not Reactive with CO 
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